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ABSTRACT 
Indigenous plants have long been used by African populations in their cultural lives and health 
care. Sutherlandia frutescens (SF) is a popular traditional medicinal plant found in various parts 
of southern Africa and used for treatment or management of different diseases, including cancer 
and HIV/AIDS. In this study, the biochemical effects of various dilutions (1/50, 1/150, 1/200, 
and 1/300) of SF 70% ethanol (SFE) and deionised water (SFW) extracts in cancerous H9 and 
normal T cells were examined. Untreated, 70% ethanol-treated and camptothecin (CPT, 20jiiM) 
treated cells were used as reference samples for comparison. Cytotoxicity, apoptotic enzymes 
activity, oxidant scavenging and antioxidant promoting abilities, cellular morphology and 
cytokine signalling effects were assessed using the methylthiazol tetrazolium (MTT) assay, 
adenosine triphosphate (ATP) assay, caspase-3/-7 activity assay, thiobarbituric acid reactant 
substance (TBARS) and glutathione (GSH) assays, fluorescence microscopy and an ELISA-
based cytokine analyses assay respectively. 
Sutherlandia frutescens ethanol and water extract dilutions (1/50 and 1/200) were shown to be 
cytotoxic to H9 T cells in a dose- and time-dependent manner with the SFE extract having an 
average IC50 of 1/40 after 24 hours while SFW extract reached a similar IC50 only after 48 hours. 
In normal T cells, the SFE extract induced proliferation after 24 hours but this was reverse after 
48 hours. The SFW extract dilutions did not significantly change cell viability after 24 hours but 
significantly increased cell viability after 48 hours. Both SFE and SFW extracts dilutions 
induced a dose- and time-dependent inhibition of caspase-3/-7 activity in both H9 and normal T 
cells. Both types of extracts were also shown to efficiently remove lipid peroxides from 
supernatants of treated cell lines, with SFW extract having a more lasting effect. In the GSH 
assay, the SFE and SFW extract dilutions reduced GSH levels in H9 T cells, with the SFW 
extract dilutions being more effective. In normal T cells, the higher dilutions (1/150 and 1/300) 
of SFW extract increased GSH levels significantly while lower dilutions (1/50) of both SFE and 
SFW extracts significantly inhibited GSH levels. Lower dilutions (1/50) of SFE and SFW 
extracts induced chromatin condensation in both H9 and normal T cells after 48 hours 
incubation. Using treated peripheral blood mononuclear cells (PBMCs) supernatants, SFE and 
SFW extract dilutions were shown to reduce the levels of pro-inflammatory cytokines IL 1 p and 
TNF-a in a dose-dependent manner. These results further confirmed the anticancer abilities of 
SF and showed that higher concentrations of this medicinal plant can be toxic to normal T cells 
in vitro while lower concentrations can stimulate the immune cells. Therefore further studies 
should be conducted with regards to the effects of SF on the immune system in both in vitro and 
in vivo systems. 
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Traditional medicines and plant-based remedies are widely used in Africa Worldwide the 
trend has also shifted towards the use of traditional medicines due to concerns about the 
costs, invasiveness and potential for toxicity of conventional mainstream remedies 
(Cowan, 1999). Herbal medicines are often used as primary treatment for different types of 
ailments in Africa and in most cases they are the only source of treatment for many people 
(Harnett et al., 2004). Most of these herbal and traditional medicines are not well-
researched, poorly regulated, may contain adulterated products, and may produce adverse 
effects (Mills et al, 2005a). 
Despite the above stated flaws, the use of traditional medicines by Africans is widespread 
and is promoted by Ministries of Health of several African nations, including South Africa 
Two herbal remedies (Hypoxis hemerocallidea and Sutherlandia jrutescens) are currently 
recommended by the South Africa Ministry of Health for management of many ailments 
including cancer and human immunodeficiency virus (HTV) (Mills et al, 2005a) Both of 
these remedies have been shown to significantly affect enzymes (cytochrome P450 
enzymes CYP3A4, CYP17 and CYP21) which are important for antiretroviral metabolism 
and therefore have the potential for drug interactions. Therefore efforts should be made by 
mainstream health professionals to provide validated information to traditional healers and 
patients on the careful use of herbal medicines (Mills et al, 2005b). 
1 
South Africa has a rich diversity of medicinal plants (Bessong et al., 2004). Very few 
studies have been conducted in South Africa to assess the value and efficacy of these 
herbal plants that are commonly used by traditional healers for treatment of different 
sicknesses. Of those that have been conducted, the medicinal plants have been shown to be 
safe and effective in improving the health status of patients and they have warranted 
further research (Tshibangu et al, 2004). Plants are known to be a rich source of secondary 
metabolites. These secondary metabolites have been shown to have in vitro antimicrobial 
and antiviral activity. Twenty five to 50% of all current pharmaceutical products are 
derived from plants (Cowan, 1999). 
Sutherlandia frutescens (SF), a member of the Fabaceae family, is a traditional herb 
widely used by South Africans to treat a variety of ailments including gastrointestinal 
problems, tuberculosis, diabetes, rheumatoid arthritis, osteoarthritis, HIV and internal 
cancers (Mills et al, 2005a). The recommended therapeutic dose of SF in humans is 9 mg 
per kg body weight per day (Seier et al., 2002). It is regarded as the most profound and 
multi-purpose of the medicinal plants in Southern Africa, Sutherlandia frutescens is known 
for its efficacy and safety for use in many different health conditions. The Sutherlandia 
plant grows mostly in the dry, stony grassland regions of Southern Africa, especially in the 
Cape and some parts of KwaZulu Natal (Figure 1.1). 
2 
Figure 1.1: Geographical distribution of SF plant in South Africa. The plant mainly 
grows in the Cape region but it has also been shown to grow in other dry parts of the 
country like the midlands of KwaZulu Natal and the Free State 
(http://www.sahealthinfo.org/traditionalmeds/monographs/sutheiiandia.htm). 
Sutherlandia frutescens is mainly used as an immunotonic and a supplement which assists 
the body in mobilizing its own immune response to fight infections and cope with mental 
stress. It therefore acts as an adaptogenic tonic. An adaptogen refers to herbs that maintain 
health by increasing the body's ability to adapt to environmental and internal stress. They 
generally work by strengthening the immune system, nervous system and/or glandular 
systems (http://www.sutherlandia.org). 
Strengthening of the immune response is very important in debilitating conditions such as 
cancer and HIV and acquired immune deficiency syndrome (AIDS). The immune system 
is responsible for the complex task of providing defence against a vast array of potential 
3 
pathogens, whilst ensuring that the same protective mechanisms are not turned against self. 
When their function is complete, the immune cells must be removed leaving only a small 
population of memory cells. Apoptotic mechanisms play an important role in the 
development, regulation and functioning of immune cells. Malfunctioning of apoptosis can 
cause autoimmune disease, immunodeficiencies, and lymphomas (Lowe and Lin, 2000). 
Many studies have been undertaken to study the effects of this traditional herbal remedy on 
cancerous cell lines. To date, no study on the effects of SF extracts on the H9 T cell line as 
compared to normal T lymphocytes has been done. T lymphocytes are important immune 
cells involved in specific immune response. They are important in recognition and 
elimination of infected cells and are also involved in the removal of tumour cells. H9 cells 
are transformed cutaneous T lymphocytes which were clonally derived from a HUT 78 cell 
line. This cell line was acquired from a patient suffering from Sezary syndrome, a type of 
lymphoma In this study tablets of SF from PhytoNova were used to determine their effects 
on these T cell lines. The tablets were made up of a mixture of different parts of the plant 
(stem, leaves, and fruits) which have all been shown to contain active ingredients. The 
aims of this study were: 
> To determine the cytotoxicity of SF extracts in cultured H9 T-cells and isolated 
normal T cells. 
> To determine apoptotic effects of SF extracts in cultured H9 T-cells and isolated 
normal T cells. 
> To determine the morphological and nuclear effects of SF extracts in cultured H9 
T-cells and isolated normal T cells. 
> To determine the effects of SF on cytokine secretion in treated peripheral blood 




2.1 Sutherlandia frutescens 
Sutherlandia frutescens (SF) (Insizwa/Unwele in Zulu, or Cancer bush) is a well known 
and widely used traditional medicinal plant in South Africa (Sia, 2004). Sutherlandia 
frutescens is regarded as the most profound and multi-purpose of all the medicinal plants in 
Southern Africa. Despite it broad spectrums of applications, not enough reports have been 
published about the efficacy of this plant in fighting diseases (Mills et al, 2005a). 
Sutherlandia frutescens is a member of the Fabaceae family of pea and bean or pod-
bearing plants. This family forms the second largest flowering plant family. The genus SF 
is closely related to Lessertia and some botanists consider them to form one genus. The 
Lessertia genus, which includes SF, is made up of approximately ±60 species in Africa and 
most of these are found in southern Africa. Sutherlandia frutescens has other closely 
related species that are often confused with it. These are Sutherlandia montana (mountain 
cancer bush), Sutherlandia microphylla (bitterblaar), and Sutherlandia tomentosa (eendjies 
or rooikeurtjie) (Xaba and Notten, 2003). 
Sutherlandia frutescens is widely distributed throughout the dry parts of southern Africa, 
in the Western Cape and up the west coast towards Namibia and into Botswana It is also 
found in arid regions of northern KwaZulu Natal (Xaba and Notten, 2003 and Goldblatt 
and Manning, 2000). Sutherlandia frutescens is a so-called pioneer plant in that it is able to 
become established in an environment where other plants do not thrive (Parceval 
5 
2.1.2 Preparation of Sutherlandiafrutescens for medicinal use 
Traditional healers usually prepare decoctions of SF according to the type of ailment 
pointed out by the patient. The preparation ranges from using each part of the plant alone 
(leaves, flowers, stems and roots) to using mixtures of these parts. Commercial 
preparations of SF have circumvented the need for preparing a mixture of the plant 
material with all the plants parts known to have active ingredients. These commercial 
preparations come in different forms ranging from tablets, powdered material used as a tea 
preparation, liquid extract preparations to gels for topical application. 
2.13 Active constituents of Sutherlandiafrutescens 
Analyses of SF extracts have identified bioactive compounds which include L-canavanine, 
pinitol, GABA flavanoids and unique triterpenoid glucosides (tentatively called SU1). The 
plant also contains amino acids like L-arginine, small amount of saponins but no alkaloids 
(van Wyk et al., 1997). Gas chromatography/mass spectrometer profiling of tablet extracts 
of SF identified the presence of methyl paraben, propyl paraben, hexadecanoic acid, 
gamma sitosterol, and stigmast-4-en-3-one and other long chain alcohols. These were 
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Figure 2.2: Liquid chromatographic/mass spectrometer (LC/MS) atmospheric 
pressure chemical ionisation (APCI) analysis chromatogram of amino acids in SF. 
GABA had a retention time of 4.16 minutes, canavanine- 8.40 minutes and arginine-
10.95 minutes (Tai et al, 2004). 
2.13.1 L-canavanine 
L-canavanine is a non-protein amino acid that is the L-2-amino-guanidinooxy structural 
analogue of L-arginine (Figure 2.3 A). It is found in many leguminous plants and appears 
to play an important role in chemical defence of the plant. There is about 3 mg per dried 
gram of leaf material of SF (Tai et al, 2004). L-canavanine has been shown to be toxic 
against microorganisms including retroviruses (including HTV), influenza, bacteria and 
yeast and also causes growth retardation in plant cells (Jang et al., 2002; Green, 1988). 
Several studies have demonstrated the anti-proliferative effects of L-canavanine on tumour 
cells in culture. When Jurkat T cells were treated with L-canavanine for 36 hours, 
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apoptotic cell death accompanying several biochemical events such as caspase-3 
activation, degradation of poly (ADP-ribose) polymerase (PARP), and apoptotic 
deoxyribonucleic acid (DNA) fragmentation were induced in a dose-dependent manner 
(Jang et al., 2002). A possible mechanism underlying the anti-tumour activity of L-
canavanine is thought to be the incorporation of this compound into cellular proteins 
instead of L-arginine, and consequent formation of structurally aberrant proteins with 
impaired function. In vivo, the anti-proliferative effects of L-canavanine can result from its 
conversion to the arginase-mediated metabolite, L-canaline, which can disrupt biochemical 
pathways involving L-ornithine and the polyamines (Bence et al., 2002). L-canavanine has 
also been shown to selectively inhibit inducible nitric oxide synthase and therefore can be 
used in the treatment of septic shock and chronic inflammation (Suzuki et al., 2002). 
2.1.3.2 L-arginine 
L-arginine is a basic amino acid and because of structural similarity to L-canavanine 
(Figure 2.3 B), acts as antagonist to the anti-proliferative effects of this compound. There 
are approximately 3 mg per dried gram of leaves of L-arginine in SF (Tai et al., 2004). L-
arginine is particularly rich in nitrogen and is involved in a number of bodily functions. L-
arginine is a precursor of nitrogen oxide which is required for the regulation of blood 
vessels and circulation and for the transmission of nerve impulses in neurons. It is also 
involved in the release of growth hormones from the pituitary gland, of insulin from the 
pancreas and noradrenalin from the adrenal gland (Parceval pharmaceuticals). 
L-arginine has also important immune system functions. It is known to improve cellular 
immune responses, contributes to T lymphocyte formation and minimise their malfunction 
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and stimulates phagocytosis. L-arginine is also involved in the urea cycle which rids the 
















Figure 2.3: Structural similarities between canavanine (A) and arginine (B) make 
these compounds act as antagonist to each other (http//www.sutherlandia.org; 
www.chemistry.about.com/library/graphics/blargin.htm). 
2.1.3.3 D-pinitol 
D-3,0-methyl chiro inositol (D-pinitol) (Figure 2.4) is a glycan sugar found in many types 
of leguminous plants and is classified as a chiro-inositol. D-pinitol acts as a second 
messenger in a number of different metabolic processes including blood sugar metabolism 
(Lernar, 2002). Pinitol has also been described as being active against acute oedema in rat 
models (Ojewole, 2004). It is also thought to reduce the production of pro-inflammatory 
cytokines such as tumour necrosis factor (TNF)-a and interleukin (IL)-P (Tai et ai, 2004). 
It also has a positive effect in improving the ability of the muscles to store carbohydrates, 
allowing muscles to use growth whilst permitting burning of fat. This ability to increase 
muscle mass has strong applications to the treatment of wasting syndrome in cancer, 
HIV/AIDS and tuberculosis (TB) (http//www.sutherlandia.com/pinitol_frame/htm). 
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Figure 2.4: Structure of D-pinitol (Davis etal., 2000). 
2.1.3.4 Y Amino Butyric Acid (GABA) 
Gamma amino butyric acid (GABA) is both an amino acid and an inhibitory 
neurotransmitter. There is about 0.4 mg per dried gram of leaves material in SF (Tai et al., 
2004). As an inhibitory neurotransmitter, GABA along with vitamin B3 and inositol, acts 
outside the central nervous system to prevent anxiety and stress-related messages from 
reaching the motor centres of the brain. It has been used in the treatment of depression, 
manic depressive (bipolar) disorder and seizures 
(http//www.sutherlandia.com/GABA_frame/htm). GABA is supposed to have an anti-
proliferative effect on tumour cells by inhibiting cell metastasis (Ortega, 2003). GABA, if 
present in a patient's circulation at sufficiently high levels, may potentially contribute to 
the improvement in mood and wellbeing experienced by many patients (Tai et al., 2004). 
2.1.3.5 Novel triterpenoid glucosides 
Novel triterpenoid glucosides have been isolated and characterized in SF extracts, and are 
one of the key compounds used in the selection of raw material for propagation. These 
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compounds have promising biological activities, but this is still the subject of ongoing 
research (http://www.sutherlandia.org/chemistry.html). Moshe (1998) found a complex 
pattern of triterpenes in different species of SF, with limited variation within populations 
but large differences between populations. The major triterpene in commercial SF material 
is a cycloartane-type triterpene glycoside called SUl. Its structure has been determined as 
(24ft)-25-_- d-glucopyranosyloxy-3_,7_,24-trihydroxycycloartane (Figure 2.5). At least 56 
different triterpene glycosides have been detected in various species of SF and structural 
elucidation of the main compounds is ongoing (van Wyk and Albrecht, 2008). 
The triterpenoid fraction of SF inhibited both the type 1 pregnenolone- and progesterone -
induced difference spectra under LC/MS screening and elicited a type 11 difference 
spectrum in the absence of substrate. This therefore shows that the triterpenoid glucosides 
present in SF can influence the biosynthesis of glucocorticoids (Prevoo et al., 2008). 
Kikuchi et al., (2007) studied the cancer chemo preventive activity of 48 natural and semi 
synthetic cycloartane-type triterpenoids. Many of the compounds (so-called astragalosides) 
are known from the genus Astragalus L., a related species of SF. The most powerful 
inhibitory effects in an in vivo mouse skin carcinogenesis test were found in cycloartanes 
with hydroxylation at C-24 and with a 3-oxo group. This configuration is present in SUl 
(Figure 2.5). 
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Figure 2.5: Chemical structure of triterpenoid glycosides found in 
Sutherlandia frutescens (van Wyk and Albrecht et al., 2008). 
2.1.4 Recommended dosage of Sutherlandia frutescens 
The recommended therapeutic dose of SF in humans is 9 mg per kg body weight per day of 
the tablet preparation. That would be equal to about one 300 mg tablets taken twice a day 
after meals as recommended by the suppliers (Seier et al., 2002). 
2.1.5 Pharmacokinetics and pharmacology of Sutherlandia frutescens 
There has been much work done to assess the pharmacokinetics of this medicinal plant. 
Mills et al, (2005b) demonstrated in vitro effects of SF on cytochrome P450 3A4 
(CYP3A4), pregnane X receptor (PXR), and P-gylcoprotein (P-gp). Sutherlandia frutescens 
produced near complete inhibition of CYP (96%) and activated the pregnane X receptor 
nearly twofold. P-glycoprotein expression was inhibited moderately in relative to the 
positive control (verapamil). Despite the use of relatively high doses, these results 
tentatively suggest that human consumption of SF could affect antiretroviral drug 
metabolism leading to bi-directional drug interactions and loss of therapeutic efficacy. 
13 
Prevoo et al., (2008) investigated the interaction of SF with cytochrome P450 enzymes, 
CYPl 7 and CYP21, which catalyse key reactions in glucocorticoid biosynthesis. They 
showed that that SF contains bioactive compounds capable of inhibiting the binding of 
natural substrates (pregnenolone and progesterone) and the catalytic activity of CYPl 7 and 
CYP21 enzymes involved in the biosynthesis of steroid hormones. 
2.1.6 Toxicity of Sutherlandia frutescens 
Sutherlandia frutescens has a relatively long history of safe usage in Africa. Minor side 
effects reported include occasional incidents of mild loose stool, mild constipation, dry 
mouth, and dizziness in cachetic patients (Seier et al., 2002). A toxicology screening of SF 
in a primate model using dosages up to 9 times greater than the recommended dosage did 
not identify any clinical, haematological or physiological toxicity of this medicinal plant 
(MRC toxicity study, 2002). A more recent clinical trial of SF using healthy volunteers 
conducted by Johnson et al, (2007) showed no adverse events on physical, vital, blood, 
and biomarker indices between the healthy treatment and placebo groups. However 
participants taking SF reported improved appetite compared to the placebo group. No 
traceable amounts of L-canavanine were found in participant plasma. 
L-canavanine maybe associated with the autoimmune condition systemic lupus 
erythematous syndrome (SLE). Defective immune regulatory mechanisms, such as the 
clearance of apoptotic cells and immune complexes, are important contributors to the 
development of SLE (Mok and Lau, 2003). The non-protein amino acid L-canavanine can 
be incorporated in protein instead of arginine and may, if taken for a long time, result in 
autoimmunity (Prete, 1985). 
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2.1.7 Traditional uses of Sutherlandia frutescens 
Sutherlandia frutescens has been and is still used in the treatment of many ailments in 
southern Africa. The Khoi San and Nama people were known to use the plant as a 
decoction for the washing of wounds and they also used it to treat internal fevers. The 
Cape settlers regarded it as giving successful results against chickenpox, stomach 
problems, and in the treatment of internal cancers (van Wyk et al., 1997). It is also used to 
treat tuberculosis, diabetes, chronic fatigue syndrome, influenza, rheumatoid arthritis, 
osteoarthritis, peptic ulcers, gastritis, reflux oesophagitis, menopausal symptoms, anxiety, 
and clinical depression and HIV infection. It is said to be a useful bitter tonic and a little 
taken before meals will aid digestion and improve the appetite (Xaba and Notten, 2003; 
Mills et al, 2005b; Gericke et al, 2001; Dalvi, 2003). 
There has not been conclusive scientific evidence that supports the use of SF for cure of 
these different ailments. In vitro studies have mainly focused on the anti-cancer properties 
of this plant on different tumour cell lines. There has also been no data on plant's immune 
stimulating abilities and the usefulness of that property in the fight against debilitating 
illnesses such tuberculosis, cancer and HIV/AIDS. Anecdotes have been provided from 
different clinical settings of how taking preparations of SF have greatly improved the well-
being and CD4+ counts of HIV/AIDS sufferers (Jenkins, 2005). To this end, no scientific 
data has supported this claim. A clinical study has been approved by the Medical Controls 
Councils of South Africa to look at the effects of SF on HIV/AIDS patients (Naidoo, 
2007). 
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2.1.8 Scientific studies into the effects of Sutherlandia frutescens 
A burgeoning volume of scientific data has been produced on the different effects of SF in 
vitro and in vivo settings. The in vitro studies have utilised cultured cell lines to ascertain 
the cellular and anti-proliferative effects of crude extracts of SF on tumour cells. Others 
have looked at the anti-inflammatory and anti-oxidant properties of the plant extracts in 
relation to what the plant is traditionally used for in herbal medicine. In vivo studies have 
also been conducted on rats and mice for similar reasons to the ones above. Recently a 
clinical trial of SF was completed in healthy adults to evaluate the safety of the plant 
(Johnson et al., 2007) 
2.1.8.1 Anti-proliferative properties of Sutherlandia frutescens 
The effects of crude SF extracts which were prepared with 70% ethanol was investigated 
on cell numbers, morphology, and gene expression profiles on MCF-7 human breast 
adenocarcinoma cell line by Stander et al., (2007). It was found that 1.5 mg/ml of the SF 
extract induced a statistically significant decrease in cell viability (50%) when compared to 
the vehicle-treated controls after 24 h exposure. Changes of cell morphology related to 
induction of apoptosis, i.e. cytoplasmic shrinking, membrane blebbing and apoptotic 
bodies, were observed after 24 h of exposure. 
Aqueous extracts of SF inhibited growth of the oestrogen dependent cancer cell lines (DU-
145 prostate cancer cell line, MCF-7 breast cancer cell line) and stimulated the growth of 
the MCF-12A non-malignant breast cell line and MDA-MB-231 breast cancer cell line 
(Steenkamp and Gouws, 2006). Chinkwo (2005) demonstrated that crude whole plant 
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extracts of SF induced cytotoxicity and apoptosis in three different cell lines (Chinese 
Hamster Ovary (CHO) cells, Caski cervical carcinoma cells, and Jurkat T lymphoma 
cells). Ethanolic extracts of commercially available SF tablets and powder preparations 
demonstrated a concentration dependent anti-proliferative effect of several tumour cell 
lines (Tai et al, 2004). 
2.1.8.2 Anti-oxidant and anti-inflammatory effects Sutherlandia frutescens 
The study by Tai et al., (2004) also demonstrated the anti-oxidant activity in reducing free 
radical cations with an estimated activity of 0.5 /xl of SF extract equivalent to that of 10 
jiiM of Trolox that is determined in a Trolox equivalent antioxidant capacity (TEAC) assay. 
Sutherlandia frutescens did not however significantly suppress lipopolysccharide 
stimulated nitric oxide production by murine macrophage/monocytes RAW 264.7 cells, 
nor did it significantly inhibit interleukin-ip and tumour necrosis factor-a expression in the 
same cell line. 
Contrary to the finding by Tai et al., (2004) in acute oedema rat models it was 
demonstrated that the extract of SF had a significant anti-inflammatory function (Ojewole, 
2004). After an oral administration of 800 mg/ml of the extract, the animals were found to 
have reduced egg albumin-induced inflammation in their paws. Sutherlandia frutescens 
shoot aqueous extract (50-800 mg/kg i.p.) also produced significant (p< 0.05-0.001) 
analgesic effects against thermally- and chemically-induced pain stimuli in mice and 
caused significant (p< 0.05-0.001) hypoglycaemia in rats. Smith and Myburgh (2004) 
showed that warm water extract of SF is able attenuate an immobilisation stress-induced 
increase in plasma corticosteroid levels in rats. 
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Fernandes et al, (2004) investigated the effects of the hot water extract of SF on both 
luminol and lucigenin enhanced chemiluminescence of neutrophils stimulated with L-
formyl-L-methionyl-L-leucyl-phenylalanine (FMLP) as well as the superoxide and 
hydrogen peroxide scavenging properties in a cell free system. The results showed that SF 
exhibits significant superoxide and hydrogen peroxide scavenging activity at low 
concentrations. These antioxidant properties are also thought to account for some of the 
anti-inflammatory properties of this plant that have been described. 
An investigation into the effects of methanolic extract of SF on 12-0-
tetradecanoylphorbol-13-acetate (TPA)-induced COX-2 expression in mouse skin 
demonstrated that topical application of the extract inhibited TPA-induced COX-2 
expression. This inhibition appeared to be mediated by blocking the catalytic activity of 
extracellular signal-regulated protein kinase (ERK) and inhibiting the activation of 
activator protein-1 (AP-1). This data supported the use of SF as an anti-tumour remedy 
(Kundu et al, 2005). 
These antioxidant and anti-inflammatory effects of SF in in vitro systems lends support to 
the use of this medicinal plant as an immune booster. The traditional use of this plant as an 
adaptogen also led to scientific investigations into its use in HIV/AIDS patients to boost 
CD4+ counts. Accumulated evidence suggests that reactive oxygen species (ROS) can be 
scavenged through chemoprevention utilizing natural antioxidant compounds present in 
foods and medicinal plants. 
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2.2 The immune response 
The immune system is an interactive network of lymphoid organs, cells, humoral factors, 
and cytokines. The essential function of the immune system in host defence is best 
illustrated when it goes wrong; underactivity resulting in the severe infections and tumours 
of immunodeficiency, overactivity in allergic and autoimmune disease. Immunity is 
divided into two parts determined by the speed and specificity of reaction, namely the 
innate and adaptive responses (Parkin and Cohen, 2001). 
2.2.1 The innate response 
The term innate is sometimes used to include physical, chemical, and microbiological 
barriers, but more usually encompasses neutrophils, monocytes, macrophages, 
complement, cytokines, and acute phase proteins of the immune system. These 
components provide the immediate host defence against the invading pathogen. Neutrophil 
recruitment forms the central feature of the early response to infection. The recruited 
neutrophils phagocytose the invading organisms by making pseudopodia which form a 
membrane-bound phagosome around the particle. Within this compartment the organism is 
killed either by a respiratory burst or by the oxygen-independent response which uses 
highly toxic proteins or enzymes (Parkin and Cohen, 2001). 
Ingestion and killing of organisms is 100-fold more effective if the particle is first 
opsonised with specific antibody or complement. Complement binds to neutrophil Fc and 
C receptors, increasing adhesion between particle and phagocyte. This primes the cell for 
activation. Eosinophils play a major role in protection of the host from parasitic infections. 
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Such infections induce antigen-specific immunoglobulin-E (IgE) production, the 
antibodies coating the organism. Mast cells and basophils are involved in some of the most 
severe immunological reactions, such as angioedema and anaphylaxis. Natural killer cells 
have the morphology of lymphocytes but do not bear a specific antigen receptor (Parkin 
and Cohen, 2001). 
The innate immune system basically functions as an immediate host defence mechanism 
which deploys a limited number of receptors with specificity for conserved microbial 
structures. Recognition of these structures induces co-stimulators, cytokines, and 
chemokines which recruit and activate antigen-specific lymphocytes and the adaptive 
immune response (Medzhitov and Jane way Jr, 2000). 
2.2.2 Specific immunity 
Specific or adaptive immunity is the hallmark of the immune system of the higher animals. 
This response consists of antigen-specific reactions through T lymphocytes and B 
lymphocytes (Figure 2.5). In contrast to the innate response which is rapid, adaptive 
immunity takes several days or weeks to develop and it is specific. The adaptive response 
has memory, so that subsequent exposure leads to a more vigorous and rapid response 
(Parkin and Cohen, 2001). 
The characteristic of the specific immune response is the use of the antigen-specific 
receptors on T and B lymphocytes to drive targeted effector responses in two stages. 
Firstly within the lymphoid tissue, the antigen is presented to and recognised by the 
antigen specific T or B cell leading to cell priming, activation, and differentiation. This is 
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then followed by the effector response taking place, either due to the activated T cells 
leaving the lymphoid tissue and homing to the disease site, or due to the release of 
antibody from the activated B cells (plasma cells) into blood and tissues fluid, and thence 
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Figure 2.6: The role of T and B lymphocytes in the adaptive immune response 
(Parkin and Cohen, 2001). 
Development of lymphocytes from progenitor cells takes place within the bone marrow. B 
cells remain within the marrow for the duration of their development while the T cells 
migrate to the thymus at an early stage as thymocytes. The cells that emerge from the 
thymus and bone marrow have undergone gene rearrangement are naive- i.e. they have not 
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encountered their specific antigens. The lymphoid tissues provide the microenvironment 
for this activation. In addition to T and B lymphocytes, they contain efficient antigen-
presenting cells and are able to produce the cytokines necessary to maintain T and B 
lymphocytes (Parkin and Cohen, 2001). 
2.2.2.1 B lymphocytes 
B cells produce antibody which serves to neutralise toxins, prevents organisms adhering to 
mucosal surfaces, activates complement, opsonises bacteria for phagocytosis, and 
sensitises tumour and infected cells for antibody dependent cytotoxic attack by killer cells. 
In a way, B cell antibodies act to enhance elements of the innate response (Parkin and 
Cohen, 2001). 
2.2.2.2 T lymphocytes 
In the development of T lymphocytes, the delicate process of positive selection of T cells 
that can react with self-MHC and peptide adequately to induce immune responses, but are 
not excessively MHC-reactive to cause self-tissue destruction occurs in the thymus (Figure 
2.7). 
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Figure 2.7: The development of T lymphocytes in the thymus (Parkin and Cohen, 
2001). 
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Once activated, the T lymphocytes function to attack host cells that have been infected by 
viruses or microorganisms, cross-reactive transplanted tissues and tumour cells. They also 
produce cytokines which are chemical mediators that play a key regulatory role in the 
immune response. Since T lymphocytes are supposed to physically contact foreign or 
infected cells in order to destroy them, they are said to provide a cell-mediated immune 
response (Roitt et ah, 1993). 
Antigen recognition by the T cell receptor is different for CD4+ and CD8+ cells. CD4 
lymphocytes only recognise antigen presented with MHC class II and CD8 cells with 
MHC class I. T cells can also be differentiated into two populations depending on whether 
they use an a/p or y/5 type of antigen receptor. Some of the activated T cells remain within 
the lymph nodes as central memory cells. Memory cells may live for up to ten years or 
more. They react more quickly on subsequent exposure because the log phase for their cell 
division is short (12 hours) and they have a longer lifespan due to decreased apoptosis 
(Parkin and Cohen, 2001). Different populations of effector T lymphocytes have different 
functions: 
• T helper CD4+ cells 
> Th cells are subdivided functionally by the type of cytokines they produce. 
Precursor Th 0 lymphocytes become either Th 1 or Th 2 cells on 
stimulation. Th 1 and Th 2 cells are morphologically indistinguishable but 
only differ in the cytokines and response they produce. Th 1 cells produce 
IL 2, which induces T cell proliferation (including CD4+ cells in an 
autocrine response). Interleukin 2 stimulates CD8+ T cell division and 
cytotoxicity by decreasing the activation thresholds. Th 1 cells also produce 
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interferon y which activates macrophages to kill intracellular pathogens and 
induces natural killer cells to cytotoxicity. Interleukin 12 secreted by the 
interferon-y-(IFN y)-stimulated macrophages further increases interferon y 
production by T cells. A Th 1 response is essential to the host to control the 
replication of intracellular pathogens, but possibly contributes to the 
pathogenesis of autoimmune disease (Parkin and Cohen, 2001). 
> T helper 2 cells in turn produce IL 4, 5, 6, and 10 that favour antibody 
production. IL 4 induces class-switching on B cells to IgE production and 
IL 5 promotes the growth of eosinophils. Interleukin 4 provides positive 
feedback to induce further Th 2 responses and suppress Th 1 differentiation. 
Thus the Th 2 response is associated with allergic reactions (Parkin and 
Cohen, 2001). 
• T cytotoxic (CD8+) cells 
> These cells are directly cytotoxic to target cells bearing their specific 
antigen. They bind to the target cell and insert perforins into the cell 
membranes. They then release granules containing granzymes into the 
target cytoplasm. The granzymes activate caspase enzymes that induce 
DNA fragmentation and cell apoptosis. Some CD8+ T cells also have a 
suppressor (Ts) function in down regulating lymphocyte responses (Parkin 
and Cohen, 2001). 
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2.3 Apoptosis 
Apoptosis, or programmed cell death, is a key event in biological homeostasis but is also 
involved in potentiation of human diseases (Ahr et ai, 2004). As important as cell division, 
programmed cell death allows the shaping of the organism during development and tightly 
controls cell number and tissue homeostasis in adult life (Ferraro-Peyret et ah, 2002) 
Apoptosis is a tightly controlled process in which cell death is executed through the 
activation of specific signalling pathways. Within cells, there are positive and negative 
regulatory pathways of apoptosis, and it is the balance between these pathways that 
determines cell fate (Pulido and Parrish, 2003). 
The coordinated structural changes that make up the process of apoptosis are driven by a 
set of molecular interactions, sometimes known as terminal effector events. Cells that are 
undergoing apoptosis do so in a well-described pattern that is different from that of cells 
that are dying from necrosis due to physical injury, for example (DiBartolomies and Mone, 
2003). That pattern includes cell shrinkage; development of bubble-like blebs on the 
surface; ROS formation, caspase activation; chromatin condensation and DNA 
fragmentation; mitochondrial depolarisation; phosphotidylserine externalisation; and 
finally phagocytosis of the cell fragments by macrophages and dendritic cells. 
Phagocytosis of apoptotic bodies is necessary to prevent induction of inflammation. Since 
apoptosis plays such an important role in processes of development, immune response, 
morphogenesis, and pathophysiology, its disruption can have severe consequences to the 
organism (Pulido and Parrish, 2003). 
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The importance of apoptosis is also underlined by the different regulatory mechanisms 
which are in place to safeguard its execution. These include death receptors, caspases, 
mitochondria, Bcl-2, and tumour-suppressor genes (Pulido and Parrish, 2003). The process 
of death is the result of an interaction between initiating stimuli, which can be 
physiological or the result of injury in various parts of the cell, and factors that determine 
the susceptibility of the cell to activation of the terminal effector events. These pathways 
can either be a response to receptor-mediated (e.g. Fas, TNF) or non-receptor-mediated 
(e.g. DNA damage, ultraviolet (UV) irradiation) signals (Alimonti et al., 2003). Both the 
intracellular and extracellular pathways of apoptosis induction involve the transduction of 
signals which ultimately lead to activation of caspases but there are other pathways of 
apoptosis which do not involve activation of caspases that have been identified (Figure 
2.8). 
2.3.1 Extracellular activation of apoptosis 
The extrinsic pathway involves the interaction of external signals or ligands with a receptor 
at the plasma membrane which initiates a cascade of events that leads to apoptosis. The 
"death receptors" of the TNFR family include TNFR1, Fas (CD95), DR3/WSL, and the 
TNF-related apoptosis-inducing ligand (TRAIL)/Apo-2L receptors (TRAIL-R1/DR4, 
TRAIL-R2/DR5). Members of this family are characterized by two to five copies of 
cysteine-rich extracellular repeats and an intracellular "death domain". Once a ligand binds 
to the receptor, an interaction occurs with death domain adaptor proteins such as FADD, 
RIP, Daxx, and TRADD (Figure 2.8) (Pulido and Parrish, 2003; Zimmerman et al, 2001). 
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These proteins activate caspases and signalling pathways such mitogen-activated protein 
(MAP) kinase and nuclear factor (NF)-AB. Activation of kinase signalling pathways results 
in gene expression through (NF-&B) and/or activator protein-1 and inhibition of apoptosis. 
Activation of initiator caspases can lead to a caspase cascade which amplifies the apoptotic 
signal. The caspase cascade is regulated by a variety of proteins that acts as both cofactors 
(APAF-1) and inhibitors (FLIP and IAP) (Pulido and Parrish, 2003; Zimmerman et al, 
2001). 
2.3.2 Intracellular activation of apoptosis 
The intracellular pathway of apoptosis is initiated within the cell, most often through the 
disruption of cellular homeostasis. The mitochondria play a pivotal role in cell homeostasis 
and the disruption of the mitochondrial transmembrane potential is a vital initial event 
leading to apoptosis. Growth factors, cytokines and DNA damage appear to signal cell 
death through the mitochondria (Figure 2.8). The mitochondrial pathway of apoptosis is 
also a target of oncogenic mutations. These diverse signals affect the function of B-cell 
lymphoma (Bcl)-2 family members which, in turn, can modulate the mitochondrial 
transmembrane potential (Pulido and Parrish, 2003; Lowe and Lin, 2000). 
The instability of the mitochondrial membrane results in the release of cytochrome c which 
binds to apoptotic activating factor-1 (APAF-1). Recently, a new protein with the dual 
name Smac/DIABLO has been discovered, which is released from the mitochondria along 
with cytochrome c during apoptosis. While cytochrome c forms an apoptosome with 
APAF-1 and procaspase 9 leading to caspase activation, Smac/DAIBLO functions to 
promote caspase activation by associating with the apoptosome and by inhibiting IAPs. It 
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has been shown that cytochrome c and Smac/DIABLO are released co-ordinately 
(Zimmerman et al, 2001). 
Mitochondrial-induced apoptosis may also involve a caspase-independent pathway. A 
change in the mitochondrial transmembrane potential may cause the release of apoptosis-
inducing factor (AIF), which activates a deoxyribonuclease (DNase) leading to apoptosis 
(Pulido and Parrish, 2003). Endonuclease G has been identified as one of the proteins 
released along cytochrome c during apoptosis. It is a nuclease involved in mitochondrial 
DNA replication but when released from the mitochondria, it translocates to the nuclease 
where it induces DNA fragmentation independent of caspase activation (van Loo et al., 
2001). 
Mitochondrial membrane permeability is regulated through the Bcl-2 family of proto-
oncogenes. Within this family there are proto-oncogenes which are anti-apoptotic (Bcl-2) 
and those which are pro-apoptotic (Bad, Bax). Activated pro-apoptotic proto-oncogenes act 
to increase mitochondrial membrane permeability, thereby promoting apoptosis. The anti-
apoptotic protein, Bcl-2, acts to inhibit the ability of Bax or Bad to increase membrane 
potential and the balance of these proteins normally determines cell fate (Figure 2.8) 
(Pulido and Parrish, 2003). 
Other important factors involved in intracellular activation of apoptosis include excessive 
generation of reactive oxygen species (ROS) and tumour-suppressor genes. Excess ROS 
are involved in disruption of mitochondrial membrane potential leading to cytochrome c 
release and caspase cascade activation (see 2.3.4 below for detailed discussion). Activated 
tumour-suppressor genes like p53 respond to DNA damage by regulating gene expression. 
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This regulation of gene expression can suppress Bcl-2 activity and up-regulation of several 
genes that contribute to apoptosis, such as Bax or Bad (Pulido and Parrish, 2003). 
Figure 2.8: An overview of the apoptotic pathways starting from initiation of 
apoptosis externally or internally to activation of caspases and finally to cell 
degradation (Kannan and Jain, 2000). 
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2.3.3 Role of caspase activity in the apoptotic pathway 
Caspases are aspartate-specific cysteine proteases which are found in the cytoplasm as 
proenzymes. The caspase gene family contains 14 mammalian members, of which, 11 
human enzymes are known. The gene family is composed of two major subfamilies that 
are related to either ICE (caspase-1; inflammation group) or to the mammalian 
counterparts of ced-3 (apoptosis group). Caspases are activated to fully functional 
proteases by two cleavage events. The first proteolytic cleavage divides the chain into large 
and small caspase subunits, and a second cleavage removes the N-terminal prodomain. The 
active caspase is a tetramer of two large and two small subunits, with two active sites 
(Zimmerman et al., 2001). 
Based on their substrate specificity and function, caspases can be organised into initiator 
and executioner caspases. The self-activating caspases are generally known as initiators 
(i.e. caspases-8, -9, and -10), and they function to initiate and amplify a death signal. The 
other caspases are activated by other caspases and are known as effectors or executioner 
caspases (i.e. caspases-2, -3, -6, and -7). Activation of effector caspases causes the 
degradation of DNA, the nuclear lamina, the cytoskeleton, and other critical components of 
cellular integrity (Pulido and Parrish, 2003; DiBartolomies and Mone', 2003). 
2.3.4 Oxidative stress and apoptosis 
Under normal conditions, aerobic cells are enabled with extensive antioxidant defence 
mechanisms to counteract excessive ROS. When pro-oxidants overwhelm antioxidants, 
oxidative stress occurs. Reactive oxygen species have been shown to be both beneficial 
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and deleterious. At low concentration, ROS act as second messengers in signal 
transduction pathways. Excess amounts of ROS, however, can cause extensive oxidative 
damage to many vital components of the cell. The paradoxical role of ROS in 
physiological events can be illustrated by the role of superoxide radicals in the immune 
response. It is universally accepted that the production of superoxide radical by activated 
neutrophils and other phagocytes is an essential component of immunological defence 
mechanisms against bacteria. Many diseases results from unregulated changes in ROS 
levels (Table 2.1) (Kannan and Jain, 2000). 
The mitochondria are a source of ROS and a target of excessive ROS generation. Excess 
ROS increases the mitochondrial membrane permeability and damages the respiratory 
chain resulting in increased ROS production (Pulido and Parrish, 2003). Damage to the 
mitochondrial membrane not only causes release of apoptosis-inducing cytochrome c, it 
also dramatically depletes the cellular energy supply. These effects potentiate occurrence 
of cell death either by necrosis or apoptosis (Kannan and Jain, 2000). 
Reactive oxygen species, especially hydroxyl radicals, can react with all biological 
macromolecules, i.e. lipids, proteins, nucleic acids, and carbohydrates. The initial reaction 
generates a second radical, which reacts with a second macromolecule and this chain 
reaction is continued to amplify the ROS effect. Among the more susceptible targets of 
ROS are polyunsaturated fatty acids of membrane phospholipids. The lipid radicals 
generated during the early encounter with an oxidant add molecular oxygen to produce 
lipid dioxyl radical. This pro-oxidant reacts with an allelic hydrogen from another 
unsaturated side chain producing a lipid hydroperoxide (LOOH) and thus propagating the 
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chain reaction. Lipid peroxidation is an important biological consequence of oxidative 
cellular damage and aging (Kannan and Jain, 2000). 
Table 2.1: Diseases that are influenced by oxidative stress or apoptosis (adapted from 
Kannan and Jain, 2000). 
Neurodegenerative diseases (Alzheimer's, Parkinson's) 
Autoimmune disease (e.g. rheumatoid arthritis) 
Human immunodeficiency virus (AIDS) 
Diabetes mellitus 
Cancers of lung, colon, breast and others 
Alcohol induced liver disease 
Hepatitis-C induced liver disease 
Ischemic reperfusion damage-heart, liver 
2.3.5 Antioxidants, immune response and cell death 
An antioxidant can be defined as a compound that inhibits or delays the oxidation of 
substrates even if the compound is present in a significantly lower concentration than the 
oxidized substrate. Mechanism of action may include the scavenging of ROS. Others 
include the prevention of ROS formation by metal binding or enzyme inhibition. Chain 
breaking antioxidants prevent damage by interfering with the free radical propagation 
cascades. The antioxidant compounds are usually recyclable in the cell or are irreversibly 
damaged, but their oxidation products are less harmful or can be further degraded to 
harmless substances in downstream processing. At the cellular and organism level the 
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antioxidant protection is provided by numerous enzymes and endogenous small molecular 
weight antioxidants such as ascorbic acid, uric acid glutathione, tocopherols and several 
others (Matkowski, 2008). 
Over the past two decades, an expanding body of evidence from epidemiological and 
laboratory studies have demonstrated that some edible plants as a whole, or their identified 
ingredients with antioxidant properties have substantial protective effects on human 
carcinogenesis (Atawodi, 2004). The antioxidant activity of plant secondary metabolites 
has been widely established in in vitro systems. Medicinal compounds are of particular 
interest and much effort has been devoted to obtaining some of the most active and 
precious therapeutics. Numerous alkaloids, saponins, cardenolides, anthraquinones, 
polyphenols and terpenes have been reported from in vitro cultures (Matkowski, 2008). 
Many of the protective functions of immune cells depend on the fluidity of the membranes 
of the cell. As the concentration of polyunsaturated fatty acids in the membranes is 
increased, the potential for membrane lipid peroxidation mediated by free radicals also is 
increased. Lipid peroxidation decreases membrane fluidity, which adversely affects 
immune responses. The degree of unsaturation of the lipids incorporated into membranes 
alters the exposure of membrane receptors and their activities (Bendich, 1993). 
Oxidative stress may be detrimental in acquired immunity by activation of nuclear factor 
kappa B, which governs gene expression involving various cytokines, chemokines, and cell 
adhesion molecules, among others. However, antioxidant supplementation essentially 
reverses several immune deficiencies, resulting in increased levels of interleukin-2, 
elevated numbers of total lymphocytes and T-cell subsets, enhanced mitogen 
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responsiveness, increased killer cell activity, augmented antibody response to antigen 
stimulation, decreased lipid peroxidation, and decreased prostaglandin synthesis (Knight, 
2000). 
One of the most important antioxidants in the immune response is glutathione. Reduced 
glutathione (y-glutamyl-cysteinyl-glycine; GSH) is the most abundant low-molecular 
weight thiol in animal cells and is involved in many cellular processes including 
antioxidant defence, drug detoxification, cell signalling, and cell proliferation. Other novel 
roles of GSH include gene expression, protein glutathioylation, and nitric oxide (NO) 
metabolism (Table 2.2). The synthesis of GSH from glutamate, cysteine, and glycine is 
catalyzed sequentially by two cytosolic enzymes, y-glutamylcysteine synthetase and GSH 
synthetase. The synthesis of GSH is regulated primarily by y-glutamylcysteine synthetase 
activity, availability of cysteine, and GSH feedback inhibition. Glutathione can be 
transported out of cells via a carrier-dependent facilitated mechanism into plasma. Plasma 
GSH originates mainly from the liver but some of it can come from the diet. The 
interorgan metabolism of GSH functions to transport cysteine in a nontoxic form between 
tissues, and also helps maintain intracellular GSH concentrations and redox state (Wu et 
al, 2004; Franco et al, 2007; Armstrong et al, 2002). 
Adequate GSH concentrations are necessary for the proliferation of cells, including 
lymphocytes. Glutathione is also essential for activation of T-lymphocytes and 
polymorphonuclear leukocytes as well as for cytokine production, and therefore for 
mounting successful immune responses when the host is immunologically challenged. A 
shift in the GSH/glutathione disulphide (GSSG) redox state toward the oxidizing state 
therefore activates several signalling pathways which reduce cell proliferation and increase 
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apoptosis. Thus, oxidative stress plays a key role in the pathogenesis of many diseases, 
including cancer, inflammation, Alzheimer's and Parkinson diseases, HIV/AIDS, and 
diabetes (Wu et al, 2004). 
Table 2.2: Roles of glutathione in animals (adapted from Wu et al, 2004) 
Antioxidant defence 
Scavenging free radicals and other reactive species 
Removing hydrogen and lipid peroxides 
Preventing oxidation of biomolecules 
Metabolism 
Synthesis of leukotrienes and prostaglandins 
Conversion of formaldehyde to formate 
Production of D-lactate from methylglyoxal 
Formation of mercapturates from electrophiles 
Formation of glutathione-NO adduct 
Storage and transport of cysteine 
Regulation 
Intracellular redox status 
Signal transduction and gene expression 
DNA and protein synthesis, and proteolysis 
Cell proliferation and apoptosis 
Cytokine production and immune response 
Protein glutathioylation 
Mitochondrial function and integrity 
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2.3.6 Apoptosis and T lymphocytes regulation 
Apoptosis has been shown to play a role in regulating the type of T lymphocytes released 
into circulation. In the thymus immature T lymphocytes are selected based on their ability 
to recognise self-antigens displayed by dendritic cells. Immature lymphocytes that lack the 
antigens receptors allowing then to respond to self-antigens escape the thymus, while self-
reactive lymphocytes receive signals to undergo apoptosis. Several million precursor T-
lymphocytes enter the thymus daily, with only 1 to 2% leaving to become function T-
lymphocytes (DiBartolomies and Mone, 2003). 
2.4 Apoptosis versus Necrosis 
Apoptosis is characterised by chromatin condensation, nuclear fragmentation and 
formation of apoptotic bodies. These apoptotic bodies are eventually phagocytosed by 
macrophages. Apoptosis is tightly regulated by molecular mechanisms that appear to be 
evolutionary conserved and is therefore thought to be an active process in removing 
unnecessary cells. In most but not all forms of apoptosis, nuclear DNA is cleaved at 
internucleosomal sites. Apoptotic cells appear shrunken with membrane blebbing 
(Tsujimoto, 1997). 
Necrosis (also referred to as accidental cell death) refers to the morphology most often 
seen when cells die from severe and sudden injury, such ischemia, sustained hyperthermia, 
or physical or chemical trauma. In necrosis there are early changes in mitochondrial shape 
and function, and the cell rapidly becomes unable to maintain homeostasis. The plasma 
membrane becomes the major site of damage, causing it to lose its ability to regulate 
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osmotic pressure which leads to cell swelling and rupture. Many of the substances 
released, such as prostaglandins and thromboplastin, are inducers of inflammation. 
Because cell injury of this type is often extensive, the inflammatory response is desirable, 
so that debris may efficiently be cleared away and the process of repair begins (Cohen, 
1993; DiBartolomies and Mone, 2003). 
In pathological regions or when cells are subjected to pathological reagents, it has often 
been observed that apoptotic cells also appear, indicating that accidental cell death can also 
progress by apoptosis. Furthermore, dying cells with non-apoptotic morphology are 
observed during naturally occurring cell death. Thus, apoptosis and some forms of necrosis 
must share common steps (Figure 2.9). Intracellular ATP levels have been implicated both 
in vitro and in vivo as a determinant of the cell's decision to die by apoptosis or necrosis. 
As apoptosis is an active process, it very much an ATP-dependent process while necrosis 
is ATP-independent (Tsujimoto, 1997). 
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Figure 2.9: Diagram illustrating that apoptosis and some forms necrosis share a 
common signal transduction pathway (Tsujimoto, 1997). 
2.5 Apoptosis and Cancer 
The realization that apoptosis is a gene-directed program and maybe as important as 
mitosis has been significant for our understanding of developmental biology and tissue 
homeostasis. This genetic basis of apoptosis implies that cell death, like any other 
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metabolic or developmental program, can be disrupted by mutation (Lowe and Lin, 2000). 
In fact, defects in apoptotic pathways are now thought to contribute to a number of human 
diseases, ranging from neurodegenerative disorders to malignancy (Thompson, 1995). This 
has also led to the realization that apoptosis and the genes that control it have a reflective 
effect on the malignant phenotype. For one it is clear that some oncogenic mutations 
disrupt apoptosis leading to tumour initiation, migration and metastasis. Furthermore, 
compelling evidence points to other oncogenic mutations promoting apoptosis, thereby 
producing selective pressure to override apoptosis during multistage carcinogenesis (Lowe 
and Lin, 2000). 
The evolution of the normal cell to a malignant one involves processes by which genes 
involved in normal homeostatic machineries that control proliferation and cell death suffer 
mutational damage which results in the activation of genes stimulating proliferation or 
protection against cell death, the oncogenes (e.g. Bcl-2), and the inactivation of genes 
which would normally inhibit proliferation, the tumour suppressor genes (e.g. phosphor-
protein 53 (p53)) (Bertram, 2001). This formation of cancerous cells can result from 
sequential acquisition of mutations which arise as a consequence of damage to the genome. 
Mutations can be a result of errors in replication of DNA, the intrinsic chemical instability 
of certain DNA bases or from attack by free radicals generated during metabolism. 
The immune response to a foreign invader involves the proliferation of lymphocytes (T 
and/or B cells). The immune system is responsible for the complex task of providing 
defence against a vast array of potential pathogens, whilst ensuring that the same protective 
mechanisms are not turned against self. When their job is complete, they must be removed 
leaving only a small population of memory cells. Apoptotic mechanisms play an important 
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role in the development, regulation and functioning of immune cells. Malfunctioning of 
apoptosis can cause autoimmune disease, immunodeficiencies, and lymphomas. Some B-
cell leukaemia's and lymphomas express high levels of Bcl-2, thus blocking apoptotic 
signals they may receive. The high levels result from a translocation of the Bcl-2 gene into 
an enhancer region for antibody production. It is well documented that most cytotoxic 
anticancer agents induce apoptosis, raising the intriguing possibility that defects in 
apoptotic contribute to treatment failure (Lowe and Lin, 2000). 
2.5.1 Apoptosis and cancer therapy 
Most anticancer agents now in use were developed using empirical screens designed to 
identify agents that selectively kill tumour cells. It is now well established that anticancer 
agents induce apoptosis, and that disruption of apoptotic programs can reduce treatment 
sensitivity. An example of this disruption is seen in agents targeting p53 which become 
ineffective if p53 is lost or mutated. Other researchers have shown that p53 is not strictly 
required for drug-induced cell death. Indeed, at sufficient doses virtually all anticancer 
agents induce apoptosis and other forms of cell death independently of p53. The only thing 
unclear is the extent to which apoptosis contributes to treatment sensitivity in carcinomas 
(Lowe and Lin, 2000). 
Anticancer agents have also been shown to induce apoptosis in normal tissues as well as in 
tumours. A link between apoptosis in tumours and that occurring in normal tissue has been 
suggested to contribute to the toxicity of chemotherapy (Lowe and Lin, 2000). This link 
has shown the need for an anticancer agent which will be selective for tumours while 
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sparing normal tissues, unlike chemotherapy and radiation which cause loss of normal 
cells. 
2.5.2 Cancer, cytokines and the immune system 
Cytokines are secreted or membrane-bound proteins that regulate the growth, 
differentiation and activation of immune cells. They also control immune cell trafficking 
and the cellular management of immune organs. Therefore, any disturbance in the 
regulation of cytokine production is thought to be one of the important factors in the 
development of diseases. Disorders such as HIV/AIDS, autoimmune disorders and cancer 
are known to be some of the diseases affected by cytokine dysregulation (Salazar-Onfray 
et al, 2007; Borish and Steinke, 2003). 
Tumour initiation and growth can be indirectly influenced by cytokmes through their 
assorted immune activities. The role of cytokines in modulating the tumourogenesis is 
mediated by their ability to regulate antigen-specific anti-tumour responses and by the 
activation of non-specific mechanisms, including those involved in the processes of 
inflammation and innate responses. Cytokines can influence the growth of tumours by 
acting directly on tumour cells as growth promoters, growth inhibitors or indirectly by 
attracting inflammatory cell types and affecting angiogenesis (Salazar-Onfray et al., 2007). 
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2.6 Conclusion 
A search through the literature has demonstrated the lack of information with regards to the 
effects of SF on the immune system. This has given this study added importance as this 
plant is purported as an immune booster. A fully functional immune response is very 
important when dealing with diseases such as cancer, HIV/AIDS and other infections 
which are traditionally treated with SF. Cancer is a debilitating disease in which an 
individual's cells divide uncontrollable. Induction of apoptosis in cancerous cells has been 
shown to be an important process which is disrupted in carcinogenesis. Conventionally 
chemotherapy and radiation have been shown to induce cell death in both tumours and 
normal tissues. Therefore if SF is shown to be able to induce apoptosis only in transformed 
cancerous cells while sparing normal cells, it would have an important role in cancer 
treatment. Added to that, if SF can also be shown to protect normal T cells and cause their 
proliferation, it would also have a place in fighting many other infections in which the 
immune system is compromised. 
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CHAPTER 3 
TISSUE CULTURE PROTOCOLS 
3.1 Cell Culture 
Tissue culture is a general term for the removal of cells, tissues, or organ from an animal or 
plant and their subsequent placement into an artificial environment conducive to growth 
(Ryan, 2008). Tissue culture can also be described as a method of keeping tissue alive and 
growing in vitro in a tissue culture media containing a rich mixture of essential amino 
acids, vitamins, and peptides, thus replicating conditions in which the tissue normally 
grows in an animal or human. The technique of culturing cells outside the organism may 
be used for a variety of cells provided the in vitro environment in which they are 
propagated replicates the in vivo system of the organism (Terse et al., 1993). 
There are two main ways of obtaining cell cultures. When cells or cultures are derived 
directly from excised, normal animal tissue and cultured either as an explant culture or 
following dissociation into a single cell suspension by enzyme digestion, they are called 
primary cultures. The preparation of primary cultures is labour intensive and they can be 
maintained in vitro only for a limited period of time. Continuous cultures, on the other 
hand, are comprised of a single cell type that can be serially propagated in culture either 
for a limited number of cell divisions (approximately thirty) or otherwise indefinitely. 
They have this ability because they have been transformed into tumour cells or were 
obtained from clinical tumours. Transformed cell lines present the advantage of almost 
limitless availability, but the disadvantage of having retained very little of the original in 
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vivo characteristics (Freshney, 1987; European Collection of Cell Culture (ECACC) 
Handbook, 2006). 
Cell lines derived from clinical human tumours have been crucial to building our 
understanding of the molecular pathophysiology of cancer and its treatment. They are also 
as important in forming an in vitro model system for rational drug discovery and 
development. This is because they are easy to maintain and manipulate in vitro. However, 
monolayers are generally poor at reflecting the in vivo sensitivity of the parent histology to 
classic chemotherapeutics (Greshock et ah, 2007). In this study, H9 lymphoma cells and 
normal T lymphocytes were used to study the effects of SF extract dilutions on cancerous 
and normal immune cells. H9 cells are transformed cutaneous T lymphocytes which were 
clonally derived from a HUT 78 cell line. This cell line was acquired from a patient 
suffering from Sezary syndrome, a type of lymphoma (Mann et al, 1989). 
Lymphocytes and the derived cell lines require specialised environments for their 
successful culture and growth. The essential requirements for an optimum cell culture 
environment are temperature, hydrogen-ion concentration (pH), gas phases and media 
containing the necessary nutrients. RPMI-1640 medium has been used for the culture of 
human normal and neoplastic leukocytes. RPMI-1640 was developed by Moore et al., 
(1968) at Roswell Park Memorial Institute. RPMI-1640, when properly supplemented, has 
demonstrated wide applicability for supporting growth of many types of cultured cells, 
including fresh human lymphocytes (ECACC Handbook, 2006). For this study, RPMI-
1640 was used for culturing the lymphocytes cell lines and was supplemented with foetal 
calf serum (FCS), A^-2-Hydroxyethylpiperazine-7V'-2-ethane-sulphonic acid (HEPES) 
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buffer, L-glutamine and Pen-Strep-Fungizone (PSF). A full discussion of how these cell 
lines were cultured follows below. 
3.2 Materials and Methods 
This study received full ethical approval on the 11th of March 2008 from the Biomedical 
Research Ethics Committee and Higher Degree Committee. This was after the initial ethics 
approval granted in 2007 was amended to remove the HIV part of the study. The reference 
number given to the first application was EXP057/06 and the same reference was kept for 
the amended protocol. 
3.2.1 Materials 
RPMI-1640 containing HEPES buffer (25mM), FCS, PSF, L-glutamine were purchased 
from Adcock Ingram (South Africa). Plastic tissue culture flasks and Histopaque 1077 
were purchased from Sigma Aldrich (SA). BD IMagnet™ and BD IMag™ Human T 
lymphocytes Enrichment Set- DM for isolating T cells from peripheral blood mononuclear 
cells (PBMCs) were purchased from BD BioSciences (SA). Dimethyl sulphoxide (DMSO), 
Ethanol and all other organic solvents were purchased from Merck Chemicals (SA). 
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3.2.2 Methods 
3.2.2.1 Aseptic techniques and good laboratory practices 
Aseptic techniques were strictly adhered to at all times during culturing of cells in the 
tissue culture laboratory. Protective gear (i.e. laboratory coat, closed shoes and gloves) 
were used at all times. All cell culture work was carried out in a Lab Aire biological safety 
cabinet (Class 2) equipped with a vertical laminar flow hood and UV light. To minimise 
contamination, all work surfaces were swabbed with 70% ethanol before and after use. All 
materials used in the tissue culture were sterilised either by filtering with 0.45 /xm filters or 
by autoclaving. 
3.2.2.2 Growth of H9 cells 
The T cell lymphoma cell line, H9, was a kind gift from Professor Raveen Parboosing 
(Department of Virology at Inkosi Albert Luthuli Central Hospital). The H9 suspension 
cells were cultured in RPMI-1640 medium supplemented with 10% FCS together with 1% 
PSF, and 1% L-glutamine. The cells were incubated at 37°C in 5% carbon dioxide (CO2). 
The CO2 provides the natural buffering system where gaseous CO2 balances with the CO2 / 
HCO3 content of the culture medium in order to maintain the pH at a range of 7.2 to 7.4. 
FCS is a complex mixture of albumin, growth factors, growth inhibitors, hormones, amino 
acids, carbohydrates and lipids and is an important component of cell culture medium. This 
serum also provides buffering capacity to cultures and is important for slow growing cells 
or where the seeding density is low. Further, FCS has an advantage in that it can be used 
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for many different cell lines which have different growth factor requirements. The use of 
FCS in media also increases the risk of contamination. Heat inactivation of serum 
(incubation at 56°C for 30 minutes) can help to reduce the risk of contamination since 
some viruses are inactivated by this process (ECACC Handbook, 2006). 
Pen-Strep-Fungizone is an antibiotic combination of Penicillin, Streptomycin and 
Fungizone which are effective against Gram positive and Gram negative bacteria and 
fungi. L-glutamine is required in cell culture media formulations because it supports cell 
growth. Glutamine becomes essential cells that have high energy demands and synthesize 
large amounts of proteins and nucleic acids. It is an alternative energy source for rapidly 
dividing cells and cells that use glucose inefficiently. Although L-glutamine is synthesised 
by all normal cells, transformed cancerous cells are dependent on exogenous sources 
(ECACC Handbook, 2006). 
The H9 cell line was maintained at 1 x 105 — 1 x 106 cells/ml. Splitting was done twice 
weekly to maintain the flasks at 80%- 90% confluence. H9 cells grow as a single cell 
suspension with some clumping. Their morphology is mature lymphocytic (National 
Institute of Health (NIH), 2005). 
3.2.2.3 Subculture of H9 cells 
Cultures derived from blood (i.e. lymphocytes, B cells, etc) mostly grow in suspension as 
either single cells or clumps. For these cell types, subculturing by dilution of each flask is 
relatively easy. But cells that grow in clumps may necessitate that they are pelleted to a 
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single cell suspension by centrifugation and re-suspension by pipetting before they are 
counted and subcultured (ECACC Handbook, 2006). 
H9 cells were subcultured while growing in exponential growth phase. Rapidly growing 
cells were bright, round and refractile when viewed under the microscope. Gently tapping 
on the side of the flasks allowed the removal of some clumps. Subculturing of each flask 
was dependent on the confluence of cells and their growth rate. The process of 
subculturing involved centrifugation to remove the old media and diluting the cells into 
two new flasks with new pre-conditioned RPMI-1640 media. A small quantity (100- 200 
ul) of the cell suspension was used for cell quantification to determine the seeding density 
(Figure 3.1). 
View culture under light microscope 
, i zr 
Pellet cells by centrifugation 
Replace old media with new media 
Count cells to ensure viability and correct seeding 
volume 
• J L _ — -_-™_~__^OT^-™_^™»^™ 
Subculture every 2-3 days 
Figure 3.1: Schematic illustration of the subculture process in suspension cultures. 
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3.2.2.4 Cell quantification 
Cell culture experiments require that the number of cells in an assay must be quantified to 
ensure maximum growth. This in turn gives results with better reproducibility (ECACC 
Handbook, 2006). Haemocytometers are counting chambers developed to count blood cells 
but are used for other cell types. It is a thick glass slide with two counting platforms in its 
centre. The grid is divided into 9 large squares, each 1mm x 1mm, by triple lines. Each 
large square is divided into 25 medium squares, each 0.23mm on a side, and each medium 
square is further divided into 16 small squares, each 0.05mm on a side (Figure 3.2). The 
haemocytometer can be used where cell densities are in the range 5 x l0 4 -10 7 cells/ml. 
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Figure 3.2: Diagram of the haemocytometer grid. 
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Trypan blue, a vital dye, is used to stain cells and viability is determined using a 
haemocytometer. The reactivity of trypan blue is based on the fact that the chromopore is 
negatively charged and does not interact with the cell unless the membrane is damaged. 
Therefore, all the cells which exclude the dye are viable (Freshney, 1987). 
The H9 cells were suspended in RPMI-1640 and under sterile conditions 100-200uL of the 
cell suspension was placed into an equal volume of 0.4% Trypan blue (2x dilution) 
(appendix 1). This was mixed by pipetting up and down a few times and left at room 
temperature for 10 minutes. An equal amount (10 fi\) was pipetted into each of the two 
haemocytometer chambers, covered with a clean coverslip and viewed under a light 
microscope (20 x magnification). The number of viable (appeared bright) and dead cells 
(stained blue) were counted. Ideally more than a hundred cells were counted in order to 
increase the accuracy of the cell count. The concentration of viable cells was calculated 
using the following formulae: 
Concentration of viable cells = (Total unstained viable cells / Total number of cells 
[stained and unstained]) x 100 
Total number of viable cells/ml = Average count per square x dilution factor x 104 
Dilution factor = 2 (volume of cell suspension and trypan blue 1:1) 
104 = correction factor (supplied by haemocytometer manufacturer) 
The cell counts were repeated twice to ensure accuracy of the number of cells treated for 
each experiment. 
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3.2.2.5 Cryopreservation of cells 
Cryopreservation enables stocks of cells to be stored preventing culture of many flasks at 
any given time. Other advantages of cryopreservation include reducing microbial 
contamination of cultures, reduced cross-contamination with other cell lines, reduced 
genetic drift and morphological changes and a reduction in cost. The basic principle of a 
successful cryopreservation is slow freeze and quick thaw. Although the precise 
requirement may vary with different cell lines as a general guide cells should be cooled at a 
rate of-1 C to -3 C per minute. Cells should be in a log phase of growth when they are 
stored. FCS and a cryoprotectant like dimethyl sulphoxide (DMSO) should also be used in 
the cryopreservation media. A cryoprotectant prevents the formation of ice crystals 
(ECACC Handbook, 2006). 
The cryopreservation media for the H9 cells comprised RPMI-1640, DMSO and FCS 
(appendix 1). For cryopreservation, a confluent flask of H9 cells was identified and viewed 
under microscope to assess the degree of cell density and cell viability. The cells were then 
centrifuged at 400g for 10 minutes to remove culture which was then replaced with 2 ml of 
cryopreservation media. This suspension was aliquoted into cryovials and placed into a 
nalgene cooler (Figure 3.3). The nalgene cooler is a container which is filled with 
isopropanol and allows the slow freezing of preserved cells up to -70°C without the 
necessity to monitor the freezing process. Cultures cryopreserved in this way were easily 
resuscitated when a new culture was needed. 
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View culture under light microscope 
Pellet cells by centrifugation 
"~T~~~ 
Remove old media and add cryopreservation 
media 
Aliquot into cryovials and place into nalgene slow 
freezer 
Store at -70 °C until required 
Figure 3.3: Schematic diagram representing the H9 cells cryopreservation process. 
3.2.2.6 Resuscitation of Frozen Cells 
It is vital to thaw cells correctly in order to maintain the viability of the culture and enable 
the culture to recover more quickly. Dimethyl sulphoxide is toxic above 4°C therefore it is 
essential that cultures are thawed quickly and diluted in culture medium to minimize the 
toxic effects. A water bath at 37°C is better to use for fast thawing than placing the 
cryovials in an incubator (ECACC Handbook, 2006). 
For H9 cells resuscitation, the cryovials were removed from the -70°C freezer and placed 
directly into the water bath at 37°C. Water was prevented from entering the cryovials by 
sealing them completely. The cryovials were allowed to thaw for 1-2 minutes. The thawed 
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cells were then pipetted into flasks with pre-conditioned media The flasks were placed 
into the incubator overnight to allow cells to recover. The media was removed the next day 
and replaced with new preconditioned media without any cryopreservation media 
3.2.3 Isolation of Human T cells from whole blood 
3.2.3.1 Isolation of Peripheral Blood Mononuclear Cells (PBMCs) from whole blood 
Blood from a healthy individual (myself) was drawn into lithium heparin vacutainer tubes 
(5ml). The blood was then carefully layered onto equal amounts of Histopaque 1077 in 
Sterilin tubes (15 ml). These tubes were then centrifuged at 1700 rpm for 30 minutes at 
25°C. After centrifugation, the tubes had four different layers (Figure 3.4) making up 
different components of blood and Histopaque 1077. These were the plasma layer at the 
top, the buffy coat, which had the PBMCs, was below the plasma, Histopaque 1077 made 




Red Blood Cells 
1 Blood 
Histopaque 1077 
Fig 3.4: Separation of whole blood using sucrose density gradient yields 4 distinct 
layers following centrifugation. 
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The plasma layer was carefully aspirated and discarded. The buffy coat containing PBMCs 
was aspirated into new 15 ml centrifuge tubes and washed twice with phosphate buffered-
saline (PBS, 5 ml), (2400 rpm for 20 minutes at 25°C). The final pellet was re-suspended 
in BD IMag Human T lymphocytes isolation buffer. 
3.2.3.2 Isolation of Human T cells from PBMCs 
The BD IMag™ Human T Lymphocyte Enrichment Set - DM was used for negative 
selection of T lymphocytes from PBMCs. The Biotinylated Human T Lymphocyte 
Enrichment Cocktail contains monoclonal antibodies that recognize antigens expressed on 
erythrocytes, platelets, and peripheral leukocytes that are not T lymphocytes. The BD 
IMag™ Streptavidin Particles Plus- DM are magnetic nanoparticles that have streptavidin 
covalently conjugated to their surfaces. With these two components, the BD IMag™ 
Human T Lymphocyte Enrichment Set- DM avoids the inadvertent activation of the 
enriched T lymphocytes by using reagents that do not directly bind to those T cells (BD 
IMag™ Technical Data Sheet, 2006). 
The Biotinylated Human T Lymphocyte Enrichment Cocktail simultaneously bound 
erythrocytes, platelets, and most leukocytes except the T lymphocytes. After washing away 
excess antibody, BD IMag™ Streptavidin Particles Plus - DM was added to the cell 
suspension and bound the cells bearing the biotinylated antibodies. The tube containing 
this labelled cell suspension was then placed within the magnetic field of the BD 
IMagnet™. Negative selection was then performed to enrich for the unlabelled T cells. 
Labelled cells migrated toward the magnet (positive fraction), leaving the unlabelled cells 
in suspension so they could be drawn off and retained (enriched fraction). The negative 
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selection was repeated twice to increase the yield of the enriched fraction (Figure 3.5). The 
combined enriched fraction contained T lymphocytes with no bound antibodies or 
magnetic particles. These cells were ready for downstream applications such as tissue 
culture (appendix 1). 
3.3 Conclusion 
The protocols used in tissue culture were according to published methods and were applied 
according to supplier's stringent instructions. The growth of H9 cells was optimal and they 
showed resilience to changes in their environment. The normal human T cells also showed 
optimal growth when incubated for up 48 hours despite the long processing procedures. 
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{The circled numbers correspond to the steps of the Protocol on the following page.) 
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Figure 3.5: Human T lymphocytes enrichment flow chart using the BD IMag™ 




CYTOTOXICITY OF SUTHERLANDIA FRUTESCENS ON 
CULTURED H9 CELLS AND NORMAL T CELLS 
4.1 Introduction 
In vitro cytotoxicity assays are useful in that they measure the effects of toxic chemicals on 
the basic functions of cells, and that the toxicity can be measured by assessing cellular 
damage. The development of in vitro cytotoxicity assays has been driven by the need to 
rapidly evaluate the potential toxicity of large numbers of compounds, to limit animal 
experimentation whenever possible, and to carry out tests with small quantities of 
compound (www.noabbiodiscoveries.com). 
There are three basic parameters upon which these measurements are based. The first assay 
type measures cellular metabolic activity. An early indicator of cellular damage is a 
decrease in the metabolic rate. Tests which can measure metabolic function measure 
cellular ATP levels or mitochondrial activity. A second parameter often tested is the 
measurement of membrane integrity. The cell membrane forms a functional barrier around 
the cell, and traffic into and out of the cell is highly regulated by transporters, receptors and 
secretion pathways. Damaged membranes lose this regulation and allow substances to 
migrate through the membrane unregulated. Changes in metabolic activity have been 
shown to be better indicators of early cell injury while effects on membrane integrity are 
indicative of more serious injury, leading to cell death. Another parameter often measured 
to indicate cytotoxicity is the direct quantification of cell numbers, since cytotoxicity 
58 
normally decreases cell numbers. Cell numbers can be measured by direct cell counting, or 
by the measurement of total protein or DNA, which are proportional to the number of cells 
(www.noabbiodiscoveries.com). 
4.2 The MethylThiazol Tetrazolium (MTT) Assay 
Chemosensitivity tests are commonly utilised in both research and clinical environments to 
determine the effects of compounds on tumour cells. A positively charged yellow 
tetrazolium salt, 3-[4,5-dimethylthiazol-2-yl]-2,5-diphenyltetrazolium bromide (MTT), , is 
widely used as an indicator of cell viability and metabolism in cultured cells. This assay 
was first described by Mosmann (1983). The MTT assay offers a quantitative, convenient 
method for evaluating a cell population's response to external factors, whether it is an 
increase in cell growth, no effect, or a decrease in growth due to necrosis or apoptosis 
(Cooke and O'Kennedy, 1999; Newman et al, 2000; ATCC, 2001). 
The mechanism by which the tetrazolium salts are converted to coloured complexes 
appears to involve the reduction by the addition of electrons donated by several 
dehydrogenases, where this may be in cytosolic enzymes or mitochondrial enzymes of the 
respiratory chain. The reduction of the yellow MTT salt is followed by the formation of 
purple formazan crystals (Figure 4.1). MTT is taken up by cells by endocytosis, reduced in 
the cytosolic, endosomal or lysosomal compartments, and then transported to the 
extracellular space through exocytosis in the form of needle-like formazan. A 
solubilisation solution (DMSO) is added to dissolve the insoluble purple formazan product 
into a coloured solution. Different cell types have tremendous differences in their rate of 
MTT reduction (Cooke and O'Kennedy, 1999; Molinari et al, 2005). 
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Figure 4.1: The reduction of the MTT salt to form formazan crystals in metabolically 
active cells (Rode et ai, 2004). 
The absorbance of this coloured solution can be quantified by measuring at a certain 
wavelength (usually between 595 and 655 nm) by a spectrophotometer. This reduction 
takes place only when mitochondrial reductase enzymes are active, and therefore 
conversion is directly related to the number of viable cells. When the amount of purple 
formazan produced by cells treated with a compound of interest is compared with the 
amount of formazan produced by untreated control cells, the effectiveness of the 
compound in causing death of cells can be deduced, through the production of a dose-
response curve (American Type Culture Collection (ATCC), 2001). 
The advantages of tetrazolium salts in monitoring growth of cultures are apparent in the 
use of microplate assays where avoidance of radioisotopes replaces the use of 
[3H]thymidine incorporation and related approaches. The assay has other advantages of 
being a rapid, semi-automated technique. The tetrazolium method also affords another 
advantage in that the yellow water soluble tetrazolium salt is converted upon reduction to a 
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lipid insoluble, purple formazan that becomes trapped within the cell (Newman et al., 
2000; Cooke and O'Kennedy, 1999). 
The MTT assay also has various disadvantages when used to measure cell viability. These 
include the inability to distinguish between cytostatic and cytotoxic effects, as well as the 
observation that some test compounds may interfere with the reduction of the MTT salt. In 
addition, succinate dehydrogenase, localized in the mitochondria as part of the 
tricarboxylic acid cycle (TCA), is only one of a number of oxidative enzymes that can 
form reducing equivalents and therefore measuring its activity may not be a very good 
predictor of cytotoxicity (Cooke and O'Kennedy, 1999). 
4.3 Luminescent Cell Viability ATP assay 
One evident physiological difference in cells undergoing apoptosis versus necrosis is in 
intracellular levels of ATP. Cell death via the apoptotic pathway is an energy dependent 
process that requires ATP. Longer incubation of cells under ATP-depleting conditions 
results in necrotic cell death. Incubation of cells in glucose-free medium with an inhibitor 
of the mitochondrial FQ FpATPases reduces intracellular ATP levels and completely 
blocks the Fas/Apo-1-stimulated apoptosis. ATP supplied through glycolysis and oxidative 
phosphorylation restores the apoptotic cell death pathway in these cells. ATP depletion has 
also been shown to inhibit caspase-3 activation and when ATP is depleted after the 
activation of caspase-3, subsequent apoptosis is significantly blocked. Thus, ATP-
dependent steps exist both upstream and downstream of caspase-3 activation in apoptotic 
signal transduction (Eguchi et al, 1997). 
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Therefore, loss of ATP in cells has been used as an indicator of cell death. In contrast, cell 
proliferation has been recognised by increased levels of ATP. The advent of luminometers 
has allowed detection of changes in ATP levels in ultra-small amount of sample 
preparations. A luminometer is a photometer used for measuring very low light levels. For 
our experiments, we utilised a Modulus™ Microplate Luminometer (Turner BioSystems), 
a super sensitive luminometer. It also comes preloaded with luminescence and 
fluorescence protocols. 
The luminometer in combination with the Promega CellTiter-Glo™ Luminescent Cell 
Viability Assay Kit provides a convenient, rapid, and sensitive procedure for determining 
the number of viable cells in a culture. Presence of metabolically active cells is signalled 
by ATP quantitation. The method utilises bioluminescent detection of the ATP levels for a 
rapid screening of cell death in cells. The assay uses luciferase as the detection enzyme 
because mammalian cells lack endogenous luciferase activity. Luciferase enzyme requires 
ATP in order to generate light. Metabolically active cells produce ATP as energy for 
respiration and other vital processes. After an equal volume of CellTiter-Glo™ Reagent is 
added to the cell culture, luminescence is measured. Light signal is proportional to the 
amount of ATP present which correlates with the number of viable cells present (Turner 
BioSystems Application Notes, 2008). 
The cytotoxicity of SF was investigated on cancerous H9 T lymphocytes and normal T 
cells. Commercially available SF tablets (PhytoNova) were extracted with 70% ethanol 
and deionised water respectively and were diluted into 1/50 and 1/200 dilutions of each 
tablet extract. These dilutions were then used to treat the T cell lines over incubation 
periods of 24 and 48 hours. Tai et al. (2004) showed that SF had an IC50 of 1/150 (70% 
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SFE extract) using Jurkat T cells. We chose two concentrations which would cover this 
range as different cell lines have been shown to react differently to SF. 
The use of an organic solvent extract like that of ethanol has been favoured as it has been 
shown to extract more of the plant's active ingredients. Because of the use of ethanol as an 
extracting solvent, this made it necessary that a vehicle (ethanol) control be included in the 
experimental setup. Camptothecin (CPT) at a concentration of 20 juM was included as 
positive control. The SFW extracts were included because commercial tablets which were 
ready for human consumption were used in this experiment. Sutherlandia frutescens tablet 
dosages are taken with water and the SFW extracts would better reflect what happens in 
vivo during absorption and metabolism. This type of experimental setup was utilised for 
both the MTT and ATP assays. A similar theme was followed for all the other assays that 
performed. 
4.4 Materials and Methods 
4.4.1 Materials 
The tetrazolium salt (MTT) was purchased from Sigma Chemical Company (SA). DMSO 
and ethanol were purchased from Merck Chemicals (SA). Promega CellTiter-Glo™ 
Luminescent Cell Viability Assay Kit was purchased from Promega (SA). Modulus™ 
Microplate Luminometer was from Turner BioSystems (USA). SF tablets were purchased 
from King Edward Pharmacy (Durban). 
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4.4.2 Methods 
4.4.2.1 Extraction of Sutherlandia fmtescens tablets 
Sutherlandia frutescens tablets (PhytoNova) were used in this study. Each tablet was 
extracted according to the method of Tai et al, (2004). Briefly, SF tablets containing 
300mg of raw herb powder (per tablet) compounded with inert excipients were extracted 
with 2.2 ml of 70% ethanol/triple distilled water at room temperature for 2 hours on an 
orbital shaker. The suspension was then centrifuged at 5 000 xg for 10 minutes and the 
supernatant was removed. The extracts were filter sterilised with 0.45 /xm filters. These 
extracts were further diluted to 1/50, 1/150, 1/200, and 1/300 (appendix 2) with complete 
culture medium (RPMI-1640 supplemented with 10% FCS, 1% L-glutamine, and 1% 
PSF). Each dilution was made up to 1 ml. The extracts could be stored at 4 °C for up to 
three months without the loss of efficacy. 
4.4.2.2 Preparation of MTT Salt Solution 
A 5mg/ml MTT salt solution was made by dissolving 5mg of the salt in 1 ml of Paste 
MTT salt solution was prepared just before it was used. 
4.4.2.3 Preparation of Promega CellTiter-Glo™ Luminescent Cell Viability Assay Kit 
The cell viability kit for ATP was made up of a CellTiter-Glo™ Substrate and CellTiter-
Glo™ Buffer. To make the CellTiter-Glo™ Reagent, the whole contents of one bottle of 
CellTiter-Glo™ Buffer (10ml) were transferred into one bottle of CellTiter-Glo™ 
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substrate. The contents were mixed by inversion until the substrate was thoroughly 
dissolved. The reconstituted reagent was used when properly warmed up to room 
temperature and could be stored at 4 C for two days with 5-20% loss of activity. 
4.4.2.4 Treatment of H9 cells and normal T cells for both the ATP and MTT assays 
A confluent flask (75 cm ) with 30 ml of exponential growing H9 suspension cells was 
used for the MTT assay. A cell count was determined using trypan blue to give a cell 
number of 2.5 x 106 cells/ml. Aliquots of the cell suspension (2 ml) were transferred into 
each well of a 6-well plate. The 6-well plates were labelled according to the different 
treatment dilutions and types. Dilutions of SF (4 ml/well) were then added to each of the 
treatment wells. The well for the vehicle control (70% ethanol) had a similar amount of H9 
cells and ethanol diluted into 4 ml. A CPT, 20 /xM, positive control was also prepared. An 
untreated control was made in which 2 ml of cells in a well had 4 ml of CCM added to 
them (Figure 4.2). The 6 well plates were then incubated for 24 and 48 hours at 37 C in an 
incubator. 
A similar treatment procedure was followed for the normal T cells. T cells were isolated 
from PBMCs using the Human T Lymphocyte Enrichment Set - DM (BD IMag™), 
washed with PBS and then diluted in RPMI-1640 media. A cell count (as described 
previously) of 1.5-2 x 106 cells/ml was determined. Separate 6 well plates were used for 
the treatment of normal T cells. The treatment with SF and the three controls were 
performed similarly to the H9 cells. 
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Figure 4.2: A schematic illustration of the treatment procedure in 6 well plates for 
both the H9 cells and normal T cells in performing the MTT assay. 
4.4.2.5 The MTT assay 
At the end of each incubation period (24 and 48 hours), a 100 ul from each treatment 
concentration was pippetted into three different wells of a 96-well plate (Figure 4.3). A 
freshly prepared MTT salt solution (10 ul of 5 mg/ml working solution) was added into 
each of the 96 wells. The untreated control, 70% ethanol treated cells and the CPT treated 
cells were also treated in the same way. This procedure was the same for both the H9 cells 
and the normal T cells. The 96-well plate with treated cells and the MTT salt were then 
incubated for 4 hours at 37 °C. 
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Figure 4.3: An illustration outlining the set up of the MTT assay in the 96-well plate. 
The wells from column A to C were for the treatment of H9 cells and columns F to H 
were for normal T cells. 
After incubation with the MTT salt, the 96-well plate was centrifuged at 500 xg for 10 
minutes to pellet the suspension cell lines. The culture media and excess MTT salt were 
aspirated and DMSO (100 ul/well) was added to each well. The plate was incubated for an 
hour at 37 °C to allow solubilisation of the purple formazan. The absorbance of the treated 
wells and controls was then spectrophotometrically determined at a wavelength of 595 nm 
with a reference wavelength of 655 nm using a Bio-Tek microplate reader. The assay was 
repeated three times and cell viabilities of the different treatments were the average of the 
triplicate readings. The cell viabilities of the treated cells as compared to the untreated 
control were used to generate a dose-response curve for the SF extracts. 
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4..2.5.1 Statistical analyses of the MTT results 
The percentage cell viability for the average absorbance of each treatment was calculated 
using the following formula: 
Average absorbance of treated cells 
Cell Viability = x 100 
Average absorbance of untreated control cells 
Data analyses were done on Microsoft Excel to obtain the averages, cell viability 
percentages and the standard deviations. The different levels of significances within the 
separate treated groups were analysed using one-way analysis of variance (ANOVA) and 
the differences between the treated cells and the control cells were analysed using the 
Tukey and Bonferroni methods for multiple comparisons. Differences with/? < 0.05 were 
considered statistically significant. 
4.4.2.6 Luminescent Cell Viability ATP assay 
Luminescent Cell Viability ATP assay was only done on H9 T cells in order to confirm the 
anti-proliferative effects of SF on cancerous cells. After the end of each incubation period 
(24 and 48 hours), a 100 /xl from each treatment concentration was pipetted into two 
different wells of a white opaque 96 well plate. It is crucial to use white opaque plates 
when doing a luminescence assay as these plates are able to reduce the cross-reactions and 
background luminescence due to the specially formulated composition of the white resin. 
This increases assay sensitivity by reflecting emitted light into the detector. 
The ATP assay was done in duplicate, due to the high sensitivity of the assay. Cells were 
aliquoted into designated wells of a 96-well plate as in the MTT assay and allowed to come 
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to room temperature. The CellTiter-Glo Reagent was mixed immediately before use and 
was added to the wells with treated cells at 25 /xl per well. The plate was shaken on a plate 
shaker for 2 minutes at 300 rpm. This plate was then incubated out of direct light for 10 
minutes at room temperature after shaking. 
The Modulus™ Microplate Luminometer from Turner BioSystems comes with a 
preinstalled protocol for analysis of samples for the Promega CellTiter-Glo™ Luminescent 
Cell Viability Assay Kit. The instrument was turned on 20 minutes before use to pre-warm 
and pre-condition it. At the end of the incubation period, the plate was put into the 
luminometer and the relative light units (RLU) of the samples were measured. A dose 
response curve was also generated for the ATP levels using the RLU and the dilutions of 
SF and different control samples. Basically the RLU, which are equivalent to 
luminescence, reflect the amount of ATP in a given sample. 
4.4.2.6.1 Statistical analysis of ATP assay results 
As mentioned above, the amount of luminescence obtained for each sample represents the 
amount of ATP detected by the luciferase enzyme. Therefore a comparison of the average 
reading of each sample to the next sample gives the differences in ATP levels between 
samples. Data analyses were done on Microsoft Excel to obtain the averages, percentage 
ATP levels relative to the untreated control and the standard deviations of each treatment. 
The different levels of significances within the separate treated groups were analysed using 
one-way analysis of variance (ANOVA) and the differences between the treated cells and 
the control cells were analysed using the Tukey and Bonferroni methods for multiple 
comparisons. Differences with;?< 0.05 were considered statistically significant. 
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4.5 Results and Discussion 
4.5.1 The MTT assay 
Sutherlandia frutescens 70%> ethanol (SFE) and deionised water (SFW) extracts dilutions 
were incubated with H9 T cells and normal T cells for 24 and 48 hours (appendix 5 for all 
spectrophotometer readings). In the H9 T cells after 24 hours, the cell viability decreased 
significantly (p= 0.001) in both dilutions of the SFE extract as compared to the untreated 
control cells (Figure 4.4). The 50%> inhibition (IC50) of cell viability for the SFE extract 
dilution was estimated to be 1/40 after 24 hours incubation. The number of viable cells in 
the SFE extract dilutions was significantly (p< 0.05) lower than that of the vehicle control 
cells (70% ethanol-treated), which indicated that the effect of the extract was independent 
of ethanol. The SFE extract vehicle control was made by using the equivalent amount of 
70% ethanol as used in making up the lowest dilution (1/50) of the SFE extract. 
The positive control, camptothecin, induced the higher levels of cell death when compared 
to both the SFE and SFW extracts but this effect was not statistically significant (p> 0.05). 
Camptothecin is a secondary metabolite of Camptotheca plant and is known to induce 
apoptosis in cancer cells but is also known to induce apoptosis cell death in normal cells. 
Camptothecin acts by interrupting the breakage/reunion cycle of mammalian DNA 
topoisomerase 1 by trapping a reversible topoisomerase 1 -DNA cleavable complex (Chen 
et al., 1993). The 1/50 SFW extract dilution significantly (p= 0.049) decrease H9 T cell 
viability when compared to the untreated control cells. The cytotoxicity of the SFW 
extracts to H9 T cells showed a dose-dependent trend after 24 hours of incubation, with the 
lowest dilution (1/50 SFW) inducing the higher cytotoxicity (Figure 4.4). 
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The effects of the SFE and SFW extracts on normal T cells after 24 hours showed a 
different effect as observed on H9 T cells. Overall bom the SFE and SFW extracts 
dilutions significantly (p= 0.003) increased cell proliferation when compared to the 
controls. The SFE extract dilutions were more potent at increasing cell proliferation, with 
the highest dilution (1/200) being more effective as compared to the untreated control cells. 
Both SFE extract dilutions were not significantly (p= 0.122 and p=0.232) different from 
the vehicle control, which meant the observed proliferative effects were related to the use 
of ethanol for extracting the tablets. The same dose-dependent cell proliferative effects 
were observed with the SFW extract dilutions but this was not significant (p= 0.391 andp= 
0.139). Camptothecin did not induce significant normal T cell cytotoxicity as in H9 T cells. 
The effects of CPT on normal T cells were significantly (p= 0.005) different to the 
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Figure 4.4: A dose response curve of different extract dilutions of Sutherlandia 
frutescens on the H9 T cells and normal T cells over a period of 24 hours. 
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The dose-dependent decrease in H9 T cell viability was still evident after incubation of 
these cells with the extracts of SF for 48 hours (Figure 4.5). In the SFE extract dilutions, 
this trend also became time-dependent as the lowest dilution (1/50) significantly (p= 0.001) 
decreased cell viability to 27% of the untreated control cells. This was well below the IC50 
of the extract (1/105) after 48 hours. There was significant (p= 0.001) difference between 
the vehicle control and the SFE extract dilutions treated cells. In the SFW extract dilutions, 
the lowest dilution (1/50) was shown to have significantly (p= 0.014) decrease the number 
of viable cells as compared to the untreated control cells (appendix 5). 
The effects of the SF extracts on normal T cells change after 48 hours incubation as 
compared to the 24 hours incubation (Figure 4.5). The proliferative effects of SFE extract 
dilutions were significantly reversed as compared to levels of viability at 24 hours, i.e. 
254% cell viability at 24 hours versus 109% viability after 48 hours in the 1/50 SFE extract 
dilution. The vehicle control was not statistically significant (p- 0.611) from the SFE 
extract dilutions, meaning that the effects of the extract was not independent of ethanol. In 
contrast to the reversal of cell proliferation in the SFE extract dilutions, the SFW extract 
dilutions showed a time-dependent increase in cell viability after 48 hours incubation. This 
proliferation was significantly higher than the untreated cells (p= 0.004), the SFE extract 
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Figure 4.5: A dose response curve of different extract dilutions of Sutherlandia 
frutescens on the H9 T cells and normal T cells after 48 hours incubation. 
Sutherlandia frutescens is a traditional remedy that has been purported as having 
anticancer properties. Some of the anticancer theories have been proven in in vitro assays 
with transformed malignant cell lines. Sutherlandia frutescens is also said to be a potent 
immune booster and an adaptogen. The immune boosting effects of this plant have not 
been conclusively tested in vitro while a few studies have looked at the effects of SF on 
blood parameters in vivo on healthy subjects. No study has shown that SF can selectively 
induce cytotoxicity in malignant cells while sparing the normal cells. 
Tai et al., (2004) looked at the effects of the SF on different malignant cell lines. Three of 
these cell lines were related to the immune system, i.e. human leukaemia Jurkat cell line, 
human pre-myelocyte HL60 cells and murine RAW 264.7 macrophage/monocyte cells. 
Using SFE extract dilutions of each SF tablet, they showed that SF extracts induced 50% 
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inhibition of proliferation of Jurkat cells at 1/150 and HL60 cells at 1/200 dilutions. These 
were higher dilutions than we found in our experiments (1/40 after 24 hours and 1/105 
after 48 hours) but different cell lines have been shown to react differently to this 
medicinal plant. Suspension cell lines like Jurkat and H9 T cells, which are normally found 
in blood, have been shown to respond to higher concentrations of SF than attachment 
cultures. 
Sutherlandia frutescens ethanol extracts from plant material of the SF plant were tested for 
their influence on cell numbers, morphology and gene expression profiles in a MCF-7 
human breast adenocarcinoma cell line. A statistically significant decrease to 50% viability 
of malignant cell numbers was observed after 24 hours of exposure to 1.5 mg/ml SF extract 
when compared to the vehicle-treated controls (Stander et ah, 2007). The results of this 
were consistent with these findings as they showed that the 70% ethanol used for 
extraction of tablets did not play a significant role inducing cytotoxicity in H9 T cells. 
Aqueous extracts of SF at a concentration of 50 /xg/ml were tested for their cytotoxic 
ability in vitro against three human cancer cell lines: DU-145 prostate cancer cells, MDA-
MB-231 and MCF-7 breast cancer cells and a non-malignant breast cell line MCF-12A. 
The aqueous extracts inhibited growth of the oestrogen-dependent cancer cell lines and 
stimulated the growth of the MCF-12A and MDA-MB-231 cells (Steenkamp and Gouws, 
2006). Chinkwo (2005) found the crude aqueous whole plant extracts of SF to induce 
cytotoxicity in Jurkat T cells among the cell lines he used. The results obtained in study 
demonstrated comparable results in H9 T cells treated with aqueous extracts of SF over 24 
and 48 hours (Figures 4.4 and 4.5). 
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Sutherlandia frutescens has been shown to contain active ingredients like L-canavanine, L-
arginine, D-pinitol, GABA, and unique triterpenoid glucosides. Flow cytometric cell cycle 
analyses of different cell lines treated with SFE extracts of SF showed that the different 
cell lines were arrested at different phases of the cell cycle. This suggested that different 
active ingredients contained in the extracts may be involved in the inducing cell death in 
different cell lines (Tai et al., 2004). Of all the active ingredients contained in SF, L-
canavanine has been the only compound shown to induce cytotoxicity in tumour cell lines 
in vitro. L-canavanine is able to contribute to the production of canavanine-containing the 
proteins that can disturb protein synthesis as well as RNA and DNA metabolic pathways 
(Sia, 2004). 
There has not been much information with regards to the anti-proliferative effects of the 
other active ingredients of SF. L-arginine, an antagonist of L-canavanine, is a precursor of 
nitric oxide (NO) which is synthesised by the nitric oxide synthase enzyme. Increased 
production of NO can lead to NO-induced cytotoxicity by oxidative injury within cells 
(Sia, 2004). The cytotoxic effects of the unique triterpenoid glucosides have not been 
tested. Haridas et al., (2004) associated triterpenoids with anti-tumour activity. These 
observations suggest that there may be many bioactive compounds present in SF, possibly 
acting synergistically to induce the anti-proliferative effects seen in H9 T cells in this study 
and in other tumour cell lines. 
According to the MTT assay results, the extracts of SF exhibited selectivity in inducing 
cytotoxicity in H9 T cells while causing proliferation in normal T cells. No published study 
has looked directly at the effects of SF extracts on normal T cells in vitro. This is in direct 
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contrast to the reported use of this traditional herbal remedy as an immune tonic. There 
have been suggestions that this plant be used in clinical trials on HIV/AIDS patients. 
A safety study of SF on vervet monkeys was conducted by the Medical Research Council 
(MRC) of South Africa. Monkeys given a dose nine times the recommend dose of SF (81 
mg/kg body weight per day for 3 months) did not show significant changes to relevant 
haematological, biochemical, and physiological parameters (MRC, 2001). A more recent 
clinical trial on healthy human adults given SF showed that there were no significant 
differences in general adverse events or physical, vital, blood, and biomarker indices 
between the treatment and placebo groups (p> 0.05) (Johnson et al., 2007). 
Fernandes et al, (2004) looked at the antioxidant potential of SF on normal neutrophils 
isolated from whole blood. Although the main purpose was to assess the oxidant 
scavenging properties, they also looked at cell viability of the neutrophils treated with hot 
SFW extracts of SF using an acridine orange/propidium iodide staining method. The SF 
hot SFW extracts, up to concentrations of 40/xg/ml, had no adverse effect on cell viability 
at 30 minutes of incubation with viability maintained at > 95%. The deionised SFW 
extracts used in our experiments with normal T cells showed a time-dependent increase in 
cell viability of the treated cells. The difference with the results of Fernandes et al. (2004) 
may be as a result of the longer incubation periods utilised in our experiments (24 and 48 
hours versus 30 minutes). 
Anecdotes from field clinics using SF to treat wasted HIV/AIDS patients have reported 
improvements in appetite and body weight gains in patients. D-pinitol has been suggested 
to contribute to the positive effects of SF (Tai et al, 2004). D-pinitol is a glycan sugar 
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which an isomer of D-chiro inositol, meaning they can work interchangeably. D-chiro 
inositol has been identified in putative insulin mediator fractions that have hypoglycaemic 
activity and appears to act downstream in insulin-signalling pathways to mimic the effects 
of insulin. The two isomers have been shown to lower blood glucose concentration in rats 
and also increased the rate of glucose disappearance in insulin-resistant and hyper-
insulinemic monkeys (Davis et al, 2000). 
Therefore there is a possibility that D-pinitol might contribute to the cell proliferation seen 
in normal T cells (Figures 4.4 and 4.5). This effect might occur via the increased shuttling 
of glucose or nutrients into cells caused by the insulin like activity of D-pinitol. Increase 
cellular glucose would be supportive of the metabolic pathways needed for cell 
proliferation by providing an energy source. Increased metabolism would also increase 
activity of dehydrogenase and this translates to increased formation of formazan crystals. 
Such an effect would also require the suppression of the anti-proliferative activity of 
compounds such as L-canavanine. Cell signalling mechanisms would need to play an 
important role in such response machineries. Cytokines play an important role in such a 
process; whether a cell would divides and replicates or undergoes senescence. Although 
the mechanism is unknown, SF active compounds may affect cell signalling coordination 
in different ways according to the metabolism of the specific cell line. 
Another important observation in the MTT assay results was the fact that there was no 
statistically significant difference between the SFE extract treated isolated normal T cells 
and the vehicle treated isolated normal T cells (Figures 4.4 and 4.5). The initial increase in 
cell viability of SFE extract treated cells was mirrored by an increase in viability of vehicle 
treated cells. The reverse was observed after 48 hours as both sets of treatment type 
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decrease cell viability. Sutherlandia frutescens ethanol extracts have been used 
successfully in malignant cell lines without the ethanol influencing the effects of the plant 
(Tai et al, 2004; Stander et al, 2007 as examples). Even in malignant H9 T cells used in 
parallel with normal T cells in this study there was a statistically significant difference 
between the SFE extract treated cells and vehicle treated cells. 
The effects of ethanol on the SFE extract treated normal T cells were to initially enhance 
the proliferative effects of SF after 24 hours incubation (Figure 4.4). The composition of 
ethanol makes this organic solvent a good source of carbon chains for the glycolytic 
pathway in energy generation. Human lymphocytes cultured with ethanol and subsequently 
assayed for natural killer (NK) activity to K562 cells have enhanced NK activity compared 
to lymphocytes cultured without exposure to ethanol. Lymphocytes retained their enhanced 
cytolytic ability for several hours after removal from the ethanol-containing medium (Rice 
etal, 1983). 
Chronic intake of alcohol is associated with increased risk of hepatoxicity. The ingestion of 
alcohol produces oxidative stress generating free radicals of oxygen and ethanol. Oxidative 
stress has been shown to be a precursor of mitochondrial depolarisation leading to 
apoptosis or necrosis. These processes play an important role in production of injury which 
appears in the liver and in other organs and tissues (Colome et al., 2003). 
Organic solvents have been used in extracting active ingredients of plant material because 
of their efficiency in binding these active compounds. If it is assumed that the same effect 
occurred when SF tablets were extracted with 70% ethanol, then more active compounds 
were found in the SFE extracts than the deionised SFW extracts. Compounds like L-
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canavanine have been shown to be toxic at high concentrations. L-canavanine may be 
associated with serious toxicities including a systemic lupus erythematous syndrome (Mills 
et al, 2005b). At high doses it blocks any DNA synthesis in vitro and affects B cell 
function in autoimmune mice at low doses (Sia, 2004). 
L-canavanine has also been shown to be cytotoxic to PBMCs in culture. The suggested 
mechanism of L-canavanine toxicity is due it antagonist effects to L-arginine and the 
metabolic conversion of L-canavanine to L-canaline, which is toxic to human PBMCs by 
disrupting polyamine biosynthesis (Bence et al., 2002). Therefore a combination of ethanol 
and anti-proliferative compounds such as L-canavanine acting synergistically could have 
resulted in drastic reduction in cell proliferation after 48 hours incubation with the SFE 
extract dilutions of SF. 
4.5.2 Luminescent Cell Viability ATP assay 
The MTT assay has been previously shown to underestimate the cytotoxicity of various 
compounds, e.g. the growth inhibitory effects of interferons (IFNs). Cells have also been 
observed to metabolise the tetrazolium salt when lethally damaged and have lost their 
ability to exclude vital dyes. Formazan production can also be induced by drugs that cause 
perturbations of the cell cycle (Cooke and Kennedy, 1999). An ATP based assay was 
therefore used to confirm the cytotoxicity of SF on cancerous H9 T cells. 
The luminescent cell viability ATP assay uses recombinant luciferase to catalyse the 
following reaction: ATP + d-Luciferan + 0 2 -> Oxyluciferan + AMP + PPi + C02 + Light 
(560 nm). When ATP is the limiting component in the reaction, the intensity of the emitted 
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light is proportional to the concentration of ATP. Based on this reaction, the amount of 
ATP in SF extract dilutions treated H9 T cells was quantified using a luminometer. In H9 
T cells incubated for 24 hours, the change in ATP levels was significant for all the samples 
analysed (p= 0.001) (Figure 4.6, appendix 5 for luminometer readings). Comparing 
between the samples, only the positive control (CPT) had significantly reduced levels of 
ATP when compared to the untreated control (p= 0.001). There was no significant 
difference between the SF treated cells and the untreated control cells (p> 0.05). ATP 
levels were significantly reduced in the lowest dilution of the SFE extract (1/50) than in the 
in the vehicle treated cells (p= 0.001). The SFE extract dilutions reduced ATP levels more 
than the deionised SFW extract dilutions, but this was not statistically significant (p> 
0.05). 
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Figure 4.6: Schematic illustration of changes in ATP levels in SF treated H9 cells 
after 24 hours incubation. 
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After 48 hours incubation, the concentration of ATP in all the samples was reduced 
according to the luminescence readings (Figure 4.7). CPT inhibited production of ATP in 
H9 T cells when compared to the untreated cells (p= 0.001). H9 T cells treated with SFE 
extract dilutions had significantly (p= 0.001) reduced levels of ATP when compared with 
the untreated control cells. There was a significant difference (p= 0.001) in ATP levels of 
the SFE extract dilution treated cells and the vehicle treated cells. The lowest dilution of 
the deionised SFW extract dilution (1/50 SFW) also reduced the ATP levels significantly 
(p= 0.001). 


























# A # 
Sutherlandia frutescens dilutions 
Figure 4.7: A bar graph illustrating the reduced levels of ATP in SF treated H9 cells 
after 48 hours incubation. 
Mitochondria are the sites of oxidative phosphorylation during which substrate oxidation 
by the electron transport chain builds a proton gradient (Ay m) and fuels ATP synthesis. 
Loss of Avj/ m is a common event following exposure to toxins leading to cellular necrosis 
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or apoptosis (Lim et al., 2007). In this study, SF has been shown to have growth inhibitory 
and cytotoxic effects induced by reduction in levels of ATP in a dose and time-dependent 
manner. Therefore active ingredients in SF, like most other plant secondary metabolites, 
target the mitochondria for induction of toxicity leading to cell death. 
Mitochondria are not only important in ATP generation but are also a major source of ROS 
production and the earliest target of drug-induced cellular injury. Excess ROS is capable of 
reacting with NADH dehydrogenase, aconitase, and other enzymes that may account for 
inhibition of ATP production (Lim et al., 2007). ATP levels have been shown to determine 
the mode of cell death. Intracellular ATP levels were measured during cell death and 
shown to remain unchanged until the very end of the apoptotic process such as disruption 
of plasma membrane. Since it has been reported that loss of mitochondrial membrane 
potential which halts mitochondrial ATP production is an early step in apoptosis, 
intracellular ATP required for the rest of apoptotic processes must be provided from 
glycolysis (Tsujimoto, 1997). Leist et al., (1997) have shown that intracellular energy 
levels are dissipated in necrosis but not in apoptosis of neuronal cells. They also report 
demise of human Jurkat T cells caused by apoptotic triggers (staurosporin and CD95 
stimulation) changed from apoptosis to necrosis when cells were pre-emptied of ATP. 
Therefore, it is possible for apoptosis and necrosis to occur simultaneously in cell cultures 
exposed to the same insult. 
Another determinant of cell death mode might be the concentrations of the toxic reagents 
or drugs used. The same reagent might induce apoptosis at lower concentrations but induce 
cell death by necrosis at higher concentrations. This is probably due to the rapid collapse of 
cellular integrity including plasma membrane disruption, a large calcium influx, as well as 
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intracellular ATP depletion (Tsujimoto, 1997). That might be the case with treatment of 
cell cultures with SF. The lowest dilutions for both the SFE and SFW extracts caused the 
highest depletion of ATP after 48 ours incubations. The high concentrations of the extracts 
might induce apoptosis during early incubation, but the mode of cell death changes later 
when ATP reserves are depleted. 
4.5.3 Comparison of the effects of Sutherlandia frutescens extracts between MTT and 
ATP depletion assays on H9 cells. 
Sutherlandia frutescens reduced cell viability in a time-dependent and dose-dependent 
mode in the MTT assay. The SFE extract dilutions were more effective in reducing cell 
viability in the cancerous cell line and the effects were statistically independent of ethanol. 
The SFW extract dilutions did not significantly affect cell viability after 24 hours 
incubation but were more effective after 48 hours. 
When compared to MTT assay results, the ATP assay produced a very similar trend (Table 
4.1). The SFE extract dilutions were more effective in reducing ATP levels in H9 cells 
than the SFW extract dilutions and the effect was also time and dose-dependent. The SFW 
extracts also showed a time and dose-dependent reduction in ATP levels, with the effect 
more pronounced after 48 hours incubation. The similarity in the results obtained with both 
the MTT and ATP assays gives proof that SF is effective in inducing cell death in 
malignant H9 cells. 
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Table 4.1: Comparison of changes in cell viability assayed by the MTT assay and the 
percentage ATP concentrations measured by luminometry in H9 T cells treated with 
different dilutions of SF. 
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Cytotoxicity and cell viability assays are very important in evaluating the efficacy of 
purported medicinal plants against cancer models. The tetrazolium (MTT) assay and the 
luminescent cell viability assay are important assays in measuring metabolic function of 
cell cultures treated with anticancer agents. These assays were utilised in measuring the 
cytotoxic effects of SFE and SFW extract dilutions in cancerous H9 T cells and normal T 
cells. 
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In the MTT assay, the extracts showed a time and dose dependent cytotoxic effects in H9 T 
cells. The SFE extract was more effective in reducing H9 cell viability and this effect was 
independent of ethanol. The effect of the extracts in normal T cells was the reverse of what 
was observed in cancerous H9 cells, with cell proliferation evident after 24 hours 
incubation with both types of extracts. The SFE extract was more potent in causing 
proliferation after 24 hours but this proliferation was shown to be dependent on ethanol 
when statistically analysis was done. Cell proliferation was reversed in SFE extract treated 
cells and this was also shown to be dependent on ethanol when compared with vehicle 
treated cells. The SFW extracts treated normal T cells showed a time and dose dependent 
increase in cell proliferation. 
The luminescent ATP assay was utilised to confirm the cytotoxicity (as shown by the MTT 
assay) of SF in cancerous H9 T cells. A time and dose dependent decrease in ATP 
metabolism was observed with both SFE and SFW extracts. The ATP reducing 
diminishing effects of the SFE extracts were shown to be statistically independent of 
ethanol. Reduction in ATP metabolism has been shown to correspond with a decrease in 
cell viability. The luminescent ATP assay results combined with the MTT assay results 
confirmed that SF is cytotoxic to cancerous H9 T cells and causes cell proliferation in 
normal T cells in a dose dependent manner. 
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CHAPTER 5 
CASPASE 3/7 ACTIVATY IN H9 T CELLS AND ISOLATED 
NORMAL T CELLS AFTER TREATMENT WITH SUTHERLANDIA 
FRUTESCENS 
5.1 The role of caspase enzymes 
Early biochemical events normally dictate the mode of cell death. Cell death can follow 
two different pathways, i.e. apoptosis or necrosis. Necrosis is associated with acute cellular 
dysfunction in response to severe stress conditions or exposure to a toxicant. It is a passive 
process and is associated with a rapid depletion of ATP. Necrosis has been associated with 
some proteases, mainly calcium-activated or lysosomal proteases. Apoptosis, on the other 
hand, is a physiological process that occurs during development of multi-cellular 
organisms, during the immune response, or exposure to stress and xenobiotic agents. 
Several protease families are implicated in apoptosis, the most prominent being caspases 
(Samali et ai, 1999). 
Caspases are cysteine-containing aspartic acid-specific proteases involved in the initiation 
and execution of apoptosis. Initiator caspases (caspases-6, -8, -9 or -10) are able to activate 
effector caspases or amplify the caspase cascade by increased activation of effector 
caspases (caspase-3 and -7). Upon activation, effector caspases act on a variety of cellular 
proteins to cause arrest of the cell cycle and inactivate DNA repair, inactivate inhibitors of 
apoptosis, and dismantle the cytoskeleton of cells. During apoptosis, several important 
proteins such as Bcl-2 family members, cytochrome c, and apoptosis protease activation 
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factor-1 (APAF-1) are closely related to caspases. Pathways to activation of caspases have 
been shown to involve cellular organelles such as the mitochondria (cytochrome c release), 
endoplasmic reticulum (caspase-12 initiation), death receptors (Fas- or TNF-mediated), 
and granzyme B (Wang et ai, 2005; Samali et ai, 1999). 
The tumour cells of highly curable malignancies such as leukaemia's, testicular and Wilms 
cancer easily undergo caspase-dependent apoptosis. Most chemotherapeutic agents have 
been shown to be potent inducers of apoptosis. However, chemotherapeutic drugs also 
induce apoptosis in normal cells, limiting their use in cancer therapy (Samali et ai, 1999). 
Recently, it has become clear that inhibition of caspases does not always prevent 
irreversible loss of cellular function, although it does prevent the acquisition of apoptotic 
morphology. Alterations in mitochondrial membrane structure and function can occur in a 
caspase-independent fashion and have a higher predictive value for cell death than caspase 
activation (Green and Kroemer, 1998). 
Detection of caspase activity provides a useful assay for analyzing one of the earliest 
known biochemical events associated with apoptosis. A variety of fluorogenic caspase 
substrates have been developed for the detection of functional caspase activity using flow 
cytometry. Immunocyto-, -histochemistry, and blotting methods have also been utilised to 
study caspase activation in tissues and cell lines. Enzyme linked immunosorbent assay 
(ELISA) based methods have also been developed to achieve high throughput in a short 
space of time. In this study, we utilised a luminometer based method to analyse for 
caspase-3/-7 activation after treatment of suspension cell lines with SF. 
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5.2 Caspase-Glo 3/7 Assay 
The Caspase-GloR 3/7 Assay is a homogenous, luminescent assay that measures caspase-3 
and -7 activities. The assay provides a luminogenic caspase-3/-7 substrate, which contains 
the terra peptide sequence DEVD, in a reagent optimised for caspase activity, luciferase 
activity and cell lysis. Addition of Caspase-GloR 3/7 Reagent in an "add-mix-measure" 
format results in cell lysis, followed by caspase cleavage of the substrate and generation of 
a "glow-type" luminescent signal produced by luciferase (Figure 5.1). Luminescence is 
proportional to the amount of caspase activity present. The Caspase-Glo® 3/7 Reagent 
relies on the properties thermostable luciferase (Ultra-Glo™ Recombinant Luciferase), 
which is formulated to generate a stable "glow-type" luminescent signal and improve 
performance across a wide range of assay conditions (Promega, 2005). 
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Figure 5.1: Caspase-3/7 cleavage of the luminogenic substrate containing the DEVD 
sequence which results in luciferase reaction and generation of light (Promega, 2005). 
The Caspase-Glo 3/7 Assay is designed for use with multi-well plate formats, making it 
ideal for automated high-throughput screening of caspase activity or apoptosis. Cell 
washing, removing medium and multiple pipetting steps are not required. The caspase and 
luciferase enzyme activities reach a steady state so that the luminescent signal peaks in 
approximately one hour and is maintained for several hours with minimal loss of signal. 
This results in a rapid, sensitive and flexible caspase-3/-7 activity assay (Promega, 2005). 
5.3 Materials and Methods 
5.3.1 Materials 
Caspase-GloR 3/7 Assay kit was purchased from Promega (SA). Modulus™ Microplate 
Luminometer was purchased from Turner BioSystems (USA). 
5.3.2 Methods 
5.3.2.1 Preparation of the Caspase-Glo® 3/7 Reagent 
The Caspase-Glo® 3/7 Assay kit was made up of Caspase-GloR 3/7 buffer and lyophilised 
Caspase-Glo" 3/7 substrate. The buffer and substrate were equilibrated to room 
temperature before use. To make up the reagent, the contents of the Caspase-GloR 3/7 
buffer were transferred into the bottle of Caspase-Glo 3/7 substrate. This solution was 
mixed by swirling the contents until the substrate was thoroughly dissolved to form the 
working reagent. 
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5.3.2.2 Treatment of H9 cells and isolated normal T cells for Caspase-Glo 3/7 Assay 
H9 T cells and isolated normal T lymphocytes were treated in a similar manner to what 
was described for the MTT and ATP assays (paragraph 4.4.2.4, chapter 4). The difference 
was that three different dilutions of each of the SFE and SFW extracts (1/50, 1/150, and 
1/300) were utilised to increase the range of concentrations. The vehicle control (70% 
ethanol) and positive control (20 uM CPT) were also included as before. The incubation 
periods were kept at 24 and 48 hours. The full illustration of the treatment setup for the 
Caspase-Glo® 3/7 Assay is in Figure 5.2 below. 
Figure 5.2: A schematic illustration of the treatment procedure in 6 well plates for 
both the H9 cells and isolated T cells in performing the Caspase-Glo® 3/7 Assay. 
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5.3.2.3 Caspase-GUT 3/7 Assay 
At the end of each incubation period (24 and 48 hours), a 100 /il of each treatment type 
was pipetted into duplicate wells of a white-walled 96-well plate compatible with the 
luminometer. This was done for the H9 T cells and isolated normal T cells. A 100 /xl of 
RPMI-1640 was added into separate duplicate wells to serve as a blank for the reaction 
(Figure 5.3). Preconditioned Caspase-Glo® 3/7 reagent was added into each well at a ratio 
of 1:1 to the amount of cells in each well. The treated cells and the Caspase-Glo® 3/7 
reagent were allowed to equilibrate to room temperature before they were mixed. After 
mixing the two components, the plate was covered and gently shaken on a plate shaker at 
300-500rpm for 30 seconds. The plate was then incubated at room temperature in the dark 
for an hour. Luminescence for each sample was measured in a plate-reading Modulus™ 
Microplate Luminometer as directed by the manufacturer (Figure 5.4). The assay was 
repeated three times to confirm the observed results. 
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Figure 5.3: An illustration outlining the setup of the caspase assay in the white-walled 
96 well plate. The wells from column A to B were for the treatment of H9 cells and 
columns E to F were for normal T cells. 
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Figure 5.4: A schematic diagram of the Caspase-Glo 3/7 Assay protocol (Promega, 
2005). 
5.3.2.4 Statistical analysis 
The amount of luminescence obtained for each sample represented the amount of caspase 
activity detected by the luciferase enzyme. All the obtained luminescence readings were 
subtracted from the average reading of the blank. Therefore a comparison of the average 
reading of each sample to the next sample gives the differences in caspase activity between 
samples. Data analyses were done on Microsoft Excel to obtain the averages, percentage 
caspase activity relative to the untreated control and the standard deviations of each 
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treatment. The percentage caspase activity was calculated using the formula similar to the 
one used to calculate cell viability in the MTT assay (paragraph 4.3.2.5.1). The different 
levels of significances within the separate treated groups were analysed using one-way 
analysis of variance (ANOVA) and the differences between the treated cells and the control 
cells were analysed using the Tukey-Kramer multiple comparison methods. Differences 
with/?< 0.05 were considered statistically significant. 
5.4 Results and Discussion 
H9 T cells exhibited high caspase-3/-7 activity in the absence of an apoptosis inducing 
agent. This activity did not seem to lead to induction of apoptosis and cell death. This 
observation was confirmed by repeating the caspase-3/-7 assay with different cultures of 
H9 T cells which were grown at different times within a space of three months. Incubation 
of this cell line with a known inducer of apoptosis, CPT, did not increase caspase-3/-7 
activity but seemed to decrease it significantly. This decrease correlated with a decrease in 
cell viability as confirmed by the MTT assay in chapter 4. 
One-way analysis of variance in treated H9 T cells found that there was a statistically 
significant difference (p< 0.0001) between the samples after 24 hours incubation (Figure 
5.5). The SFE and SFW extract dilutions showed a concentration dependent decrease in 
caspase-3/-7 activity, with the lowest dilutions exhibiting the larger decrease in enzyme 
activity. The lowest dilution of the SFE extract significantly (p< 0.001) decreased caspase-
3/-7 activity compared to the untreated control. There was no significant difference (p> 
0.05) between the lowest SFE extract dilution and both the positive control (CPT) and 
vehicle control (70% ethanol). The highest SFE extract dilution (1/300) increased caspase-
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3/-7 activity (107%) when compared to the untreated control but this was not significant 
(p> 0.05). The lowest dilution of the deionised SFW showed no significant (p> 0.05) 
decrease in caspase-3/-7 activity. The highest SFW extract dilution (1/300) induced the 
highest caspase-3/-7 activity (121%) but this was not significantly (p> 0.05) different from 
the untreated control. 
In isolated normal T cells the SF extracts also showed a concentration dependent decreased 
in caspase-3/-7 activity as seen with the H9 T cells (Figure 5.5). The inhibition was 
significant at higher concentrations for both extracts (p< 0.001). The vehicle control did 
not change caspase-3/-7 activity when compared to untreated normal T cells but was 
significantly (p< 0.001) different from SFE extract dilutions. The highest SFW extract 
dilution significantly (p< 0.01) increased caspase-3/-7 activity (140%) when compared to 
the untreated control. The positive inducer of apoptosis, CPT, slightly increased caspase-
3/-7 activity but this was not significant. 
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Figure 5.5: A graphical illustration of changes in caspase-3/-7 activity relative to the 
untreated control cells in H9 T cells and normal T cells after 24 hours incubation with 
Sutherlandia frutescens extract dilutions. 
The decrease in caspase-3/-7 activity seen in both H9 T cells and isolated normal T cells 
after 24 hours incubation with SF extracts was either maintained or increased after 48 
hours (Figure 5.6). This trend was concentration dependent with highest concentrations of 
the SFE extract completely inhibiting caspase-3/-7 activity in both cell lines (p< 0.001). 
The vehicle control was significantly different (p< 0.001) from the SFE extract dilutions, 
meaning the extracts activity was independent of ethanol. In H9 T cells CPT decreased 
caspase-3/-7 activity in a concentration and time-dependent manner while in normal T cells 
enzyme activity remained similar to the untreated control cells (p> 0.05). 
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Figure 5.6: A graphical illustration of changes in caspase-3/-7 activity relative to the 
untreated control cells in H9 T cells and normal T cells after 48 hours incubation with 
Sutherlandiafrutescens extract dilutions. 
A comparison of the effects of SF extracts on both H9 and normal T cells showed that 
higher concentrations of both extracts decreased the caspase-3/-7 activity in both cell lines. 
This was regardless of the effects of the extracts on cell viability (as seen in the MTT assay 
and ATP assays in chapter four). The MTT assay showed that SF decreased cell viability in 
H9 T cells while it induced cell proliferation in normal T cells. Therefore the decreased 
caspase-3/-7 activity had little to do with changes in cell viability but more to do with the 
effects of SF on the caspase-3/-7 enzymes directly. Sutherlandia frutescens extracts 
inhibited activation of caspase-3/-7 enzymes in concentration and time-dependent manner. 
The pharmacokinetics of SF have not been fully studied. Harnett et al, (2004) looked at 
the anti-HIV activities of organic and aqueous extracts of SF. Their results showed that SF 
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extracts contained active ingredients against the reverse transcriptase (RT) enzyme of HIV. 
The aqueous extracts retained ±30% inhibitory activity of RT in the presence of bovine 
serum albumin (BSA). The study did not reveal the active ingredients of SF that were 
responsible for inhibition of RT. Inhibition of the RT enzyme was assumed to be a 
potential mechanism for the clinically seen improvements o AIDS sufferers when 
administered with SF. 
The effects of SF on antiretroviral (ARVs) metabolism were studied on microsome-based 
in vitro fluorometric microtitre assay. Extracts from SF showed significant inhibition of 
cytochrome P450 3A4 {CYP 3A4) metabolism. The extracts activated the modulator of 
CYP3A4 expression, pregnane X receptor, approximately twofold and also inhibited the 
activity of the P-glycoprotein enzyme. These results identified the potential for clinically 
significant drug interactions. They suggested that co-administration of ARVs and SF may 
result in early inhibition of drug metabolism and transport followed by the induction of 
drug exposure with more prolonged therapy. These bidirectional drug interactions may put 
patients at risk of treatment failure, viral resistance or drug toxicity (Mills et al., 2005 ). 
The effect of SF extracts on caspase-3/-7 activity and expression has not been studied. 
Activation of effector caspases like caspase-3/-7 has been purported as one of the 'points 
of no return' in the apoptotic process. Using cell cycle analyses in various cell lines, Tai et 
al., (2004) showed that SFE extract dilutions of SF tablets arrested the cell cycle at various 
phases in different cell lines. It was suggested that various "actives", not a single 
compound, in the extracts induced cell cycle arrest in these cell lines. Chinkwo (2005) 
demonstrated that SF extracts induced apoptosis in three different cell lines (CHO, Caski 
and Jurkat T cells). This apoptosis was indicated by the flip-flop translocation of 
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phosphotidylserine to the outer membrane. The above mentioned studies suggest that SF 
can induce apoptosis but whether this involved activation of caspse-3/-7 was not indicated. 
The use of caspase inhibitors has revealed that other pathways for apoptosis may be 
initiated. Effector caspases are activated at late stages of the apoptotic process, after 
mitochondrial outer membrane permeability (MOMP) disruption. In this case caspase 
activation constitutes a sign rather than a mechanism of cell death and the decisive event 
has occurred upstream or at the level of MOMP, which frequently marks the 'point of no 
return' of the lethal process. When inhibition of caspases does not restrain cell death, this 
often leads to a shift in the morphology of cell death from the aspects of classical apoptosis 
to the occurrence of apoptosis-like autophagic cell death or even necrosis (Kroemer and 
Martin, 2005). 
Although caspase-independent cell death is not well studied compared to caspase-
dependent apoptosis, several mechanisms have been suggested. ROS production is 
required for caspase-independent cell death in many different types of cells. The poly 
(ADP-ribose) polymerase-1 (PARP-1) hyperactivation-mediated depletion of cellular 
NAD and its precursor ATP is responsible for DNA damage-reagent-induced caspase-
independent cell death. It has been reported that PARP-1 hyperactivation prompts 
mitochondrial dysfunction, which in turn releases apoptosis-inducing factor (AIF) from the 
mitochondria to the nucleus. AIF induces DNA and chromatin condensation in the absence 
of DNA fragmentation (Xu et al, 2006; LeBlanc, 2003). 
The mechanisms of caspase-independent cell death described above would apply to the 
higher concentrations of SF (1/50, 1/150) which were seen to significantly inhibit caspase-
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3/-7 activity. Higher dilutions of the extracts were shown to either not change the caspase-
3/-7 activity or increase the activity of the enzymes when compared to the untreated 
control samples. As was the case with the effects of SF on ATP metabolism in H9 T cells, 
the modes of cell death might be affected by the concentration of the cytotoxic compound 
used (Tsujimoto, 1997). Sutherlandia frutescens might induce apoptosis at lower 
concentrations while higher concentrations might induce cell death by some form of 
necrosis due to the rapid MOMP disruption, ROS generation, ATP depletion, and 
inhibition of caspase-3/-7. 
Sutherlandia frutescens is supposed to be an efficient anticancer medicinal herb. Inhibition 
of caspase-3/-7 activity by higher concentrations of SF extracts is against the notion of 
induction of the more favourable apoptotic pathway of cell death in cancerous cells. Use of 
SF along with apoptosis-inducing chemotherapeutic agents might lead to drug interactions. 
Chemotherapeutics targeting pathways leading to effector caspase activation might be 
inhibited, which ultimately cause treatment failure. On the other hand, caspase inhibition 
might lead to induction of other forms of cell death which are not only specific for 
cancerous cells but also target normal cells. Therefore, there is a need to find 
concentrations or dosages of SF which will induce enough cell death in cancerous cells 
without affecting other therapeutic agents or inducing cell death in normal cells. 
Sutherlandia frutescens has been shown to interact with other enzymes and other cell 
components. Most of the studies on the pharmacokinetics of SF have not specified the 
active ingredient(s) responsible for inhibiting cellular enzymes. L-canavanine might be 
considered a candidate for inhibiting these enzymes because of it mechanism of action. Its 
ability to antagonise L-arginine in protein synthesis might lead to formation of defective 
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enzymes/proteins and therefore malfunction. A study by Jang et al., (2002) showed that L-
canavanine induced apoptotic cell death in Jurkat T cells. This apoptosis was accompanied 
by several biochemical events such as caspase-3 activation, degradation of PARP, and 
DNA fragmentation. The results of this study effectively exclude L-canavanine as an 
inhibitor of caspase-3/-7 activity as seen in the current study. 
Prevoo et al., (2008) recently demonstrated on the influence of SF on adrenal steroidogenic 
cytochrome P450 enzymes. Using differential fraction to study the influence of each active 
ingredient on substrate binding, they showed that SUl triterpenoid glucosides fraction was 
more effective in inhibiting enzyme activity while L-canavanine and the other compounds 
did not affect substrate binding to CYP17 and CYP21. Therefore, it is possible that high 
concentrations of the SUl triterpenoid glucosides may be responsible for the inhibition of 
caspase-3/-7 activity demonstrated by this study. 
5.5 Conclusion 
In this experimental setup, the results obtained have shown that higher concentrations of 
SF have an inhibitory effect on caspase-3/-7 activity in vitro. Cell viability assays in the 
previous chapter have indicated that inhibition of effector caspases does not prevent cell 
death in cancerous H9 T cells. Therefore, inhibition of these caspases may have activated 




OXIDANT SCAVENGING PROPERTIES AND ANTIOXIDANT 
PROMOTING ABILITIES OF SUTHERLANDIA FRUTESCENS 
EXTRACTS ON H9 T CELLS AND NORMAL T CELLS 
6.1 Introduction 
Oxidative stress can damage many biological molecules like proteins and DNA, which are 
often more significant targets of injury than are lipids, and lipid peroxidation often occurs 
late in the injury process. Free radicals are the main source of oxidative stress. A free 
radical can be defined as any species capable of independent existence that contain one or 
more impaired electrons, an impaired electron being the one that is alone in an orbital. 
Examples of free radicals include superoxide (O2") and hydroxyl (OH) - both which are 
oxygen centred radicals (RS", a sulphur centred radical), nitric oxide (NO", in which the 
unpaired electron is delocalised between both atoms), etc. A feature of the reaction of free 
radicals with non-radicals is that they usually proceed via chain reactions: one radical 
begets another. Lipid peroxidation is the most studied biologically relevant free radical 
chain reaction (Halliwell and Chirico, 1993). 
Lipids are oxidised by three distinct mechanisms; enzymatic oxidation, non-enzymatic, 
free radical mediated oxidation, and non-enzymatic, non-radical oxidation. The relative 
susceptibilities of lipids to oxidation depend on the reaction milieu as well as their 
structure. Both isolated polyunsaturated fatty acids (PUFAs) and those incorporated into 
lipids are readily attacked by free radicals, becoming oxidised into lipid peroxides. By 
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contrast, both monosaturated and saturated fatty acids are more resistant to free radical 
attack. Lipid hydroperoxides are formed as the major primary products of oxidation, 
however, they are substrates for enzymes and they also undergo various secondary 
reactions. The occurrence of lipid peroxidation in biological membranes cause impairment 
of membrane functioning, changes in fluidity, inactivation of membrane-bound receptors 
and enzymes, and increased non-specific permeability to ions such as calcium (Ca +) (Niki 
et ah, 2005; Halliwell and Chirico, 1993). 
Direct exposure of cells to oxidants such as hydrogen peroxide or redox-cycling quinones 
causes multiple intracellular alterations, including elevation of Ca , depletion of ATP, and 
oxidation of NADH, reduced glutathione (GSH) and lipids. Necrosis is the characteristic 
end point of such a dramatic disturbance in cell homeostasis. Lower concentrations of 
oxidants are known to promote the alternative apoptotic death pathway. However, recent 
experiments demonstrating apparently normal apoptosis even when cells are cultured at 
low oxygen tensions show that ROS cannot be essential mediators of apoptosis. Depletion 
of antioxidants plays a more important role in cell death (Slater et al, 1995). 
It is now well established that ROS are continuously produced in vivo. Consequently, 
organisms have evolved not only antioxidant defence systems to protect against them but 
also repair systems that prevent the accumulation of oxidatively damaged molecules. The 
human body has a multiplicity of different antioxidant defences. However, probably 
because some free radicals and other ROS play vital biological roles, antioxidant defences 
are not 100% effective. Depletion of antioxidant defences and/or rises in ROS production 
can tip the ROS-antioxidant balance and cause oxidative stress, which may result in tissue 
injury (Halliwell and Chirico, 1993). 
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The extent of lipid peroxidation can be determined by measuring 1) losses of unsaturated 
fatty acids, 2) amounts of primary peroxidation products, and 3) the amount of secondary 
products, such as carbonyls and hydrogen gases. The detection and identification of lipid 
peroxidation products has been performed by using various techniques such as co-
ordination ion-spray mass spectrometry (CSI-MIS) and electrospray ionization (ESI) or 
matrix-assisted laser desorption and ionization time-of-flight (MALDI-TOF) mass 
spectrometry. Their detection has been successfully accomplished in several in vitro 
systems, including cell culture and in in vivo systems (Halliwell and Chirico, 1993). 
To learn as much as possible about the occurrence of lipid peroxidation in biological 
materials, it is important to use techniques that give specific chemical information about 
what is present. High pressure liquid chromatography (HPLC) is the most preferred 
method for doing this but it is quite a tedious assay (Halliwell and Chirico, 1993; Niki et 
al., 2005). The thiobarbituric acid reactant substance (TBARS) content, indicative of lipid 
peroxidation, was studied in T cell lines treated with extracts of SF for our experiments. 
Antioxidant defences may be divided into four categories: prevention of the formation of 
active oxidants, scavenging, quenching and removal of active oxidants, repair of damage 
and excretion of toxic oxidant products, and adaptive responses. The inhibition of 
enzymatic lipid oxidation may be achieved by either the activation or reaction of the 
enzyme. Free radical mediated lipid peroxidation may be inhibited by the inhibition of 
chain initiation and chain propagation and/or acceleration of chain termination. Many 
natural and synthetic supplements and drugs with radical-scavenging capacity have been 
explored. The antioxidant activity in vivo is determined by several factors, such as 
reactivity towards radicals, absorption, distribution, localization and mobility of oxidant, 
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and interaction with other antioxidants. Functions that are independent of antioxidant 
action, such as induction of phase 11 biotransformation enzymes, may also be important in 
the total defence network against oxidative stress (Niki et al., 2005). 
Evidence has been presented that oxidative stress may influence the function of the 
immune system of humans and experimental animals and modify the pro-oxidant capacity 
of macrophages and neutrophils. These effects may cause a decrease in the function of 
these cells and modify the immune response to viruses and bacteria. Chemical 
antioxidants such as (3-carotene, vitamin E, vitamin C and reduced glutathione (GSH) 
improve the proliferative capacity of lymphocytes and increase host defence and 
immunoglobulin synthesis (Periera et al, 1998). Antioxidant enzymes activities can be 
studied using various spectrophotometric, ELISA or molecular expression methods. We 
utilised a luminometer based assay to study changes in GSH levels in T cell lines treated 
with extracts of SF. 
6.2 Thiobarbituric acid reactant substances (TEARS) assay 
The sensitivity of measuring TBARS has made this assay the method of choice for 
screening and monitoring lipid peroxidation. It is popular because of it simplicity and 
cheapness. Although much controversy has appeared in the literature regarding the 
specificity of TBARS toward compounds other than malondialdehyde (MDA), it remains 
one of the most widely employed assays to determine lipid peroxidation. If lipoprotein 
fractions are first acid precipitated from the sample, interfering soluble TBARS are 
minimized (Oxi-Tek, 2002; Halliwell and Chirico, 1993). 
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The principle of the assay is that lipid hydroperoxides can degrade into, among other 
things, malondialdehyde, which forms 1:2 adduct with thiobarbituric acid (TBA) (Figure 
6.1). The result is a coloured product with a maximum absorbance at 532 nm. Butylated 
hydroxytoluene (BHT) is added to the TBA solution to prevent oxidation in the reaction 
during heating. The pH for the reaction is 1.5 and heat is added to stimulate the reaction. 
Butanol is used to separate the lipid-TBA products from the unreacted TBA. Finally, 
spectrophotometric measurements are made at both 532 nm (maximum absorbance for 
TBARS) and 600 nm. The absorbance at 600 nm is due to the solution and will be 
subtracted from the absorbance at 532 nm. Absorbances from the blank reaction are 
measured to account for substances that may also result in a signal at 532 nm (Oxi-Tek, 
2002). 
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Figure 6.1: The MDA-TBA adduct (Oxi-Tek, 2002). 
TM 6.3 GSH-Glo'v' Glutathione Assay 
Reduced glutathione, the most abundant non-protein thiol, is an antioxidant found in 
eukaryotic cells. The presence of glutathione is required to maintain the normal function of 
the immune system and is also critical for the proliferation of lymphocytes. Cells of the 
immune system are also known to produce free radicals as part of their normal function, 
resulting in a need for higher concentrations of GSH than other cells. Oxidative stress and 
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free radicals can cause a decrease in GSH levels either by oxidation or reaction with thiol 
group. A change in GSH levels is important for assessing toxicological responses and can 
promote oxidative stress, potentially leading to apoptosis and cell death (Promega, 2007). 
The GSH-Glo™ Glutathione Assay is a luminescence-based assay for the detection and 
quantification of glutathione. The assay is based on the conversion of a luciferin derivative 
into luciferin in the presence of GSH, catalysed glutathione-S-transferase (GST). The 
signal generated in a coupled reaction with firefly luciferase is proportional to the amount 
of GSH present in the sample. The assay generates a stable luminescent signal and is 
simple, fast and easily adaptable to multiwall formats such as 96-well plates. This assay 
can be used for detection and quantification of GSH in cultured cells or various biological 
samples. The GSH-Glo™ Glutathione Assay can be applied for measuring glutathione 
levels as an indicator of cell viability or oxidative stress. It can also be applied for 
screening drugs and new chemical entities for their capacity to modulate glutathione levels 
in cells (Promega, 2007). 
Detection of GSH using the GSH-Glo™ Glutathione Assay is the result of the combination 
of two chemical reactions (Figure 6.2). The first reaction involves the generation of 
luciferin from a luminogenic substrate, catalysed by GST in the presence of GSH. The 
luciferin produced in the first reaction is detected as a luminescent signal generated by the 
luciferase enzyme. The second reaction is initiated by the addition of an equal volume of 
Luciferin Detection Reagent, which simultaneously stops the GSH-Glo™ reaction and 
initiates a luminescent signal that is directly proportional to the amount of luciferin formed 
in reaction 1 (Promega, 2007). 
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Figure 6.2: The two reactions of GSH-Glo™ Glutathione Assay (Promega, 
2007) 
We therefore aimed to analyse for the oxidant scavenging properties of SF in supematants 
of isolated normal T cells and H9 T cells. The second objective was to analyse for the 
ability of SF to change GSH levels in the intracellular environment of both the normal and 
cancerous T cells. 
6.4 Materials and Methods 
6.4.1 Materials 
Butylated hydroxytoluene (BHT), thiobarbituric acid (TBA), phosphoric acid (H3PO4), 
hydrochloric acid (HC1) and sodium hydroxide (NaOH) were purchased from Sigma 
Aldrich (SA). GSH-Glo™ Glutathione Assay Kit was purchased from Promega (USA). 
6.4.2 Methods 
6.4.2.1 TBARS assay 
Supematants collected from treated cells used for the MTT assay and stored at -70 C were 
used for the TBARS assay. These supernatant samples were thawed and then kept on ice 
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until the beginning of the assay. The rational behind the use of supernatant is based on the 
fact that when lipid peroxides are formed in cell membrane, they are released into the 
surrounding environment of the cells. The use of supernatants in the in vitro system is 
similar to the use of serum and plasma for analysis of lipid peroxidation in vivo. 
For each treatment concentration a sample and blank test tube was prepared by addition of 
200 jtil 7% H3PO4 into each tube. In the sample test tube 400 ju.1 TBA/BHT solutions was 
added and in the blank test tube 400 [i\ 3 mM HC1 was added instead. 400 /xl of the 
supernatant was added into both sample and blank test tubes and they were vortex 
vigorously. Both sets of test tubes were pH to 1,5 using 1 M HC1 and 1 M NaOH. The 
solutions were heated at 100 C for 15 minutes and then left to cool to room temperature. 
Butanol (1.5 ml) was added into each tube and the solutions were vortexed for 40-60 
seconds. The solutions separated into two phases after vortexing and butanol (top) phase 
was transferred into eppendorf centrifuge tubes. The tubes were centrifuged at 13 200 rpm 
for 6 minutes. Absorbance of the butanol phase was measured at 532 nm and 600 nm on a 
spectrophotometer. The final absorbance of the sample was calculated by subtracting the 
absorbance reading of the blank from that of the corresponding sample. The concentration 
of lipid peroxides was calculated using the following formula: 
Concentration = Absorbance/absorptivity coefficient 
The absorptivity coefficient for TBARS given by Dr Marcelo is 156 mM" (Ramos-
Vasconcelos and Hermes-Lima, 2002). 
109 
6.4.2.2 GSH-Glo,lvl Glutathione Assay 
6.4.2.2.1 Preparation of GSH-Glo and Luciferin reagents 
The GSH-Glo1M reagent for suspension cultures was prepared by diluting the Luciferin-NT 
substrate and Glutathione-S-Transferase 1:50 in GSH-Glo™ reaction buffer. Each reaction 
(well) of a 96-well plate required 50 /xl of the GSH-Glo™ reagent; the total volume of the 
reagent prepared was adjusted according to the number of assay wells. The GSH-Glo™ 
reagent needed to be prepared immediately before use and could not be stored for future 
use. 
The luciferin detection reagent was prepared by transferring the contents of one bottle of 
luciferin detection buffer to the bottle of lyophilised luciferin detection reagent. The 
contents were mixed by inversion several times until the substrate was thoroughly 
dissolved. Each reaction (well) of a 96-well plate required 100 \i\ of the luciferin detection 
reagent meaning the luciferin detection reagent needed to be 2:1 with the GSH-Glo 
reagent for reaction to work properly. The prepared luciferin detection reagent could be 
stored for up to 4 weeks at -20 C. 
6.4.2.2.2 Treatment of cell lines and layout of the GSH-Glo™ Glutathione Assay 
H9 and isolated normal T cells were treated in a similar manner as in the caspase-3/-7 
assay but without the CPT control samples (paragraph 5.3.2.2). Three different dilutions of 
each extract of SF (1/50, 1/150, and 1/300) was used to treat the cell lines. The vehicle 
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control (70% ethanol) was also included. The incubation periods were kept at 24 and 48 
hours. 
After the end of each incubation period, 1 ml of each treatment type was transferred into 
labelled eppendorfs and centrifuged to pellet the cells. The supernatants were removed and 
stored while the treated cells were washed 2x by centrifugation using PBS. The media was 
removed because cell culture media has been shown to interfere with the GSH-Glo™ 
Glutathione Assay kit reagents and decrease their sensitivity. After the last PBS wash was 
removed, 100 /xl of PBS was added into each eppendorf and vortexed thoroughly. 50 /xl of 
each treatment was then transferred into duplicate wells of a white-walled 96-well plate 
(Figure 6.3). 50 ttl/well of prepared GSH-Glo™ reagent was added into the treated cells. 
The solution was mixed by shaking on a plate shaker and incubated for 30 minutes at room 
temperature in the dark. 
At the end of this incubation period, prepared luciferin detection reagent was added (100 
/xl/well) to stop the GSH-Glo™ reaction and initiate the luminescence to be detected by the 
luminometer. The plate was shaken again and incubated for 15 minutes at room 
temperature in the dark. Luminescence was read using the Modulus™ Microplate 
Luminometer from Turner BioSystems (Figure 6.4). The assay was repeated three times to 
show repeatability of results. 
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Figure 6.3: An illustration outlining the set up of the GSH assay in the white-walled 
96 well plate. The wells from column A to B were for the treatment of H9 cells and 
columns £ to F were for isolated normal T cells. 
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Figure 6.4: An outline of the steps involved in the GSH-Glo Glutathione Assay 
(Promega, 2007). 
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6.5 Results and Discussion 
6.5.1 TBARS assay 
The lipid peroxide concentrations in the SF extracts treated samples were compared to the 
untreated control samples and the SFE extracts was also compared to the vehicle control 
(70% ethanol). After 24 hours incubation, there was an extremely significant difference 
(p< 0.0001) between all the samples grouped together as calculated by ANOVA (Figure 
6.5). There was a very significant difference (p< 0.001) between the lipid peroxide 
concentrations in the treated samples and the untreated control samples. This was 
regardless of the SF extraction method and the type of cell line under analysis. 
Sutherlandia frutescens ethanol extract dilutions exhibited lipid peroxides scavenging 
properties which were significantly enhanced (p< 0.001) than the vehicle control, again 
showing the independent action of the extracts. 
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Figure 6.5: A bar graph illustrating the changes in supernatant lipid peroxides after 
24 hours incubation of H9 and normal T cells with extract dilutions of Suthertandia 
frutescens. 
After 48 hours incubation with both H9 and normal T cells, the SF extracts still showed a 
significant (p< 0.001) lipid peroxide scavenging properties when compared to the untreated 
control (Figure 6.6). The extracts were more effective in removing the lipid peroxides in 
the normal T cells supematants than in H9 cells but this difference was not significant (p> 
0.05). The SFW extracts was able to maintain lipid peroxide concentration at similar levels 
as there were after 24 hours incubation. The SFE extracts lost some of the lipid peroxides 
scavenging properties after 48 hours but they were still significantly lower than the 
untreated control. The loss of lipid peroxide scavenging properties in the SFE extracts 
coincided with a significant drop in peroxides in the vehicle control of the H9 cell 
supematants. This significant difference (p< 0.01) showed the SFE extracts had lost their 
scavenging properties. 
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Figure 6.6: A bar graph illustrating the changes in supernatant lipid peroxides after 
48 hours incubation of H9 and normal T cells with extracts of Sutherlandia frutescens. 
Molecular oxygen and its reaction products can cause injury to biological organisms in 
different ways. ROS products induce point mutations, deletions and gene amplification and 
rearrangement in mammalian cells, which may induce proto-oncogene activation and/or 
tumour suppressor gene inactivation. They are thought to play a role in the multiple steps 
leading to carcinogenesis. Free radical alterations of unsaturated lipids in cell membranes 
may result in loss of membrane fluidity and eventually cell lysis. TBARS is one of the 
aldehyde products of ROS degradation of membrane lipids and these aldehydes can cause 
cross links in nucleic acids, proteins and lipids (Tuzgen et al., 2003). 
These results have shown that treatment of H9 and normal T cells with SF extracts for up 
to 48 hours reduced the level of lipid peroxides in supematants. These findings are in 
agreement with the traditional use of this plant as an antioxidant. They are also in 
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agreement with some of the in vitro and in vivo studies which used SF in studying different 
aspects of oxidative stress reduction. Fernandes et al., (2004) looked at the hydrogen 
peroxide and superoxide radical scavenging properties of SF plant-extracts in phagocytes 
in a cell free system. The results indicated that hot SFW extracts possessed ROS 
scavenging properties at very low concentrations. It was concluded that these scavenging 
activities could account for some of the anti-inflammatory properties of this medicinal 
plant. 
Using another cell free system, Tai et ai, (2004) demonstrated the antioxidant activity of 
SF in reducing free radical activity. The reduction of 2,2_-azinobis(3-ethylbenzothiazoline-
6-sulphonic acid (ABTS) radical by the 0.5 fil SFE extracts was found to be equivalent to 
10 /xM of Trolox, a chemical with potent antioxidant activity. These results are strongly in 
agreement with our results with respect to the SFW extract in which the highest dilution 
(1/200) was more effective in decreasing the generation of lipid peroxides. The compounds 
directly responsible for the free radical scavenging properties in SF have not been 
identified. Fernandes et al., (2004) suggested that the antioxidant activity of SF extracts 
could be due to phenolic compounds such as tannins and flavanoids. 
Cells exhibit a broad spectrum of responses to oxidative stress, depending on the stress 
type and level encountered. Oxidative stress exceeding the antioxidant capacity level leads 
to oxidative damage, but low-level stress may enhance the defence capacity. The 
differential response of a single cell line to SF was demonstrated by Tai et ai, (2004). 
Extracts of SF were shown to be toxic to RAW 264.7 monocytes/macrophages while it 
totally blocked nitrite production at higher concentrations. A similar mechanism may be 
proposed for our results since a reduction in lipid peroxides in cancerous H9 cells did not 
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result in a decrease in cytotoxicity (MTT and ATP, chapter 4). This suggests that the two 
mechanisms, lipid peroxides scavenging and cell cytotoxicity, occurred independently of 
each other in the cell system used. 
6.5.2 GSH-Glo™ Glutathione Assay 
Changes in GSH levels in SF extract-treated cells were compared to those in the untreated 
control cells (appendix 5). The use of ethanol for extraction was evaluated by comparing 
the SFE extracts effects to those of the vehicle control. After 24 hours incubation, there 
was a significant difference (p< 0.0001) between the samples analysed (treated and control 
samples) in both the H9 cells and normal T cells (Figure 6.7). In H9 cells samples the SFE 
extracts treated samples showed a concentration dependent change in GSH concentration 
with lower dilutions significantly (p< 0.001 and p< 0.05 respectively) decreasing GSH 
levels when compared to the control. The effect of the SFE extracts in reducing GSH levels 
in these cancerous cells was independent of the vehicle (p< 0.001). The SFW extracts did 
not show concentration dependence in affecting GSH levels with the highest dilution 
(1/300) reducing GSH levels more significantly (p< 0.001) than the lowest dilution. 
In normal T cells, the effects of SF extracts on GSH levels were concentration dependent 
for both types of extracts after 24 hours (Figure 6.7). The lowest dilution of the SFE 
extracts (1/50) significantly (p< 0.001) inhibited GSH synthesis to such an extent that GSH 
was eliminated from the treated cells when compared to the untreated cells. This 
elimination of GSH levels was in contrast to the significant (p< 0.001) increase in GSH 
levels in the highest dilutions (1/300 SFE). The inhibition/elimination of GSH synthesis in 
the higher concentrations of SFE extracts was also significantly (p< 0.001) to the high 
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GSH levels in the vehicle control (70% ethanol), implying that the extract inhibited GSH 
independently of ethanol. The SFW extracts increased the levels of GSH in a 
concentration-dependent manner, with the lower concentrations of the extract inducing the 
higher levels of GSH 
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Figure 6.7: A graphical illustration of the effects of extract dilutions of Sutherlandia 
frutescens on GSH levels in H9 and normal T cells after 24 hours incubation. 
A time- and concentration-dependent trend in GSH level changes was seen after 48 hours 
incubation with SF in both H9 and normal T cells (Figure 6.8). The extracts reduced GSH 
levels in H9 cells while the lower concentrations of the extracts significantly (p< 0.001) 
increased GSH levels in normal T cells. The SFW extract dilutions were more effective in 
reducing GSH levels in the cancerous H9 cells and were also more effective in increasing 
GSH levels in normal T cells. Higher concentrations of the SFE extracts continued to 
inhibit GSH synthesis significantly (p< 0.001) in normal T cells when compared to the 
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untreated normal T cells or the H9 cells treated with similar concentrations of SF extracts. 
The normal T cell vehicle control had a significantly (p< 0.001) increased level of GSH 
after 48 hours than the highest concentration of the SFE extract (appendix 5). 
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Figure 6.8: A graphical illustration of the effects of extract dilutions of Sutherlandia 
frutescens on GSH levels in H9 and normal T cells after 48 hours incubation. 
Antioxidative defence mechanisms which protect against oxidation include enzymes such 
as glutathione peroxidise, superoxide dismutase, catalase, a selenium-dependent free 
radical scavenger and smaller molecules such as the carotenoids, ascorbic acid, 
glutathione, bilirubin, urate and the tocopherols. These antioxidants are proposed to protect 
cells and their molecular components from oxidative stress by scavenging free radicals and 
quenching lipid peroxidation chain reactions. Intracellular glutathione plays an important 
role in the protection of cells against damage from free radicals and also influences 
cytotoxicity to some chemotherapeutic agents (Tuzgen et al., 2003). 
120 
Many chemotherapeutics agents have profound effects on the cellular redox status, and 
alteration of redox status plays an important role in the induction of cell death. Cellular 
redox potential is largely determined by GSH which is mainly found in the cytosol and a 
small, but significant percentage located in the mitochondria. Mitochondrial GSH is 
important in protecting the organelle from ROS produced during coupled mitochondrial 
electron transport and oxidative phosphorylation (Armstrong et al., 2002). We showed in 
chapter 4 that SF reduced ATP levels in treated H9 cells, implying an inhibition/disruption 
in the electron transport chain. Disruption of ATP synthesis would have consequently led 
to an increase in ROS production. As a response to increased oxidative stress, mobilisation 
of the GSH content of cells could lead to depletion of the antioxidant levels. 
Another mechanism contributing to depletion of intracellular GSH as seen in H9 cells 
might be a result of GSH efflux from the cell. GSH is negatively charged at physiological 
pH, and the large intracellular negative potential of -30 to -60 mV facilitates its extrusion 
(Franco et al, 2007). By exacerbating the loss of GSH in the extracellular environment, SF 
could cause the gradient diffusion of GSH out of the cells and thereby decrease cell 
survival abilities. 
Alterations in GSH concentration have been demonstrated as a common feature of many 
pathological conditions such as AIDS, neurodegenerative disorders, and cancer (Franco et 
al., 2007). Carcinogenesis induces uncontrollable cell proliferation and increasing the GSH 
content of cells would strength their non-response to senescence. Ideally, chemotherapeutic 
agents should therefore reduce the GSH content of cancerous cells. Sutherlandia frutescens 
extracts reduced GSH levels in H9 cells over a period of 48 hours (Figures 6.7 and 6.8). 
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Intracellular GSH loss is an early hallmark in the progression of cell death (Franco et al., 
2007). 
Changes in GSH levels can be used as an indicator of cell viability (Promega, 2007). 
Although there was no direct correlation between the results of the cell viability assays 
(chapter 4) and the GSH assay results, the general trend pointed towards a relationship 
between cell viability and GSH content. The SF extracts decreased both cell viability and 
GSH levels in H9 cancerous cells while the same extracts significantly increased cell 
viability and GSH levels in normal T dells. 
The ability of high concentrations of SFE extract dilutions to inhibit or eliminate GSH in 
normal T cells might possibly be due to the effects of this medicinal plant on the synthesis 
pathway of GSH. The availability of the essential amino acid, cysteine is generally 
accepted as the rate limiting amino acid for GSH synthesis. The cysteine generated from 
transsulphuration of methionine serves as a substrate for y-glutamylcysteine synthase 
(GCS) in the GSH synthesis pathway. The GCS enzyme might also be inhibited by SF 
extracts and consequently depleting the GSH content. L-canavanine and the SU1 
triterpenoid glucosides found in SF have been reported to affect enzymes activities. 
In a recent clinical trial of SF on healthy adults, it was shown that the treatment group 
exhibited higher total protein and albumin than the placebo group (Johnson et al, 2007). 
As noted in the above paragraph, the protein content plays an important role in determining 
the GSH content of the cells. Lower concentrations of the SF extracts were shown to 
significantly increase the GSH content of normal T cells. This ability is relative to the 
capacity to increase cell proliferation but might also be caused by an increased protein 
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content of the cells. An extract which can increase GSH levels in normal cells while 
significantly decreasing GSH levels in cancerous cells is of interest. An ideal trait of a 
chemotherapeutic agent is to target cancerous cells while sparing the normal tissue. 
Certain lymphocyte functions, such as a DNA synthetic response, are favoured by 
relatively high levels of GSH. Interleukin-2 dependent functions, including cytotoxic T-
cell activity, lymphokine-activated killer cells and natural killer cells, are particularly 
sensitive to GSH depletion. Certain lymphocyte signal pathways, on the other hand, are 
enhanced by oxidative stress and favoured by low intracellular glutathione levels (Droge 
and Breitkruetz, 2000). Therefore the ability of SF to discriminate between normal and 
cancerous tissue might lie in its capacity to enhance certain cell signalling pathways under 
specific conditions while suppressing others. 
The available evidence suggests that the normal lymphocytes from healthy human subjects 
have, on average, an optimal GSH level. There is no evidence that immunological 
functions such as resistance to infection or the response to vaccination may be enhanced in 
healthy subjects by administration of GSH. However, immunological functions in disease 
may be greatly enhanced and potentially restored by supplements which increase GSH 
levels. The best studied case of GSH deficiency is HIV infection. HIV-positive individuals 
have, in general, abnormally low GSH levels and several groups have also reported a 
significant decrease in intracellular GSH levels in PBMCs from HIV-infected patients 
(Droge and Breitkruetz, 2000). Increased GSH levels in normal T cells induced by low 
concentrations of SF extracts shows that this medicinal plant can have a positive influence 
on immunological functions. 
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6.5.3 Correlation between the TBARS and GSH-Glo1M Glutathione assay results 
Analysis of lipid peroxide concentrations in the supernatants of SF extract treated cells 
showed that this medicinal plant scavenged oxidative stress products. The removal of 
peroxides did not depend on the concentration of the extracts or the type of cell line treated 
with the extracts. Higher dilutions of the extracts were as effective as lower dilutions in 
both the H9 and normal T cells. Targeting of ROS products in all supernatants was 
therefore as a result of specific activity compounds in SF extracts which scavenged for 
these products. Tannins and flavanoids have been suggested as possible contributors to 
these oxidant scavenging mechanisms (Fernandes et ai, 2004). 
Sutherlandia frutescens extracts induced different effects on the GSH concentration of H9 
cells and normal T cells. The extracts caused a time-dependent decrease in GSH content in 
H9 cells with the SFW extract dilutions being more effective than the ethanol extracts. In 
normal T cells, the extracts negatively affected the levels of GSH at higher concentrations 
but enhanced the GSH content at lower concentrations. The SFW extract dilutions were 
also more effective in increasing the GSH content of normal T cells than the ethanol 
extracts. The GSH content is closely related to cell viability in a specific sample, and 
therefore the effects of SF extracts on cell proliferation also determined the GSH levels. 
Another distinction in affecting GSH levels was the ability to discriminate between normal 
and cancerous cells. 
After treatment of a human B lymphoma (PW) with L-buthionine sulphonine (BSO), an 
inhibitor of y-glutamylcysteine synthetase, there was an early decline in cellular GSH, 
followed by an increase in ROS production. This increase in ROS induced a variety of 
124 
apoptotic signals in the absence of any external apoptotic stimuli (Armstrong et al., 2002). 
Franco et al., (2007) recently demonstrated that loss of intracellular GSH was paralleled by 
generation of ROS including superoxide anions, lipid peroxides, etc. However, inhibition 
of ROS formation by a variety of antioxidants showed that GSH loss was independent 
from the generation of ROS. Furthermore, GSH depletion was observed to be necessary for 
ROS formation. High extracellular content of thiols like GSH inhibited apoptosis while 
inhibition of ROS generation was ineffective in preventing cell death. 
The above statements give credibility to the observed differential effects of SF extracts on 
TBARS and GSH content in H9 and normal T cells. Sutherlandia frutescens was shown to 
be an excellent scavenger of lipid peroxides in extracellular environment of both cell lines. 
While removal of ROS might be expected to improve cell survival, this was not the case 
with treated H9 cells. Decrease in GSH levels of the H9 cancerous cells reflected this cell 
death more accurately than ROS. From these results it can be concluded that the GSH 
concentration in cells determined cell fate. 
6.6 Conclusion 
In this chapter we analysed for the oxidant scavenging and antioxidant promoting 
properties of different extracts of SF. The TBARS assay showed that extracts SF are 
excellent scavengers of lipid peroxides in supernatants in treated cell lines. This 
scavenging ability did not depend on the concentration of the extracts but rather on the 
type of extraction method used, with the SFW extract dilutions more effective in this 
regard. The ROS scavenging properties of SF have been hypothesised as dependent on the 
presence of tannins and flavanoids in the extracts. 
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The results of the GSH assay did not correlate with the effects on lipid peroxide removal. 
SF extracts decreased GSH levels in H9 cancerous cells while increasing the GSH levels in 
normal T cells depending on the type and concentration of the extracts. High 
concentrations of the SFE extracts negatively affected the GSH content in normal T cells 
independent of ethanol and this again showed that high concentrations of SF can seriously 
suppress T cell proliferation. Lower concentrations of the SFW extracts significantly 
increased GSH levels in normal T cells and this in turn showed their ability to increase T 
cell proliferation. These results show that cell fate is mostly dependent on the 
concentration of antioxidants, not on the levels of oxidative stress. 
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CHAPTER 7 
MORPHOLOGICAL EFFECTS OF SUTHERLANDIA FRUTESCENS 
EXTRACTS ON H9 T CELLS AND NORMAL T CELLS 
7.1 Introduction 
Apoptosis and necrosis are two forms of cell death with clearly distinguishing 
morphological features. These cell death mechanisms can occur simultaneously in cell 
cultures exposed to the same stimulus, the intensity of the same initial insult determining 
the prevalence of one over the other. This suggests that there are common early events in 
both apoptosis and necrosis, while a downstream controller may be required to direct cells 
towards apoptosis. Levels of intracellular ATP have been shown to be one of the important 
determinants of occurrence of morphological features of apoptosis like nuclear 
condensation and DNA fragmentation (Leist et al, 1997). 
Apoptosis is characterised by chromatin condensation, nuclear fragmentation and 
formation of apoptotic bodies which are phagocytosed by other cells. In most but not all 
forms apoptosis, nuclear DNA is cleaved at internucleosomal sites. By contrast, cellular 
necrosis is defined by electron-lucent cytoplasm, mitochondrial swelling loss of plasma 
membrane integrity without drastic morphological changes in the nuclei. Nuclear DNA is 
randomly cleaved as a consequence of cellular degeneration in necrosis (Tsujimoto, 1997). 
The morphological definition of cell death modes makes electron microscopy the best way 
to assess apoptosis or necrosis. Electron microscopy application can be inconvenient in 
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cases where apoptosis and necrosis occur in the same cell culture. A versatile tool like the 
confocal laser scanning microscope, powerful for both morphological analysis and 
macromolecular localisation, can also be utilised. One of the convenient ways is to use 
fluorescence microscopy in conjunction with different fluorescent dyes for cell staining 
(Sgonc and Gruber, 1998; Tsujimoto, 1997). 
Fluorescence microscopy technique is the most rapidly expanding technique employed 
today in medical and biological sciences. Fluorescence is a member of the ubiquitous 
luminescence family of processes in which the susceptible molecules from electronically 
excited states created by either a physical, mechanical, or chemical mechanism. 
Fluorescence differs from other forms of photoluminescence in that it is a property of some 
atoms and molecules to absorb light at a particular wavelength and subsequently emit light 
of longer wavelength after a brief interval, termed fluorescence lifetime (Olympus 
microscopy manuscript). 
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Figure 7.1 Illustration of a typical fluorescence microscope (Nikon microscopy: 
http://www.microscopyu.com/articles/fluorescence/fluorescenceintro.html). 
Fluorescence microscopes can be used with a variety of fluorescent dyes to distinguish 
between viable, apoptotic and necrotic cells. Propidium iodide (PI) and the Hoechst stains 
are some of the most widely used fluorescent dyes. Hoechst dyes stain nuclei of all cells 
(varying intensity of blue) whereas PI stains only cells with disrupted membrane integrity 
(red staining). Propidium iodide is therefore a cell viability dye marker as only 
compromised cells have leaky membranes. Microscopy techniques like the use of 
fluorescent dyes are primarily qualitative determinants of cell death (Tsujimoto, 1997). 
7.2 The Hoechst stains 
The Hoechst or bisbenzimidazole dyes, Hoechst 33342 and 33258, are potent DNA minor 
groove binding ligands. Like many other DNA minor groove-binding ligands, these 
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Hoechst dyes have strong A+T base pair specificity. They induce highly specific protein-
linked, single-stranded DNA breaks on DNA in the presence of mammalian DNA 
topoisomerase 1 (Chen et al, 1997). 
The Hoechst dyes are highly positively charged and their passive diffusion across the 
cellular membrane is expectedly slow. However, Hoechst 33342 due to the ethoxy 
substitution on the 4-phenyl ring of its parent compound Hoechst 33258, has enhanced 
membrane permeability and is about 2 orders of magnitude more cytotoxic than Hoechst 
33258 (Figure 7.2). The higher cytotoxicity of Hoechst 33342 can be explained by its 
higher lipophilicity which is one of the crucial determinants for passive diffusion across 
the cellular membrane (Chen et al., 1997). 
Figure 7.2: Chemical structures of Hoechst 33342 and 33258 (Chen et al., 1997). 
Hoechst 33342 has been widely used, along with fluorescent microscopes, to stain 
morphological changes in the nuclei of cells undergoing processes leading to cell death. 
Cells to be stained with Hoechst 33342 do not require permeabilisation but do require 
physiological conditions for active transportation of the dye. The staining protocol is very 
sensitive to cell concentration and pH of the media when using cell suspensions. Cells 
should be approximately 1-2 x 106/ml in buffered media (pH 7.2). Incubation of cells at 37 
°C for an hour is usually enough for the dye to be transported into cells while the staining 
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signal has a short half-life. Hoechst 33342 has a broad fluorescence range, allowing for co-
staining with fluorescent dyes. It also works with permeabilized paraformaldehyde- (PFA) 
and ethanol-fixed cells (Kukuruga, 1997). 
Apoptotic or necrotic cells have defined morphologies when stained with Hoechst 33342 
and analysed under a fluorescent microscope. The nuclei of viable and necrotic cells 
appear round in shape, with those on necrotic cells more blue-green. The apoptotic cells 
appear to have fragmented nuclei and stain with an intensely blue-green fluorescence 
(Figure 7.3 (a), (b) and (c)). It is important to distinguish between intensely stained cells 
with nuclear condensation and those cells appearing blue-green as a result of undergoing 
mitotic cell division (Tsujimoto, 1997). 
Figure 7.3: Photomicrographs of Hoechst 33342 stained Jurkat T cells grown under 
ATP-depleting and ATP-supplying conditions and subsequently induced to die by 
oligomycin. A) Shows apoptotic cells (indicated fragmented nuclei- FN), B) necrotic 
cells and C) untreated normal cells (Eguchi etal., 1997). 
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The aim of the work reported in this Chapter was to analyse the morphological effects of 
SF extract dilutions on cultured H9 T cells and normal T cells using the Hoechst 33342 dye 
and fluorescent microscopy. 
7.3 Materials and Methods 
7.3.1 Materials 
Bisbenzimide and DMSO were purchased from Sigma Aldrich (SA). PFA was purchased 
from Merck Chemicals (SA). Glass slides and coverslips were purchased from Corning 
(Netherlands). Inverted fluorescent microscope was supplied by Olympus (USA). 
7.3.2 Methods 
7.3.2.1 Treatment of cell lines and outline of incubation procedure 
Normal T cells and H9 T cells were treated in a similar procedure to that outlined in 
paragraph 4.4.2.4 (chapter 4). Briefly, the cell lines were treated with various dilutions of 
SFE and SFW extracts and incubated over a period of 48 hours. A positive control (20 \xM 
CPT) and vehicle control (70% ethanol) were also included for both cell lines (Figure 7.4). 
The 48 hours incubation period was chosen based on the levels of cytotoxicity as shown by 
MTT and ATP assays. Both cell lines incubated over this period could be expected to show 
distinct patterns of cell death related to SF treatment. 
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Figure 7.4: A schematic illustration of the treatment procedure in 6 well plates for 
both the H9 cells and isolated T lymphocytes in performing the Hoechst staining 
assay. 
73.2.2 The Hoechst staining protocol 
At the end of the 48 hours incubation period, the treated cells and controls were removed 
from their allocated wells and dispensed into labelled sterilin tubes. The tubes were 
centrifuged at 1500 rpm to pellet the cells. The resultant supernatant was removed and 
stored at -70 °C for future use. The pelleted cells were washed by vortexing (PBS, 500 ul) 
and transferred to labelled eppendorf tubes. They were pelleted by centrifugation again and 
the pellets were stained with a Hoechst working solution (100 ul). The stained cells were 
incubated for 15 minutes at 37 °C. The Hoechst stain was washed away with PBS and the 
cells were fixed in 10% PFA for 5 minutes. After another wash step with PBS (500 ul, 
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vortex), the cells pellets were re-suspended in 100 jul PBS. This suspension was pipetted 
into glass slides which were covered with coverslips. The prepared slides were then viewed 
under an Olympus TH4-200 inverted fluorescent microscope (excitation filter 350 nm and 
barrier filter of 450 nm). 
7.4 Results and Discussion 
Staining suspension cultures on glass slides for viewing under a microscope presents with 
several challenges. Because the cultures do not attach to the slides or coverslips, they 
remain in constant motion in freshly prepared slides. The repeated movement of these cells 
makes focusing and adjustment of the fluorescent microscope very difficult. Another 
challenge involves the multiple centrifugation steps that are involved in the staining 
protocol and this may result in loss of cell numbers. 
Untreated H9 cells stained with Hoechst (Figure 7.5 A) generally displayed nuclei with 
homogenous chromatin staining characteristic of viable cells. Some of the cells showed 
signs of early condensation while a few were already fragmented. The normal T cells 
(Figure 7.5 B) displayed nuclei with a similar pattern to the H9 cells but with some cells 
showing dividing nuclei. 
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Figure 7.5: Photomicrographs of untreated H9 (A) and normal T (B) cells incubated 
for 48 hours and stained with Hoechst. Cells can be seen displaying normal (N), 
fragmented (FN), condensed (CN) and dividing (DN) nuclei (A & B- 600x). 
H9 and normal T cells treated with 20 uM CPT predominantly displayed condensed nuclei 
with bright blue-green staining indicative of apoptotic (Figure 7.6 A & B). The levels of 
condensed nuclei were similar in both cell lines and this was consistent with the known 
effects of CPT in suspension cells. 
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Figure 7.6: Photomicrographs of camptothecin treated H9 (A) and normal T (B) cells 
stained Hoechst Both cell lines show extensive nuclei condensation (CN) after 48 
hours incubation (A- 200x, B- 600*). 
The 70% ethanol treated H9 cells (Figure 7.7 A) stained with Hoechst 33342 exhibited 
similar nuclei nomenclature to those of untreated H9 cells. Most cells showed normal 
nuclei while condensed nuclei were also observed in the stained cultures. Treatment of 
normal T cells with 70% ethanol (Figure 7.7 B) induced more condensed nuclei than the 
untreated cells. 
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Figure 7.7: Photomicrographs of 70% ethanol-treated H9 (A) and normal T (B) cells 
stained with Hoechst and displaying condensed (CN) and some normal (N) nuclei (A-
600x, B- 200x). 
H9 cells treated with the SFW extract dilutions (Figure 7.8 A) displayed a significant 
number of cells with condensed and fragmented nuclei indicative of induction of cell 
death. The condensed nuclei were an indication of early stages of apoptosis while 
fragmentation was indicative of the execution stage of cell death. This is consistent with 
results of the cytotoxicity assays which showed that the SFW extracts reduced cell viability 
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in a concentration dependent manner. The effects of the SFW extract on normal T cells 
results in some nuclei showing bright blue-green staining, indicative of nuclei 
condensation (Figure 7.8 B). This staining pattern suggests that cells may be undergoing 
mitosis which causes the nucleus to fragment into two parts. This is supported by the cell 
proliferation shown in MTT assays in chapter 4. 
Figure 7.8: Photomicrographs of H9 (A) and normal T (B) cells treated with dflutions 
of SFW extract dilutions and stained with Hoechst. Cells with fragmented (FN) and 
condensed (CN) nuclei were seen in H9 cells while condensed (CN) and normal (N) 
nuclei appeared in normal T cells (A- 600x, B- 200*). 
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Similar to the effects of SFW extracts on H9 cells, the SFE extracts induced different 
levels of condensation, fragmentation and blebbing in the nuclei of treated H9 cells (Figure 
7.9 A). The effects of SFE extracts on nuclei were more pronounced than those of the 
vehicle control. While less pronounced than in H9 cells, the SFE extracts also induced 
condensation and fragmentation of chromatin in normal T cells (Figure 7.9 B). The 
observed effects were expected as the lower dilutions of the SFE extract were previously 
shown to reduced cell viability below those of untreated controls in cytotoxicity assays 
(chapter 4). 
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Figure 7.9: Photomicrographs of H9 (A) and normal T (B) cells treated with dilutions 
of SFE extracts over 48 hours stained with Hoechst. Treated H9 cells displayed 
condensed (CN), blebbing (B) and normal (N) nuclei while normal T cells had 
condensed (CN) and normal (N) nuclei (A- 600*, B- 400*). 
Several studies have presented evidence of cytotoxic effects of various SF extracts on a 
number of cancerous cell lines (Tai et ah, 2004; Steenkamp and Gouws, 2006; Stander et 
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ah, 2007; Chinkwo, 2005). The experiments on malignant H9 T cells also showed similar 
findings (MTT and ATP cytotoxicity assays). Cytotoxicity assays suffer the disadvantage 
of not being able to specify the type of cell death occurring. Only a few studies which have 
sort to ascertain the type of cell death induced by these SF extracts. 
Tai et ai, (2004) predicted the occurrence of apoptosis in several cell lines treated with 
ethanol extracts of SF using flow cytometric cell cycle analysis. Chinkwo (2004) gave a 
clearer picture of the occurrence of apoptosis in SF treated carcinoma cells using annexin 
V staining, DNA fragmentation and morphological cell staining assays. DNA 
fragmentation as indicated by the formation of a DNA ladder in an agarose gel was 
observed in CHO cells treated with aqueous extracts of SF. Treated CHO cells stained with 
the crossmon trichome dye showed chromatin condensation indicative of apoptosis. 
In this experimental setup, H9 and normal T cells treated with aqueous and ethanol extracts 
over 48 hours and stained with Hoechst 33342 showed chromatin condensation, 
fragmentation of the nuclei and some blebbing of nuclei (indicators of apoptosis). 
Important triggers of apoptosis included reduced GSH levels, increased ROS, lipid 
peroxidation, effector caspases activation and levels of ATP high enough to drive the 
apoptotic process. We have shown in chapters 4, 5, and 6 that extracts of SF decrease ATP 
levels, reduce GSH levels and inhibit caspase-3/-7 activation in a concentration and time 
dependent manner in treated H9 cells. Inhibition of caspase-3/-7 was also observed in 
treated isolated normal T cells. 
Chromatin condensation and DNA fragmentation in apoptosis are known to be dependent 
on activated effector caspases (caspase-3 and -7). These caspases, when activated, are 
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7.5 Conclusion 
Treatment of cancerous H9 T cells with SFE and SFW extracts over 48 hours induced 
chromatin condensation and fragmentation of the nuclei. Normal T cells treated in a similar 
approach were seen to have normal nuclei while some cells had condensed chromatin but 
there was no fragmentation or blebbing of the nuclei. These results show that SF can 
induce apoptosis in malignant cell lines and also have similar effects on normal cells. The 
condensed chromatins of normal T cells may be another indication that higher 
concentrations of SF can be harmful to normal tissues. 
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CHAPTER 8 
THE EFFECTS OF SUTHERLANDIA FRUTESCENS ON CYTOKINE 
SIGNALLING IN NORMAL PERIPHERAL BLOOD 
MONONUCLEAR CELLS 
8.1 Introduction 
Cytokine and chemokines are secreted proteins with growth, differentiation, and activation 
functions that regulate and determine the nature of the immune responses. They also 
control immune cell trafficking and the cellular arrangement of immune organs. Cytokines 
produced in response to an immune insult determine initially whether an immune response 
develops and subsequently whether that response is cytotoxic, humoral, cell-mediated, or 
allergic. Depending on underlining conditions, cytokines can be grouped according to 
those that are predominantly mononuclear phagocytic-derived or T-lymphocyte derived; 
mediate cytotoxic (anti-viral and anti-cancer), humoral, cell-mediated, or allergic 
immunity; and those that are immunosuppressive (Borish and Steinke, 2003). 
A cascade of responses can be seen after secretion of cytokines and often several cytokines 
are required to synergise their expression in order to produce optimal function. Cytokines 
and chemokines can promote angiogenesis, metastasis, subversion of adaptive immunity 
and changing the response to hormones and drug treatment. Another factor in analysing 
cytokine function is that each cytokine may have a completely different function, 
depending on the cellular source, target and most importantly, specific phase of the 
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immune response during which it is presented (Borish and Steinke, 2003; Germano et al., 
2008). 
The measurement of soluble cytokines in serum and plasma has become very important in 
the study and management of many diseases. Therefore it has become important to develop 
rapid, precise and cost-effective measurements of these cytokines in both clinical and 
research laboratories. Techniques such as cDNA microarrays enabled analysis of global 
gene expression but evaluation of DNA and RNA alone is limiting. Disparity between the 
relative expression levels of mRNA and their corresponding proteins have been shown. 
Protein-based analyses are more useful in the analysis of cytokines. Two dimensional 
SDS-PAGE in combination with mass spectrometry has been used in cytokine levels 
analyses but has mass limitations. Surfaced-enhanced laser desorption and ionisation 
coupled with mass spectroscopy have also been used (Elshal and McCoy Jr, 2006; Huang 
etai, 2001). 
Antibody-based protein array systems have been developed for a simple, flexible, cost 
effective, highly sensitive, and high-throughput approach. Protein array technology has 
been further developed to examine protein-protein interactions (Huang et al., 2001). 
Enzyme linked immunosorbent assays (ELISAs) have long been the standard for 
quantitative analysis of cytokines. Although they are not suited for high throughput 
multiplex analyses, ELISAs have other advantages. ELISAs, in general, use immobilised 
antibodies to capture a soluble ligand, with subsequent detection of the captured ligand by 
a 2nd reporter antibody. They use enzyme amplification of a colorimetric substrate on flat 
surfaces in 96-well plates. ELISA methodologies generally study one analyte at a time, and 
thus avoid cross-reactivities (Elshal and McCoy Jr, 2006; Tarn et al, 2002). 
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8.2 Multi-Analyte Profiler ELISArray Kit for Human Inflammatory 
Cytokines 
The human inflammatory cytokines and chemokines multi-analyte ELISArray kit analyses 
a panel of 12 pro-inflammatory cytokines using a conventional ELISA protocol under 
uniform conditions. The cytokines and chemokines represented by this array are IL la, IL 
IP, IL 2, IL 4, IL 6, IL 8, IL 10, IL 12, IL 17a, IFN-y, TNF-a, and GM-CSF (IL-
interleukin; IFN- interferon; TNF- tumour necrosis factor; GM-CSF- granulocyte 
monocyte- colony stimulating factor). The pro-inflammatory cytokines (IL 1, IL 6, and 
TNF-a) are also endogenous pyrogens. IL 4 and IL 10 can also act as anti-inflammatory 
cytokines depending on their concentration (SABiosciences manual, 2008). 
The complete kit features the best possible combination of capture and detection antibodies 
for each protein in the panel and all the needed colorimetric detection reagents. Using the 
same ELISA protocol and development or incubation times, it allows for easy of profile for 
the levels of a focused panel of 12 proteins related to inflammation with this array 
(SABiosciences manual, 2008). 
In the study reported in this Chapter the effects of SF extracts on cell signalling were 
analysed by a cytokine ELISA method. PBMCs were utilised because they are 
characterised by the presence of all the cells of the immune system. They also represent an 
environment closer to the in vivo system than the use of a single cell line which may only 
produce a limited range of cytokines. 
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8.3 Materials and Methods 
8.3.1 Materials 
The Multi-Analyte Profiler ELISArray™ Kit was purchased from SABiosciences (USA). 
8.3.2 Methods 
8.3.2.1 Treatment of isolated peripheral blood mononuclear cells (PBMCs) 
Peripheral blood mononuclear cells (PBMCs) (whole blood from a healthy individual) 
were isolated according to a method outlined in paragraph 3.2.3.1 of chapter three. The 
PBMCs were then treated with various dilutions of SF ethanol and deionised water extracts 
in RPMI-640 media over a 24 hours incubation period. Untreated control cells, CPT (20 
/xM) and PHA (10 /xg/ml) treated PBMCs were included in the experiment as controls. 
At the end of the incubation period, the cytotoxicity of SF extract dilution and control 
samples were assessed by the ATP assay as outlined in paragraph 4.4.2.6 of chapter 4. 2 ml 
of each treatment was then dispensed into sterilin tubes and centrifuged at 1000 g for 10 
minutes to pellet the cells. The supematants were stored at -20 °C and later used for the 
cytokine analysis and the pelleted cells were stored in storage media (80% RPMI-1640, 
10% FCS and 10% DMSO) at 70°C for future use. 
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8.3.2.2 Multi-Analyte Profiler ELISArray assay 
The ELISArray kit uses a standard ELISA technique and for our purposes two kits were 
purchased to accommodate the number of samples in our experiments. Each kit included 
96-well plate coated with antibodies for the various cytokines included in the microarray. 
Each row of the plate from 1 to 12 represented a single cytokines in the following order: 
IL la, IL IB, IL 2, IL 4, IL 6, IL 8, IL 10, IL 12, IL 17a, IFN-y, TNF-a, and GM-CSF. The 
kit had a negative controls and positive controls to show that assay worked. The negative 
and positive control for each cytokine to be analysed was done in single wells and 
experimental samples and controls were assayed in duplicates for statistical purposes 
(Figures 8.1 and 8.2). 
Figure 8.1: Diagram illustrating the setup of the control samples in the antibodies 
coated wells of the 96-weII plate. 
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Figure 8.2: Diagram illustrating the setup of the Sutherlandia frutescens extract 
dilutions treated samples in the antibodies coated wells of the 96-well plate. 
Incubation of the samples in the 96-well plates allowed the capture antibodies to bind their 
specific protein of interest. After washing away unbound protein, biotinylated detection 
antibodies were added to the wells to also bind the captured analyte. After washing again 
to remove unbound material, an avidin-horseradish peroxidise conjugate was added. The 
wells were again washed and the colorimetric substrate solution was added, which 
produced a blue colour in direct proportion to the amount of protein analyte present in the 
initial sample. The colour development was stopped by adding the stop solution, and the 
absorbance at 450 ran with reference at 570 nm was read in a Bio-Tek plate reader and 
compared across all samples (Figure 8.3). 
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1. Prepare all reagents. 
Set up experimental samples. Antigen Standards, and negative control. 
2. Add 50 pi assay buffer into each well of ELISArray plate. 
Transfer 50 pi of samples into the appropriate wells of the ELISArray plate. 
Incubate 2 h. 
3. Wash three times. 
4. Add 100 pi Detection Antibody Solution. Incubate 1 h. 
5. Wash three times, 
6. Add 100 pi Avidin - HRP. Incubate 30 min. 
7. Wash four times. 
8. Add 100 pi Development Solution. Incubate 15 min in the dark. 
9. Add 100 pi Stop Solution. Read OD 450 within 30 min. 
Fig 8.3: A flow diagram of the Multi-Analyte Profiler ELISArray assay procedure 
(SABiosciences manual, 2008). 
8.3.2.3 Statistical analysis 
The absorbance obtained for each sample represented the amount of cytokine present in the 
sample. All the absorbance readings were subtracted from the negative control. Therefore a 
comparison of the average absorbance of each sample to the next sample gives the 
differences in cytokine levels (e.g. IL la levels in the untreated control and 1/50 SFE 
samples) between samples. Data analyses were done on Microsoft Excel to obtain the 
averages and the standard deviations of each treatment. The different levels of 
significances within the separate treated groups were analysed using one-way analysis of 
variance (ANOVA) and the differences between the treated cells and the control cells were 
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analysed using the Tukey-Kramer multiple comparison methods. Differences with/K 0.05 
were considered statistically significant. 
8.4 Results and Discussion 
8.4.1 Interleukins la, ip, 2, and 4 
Incubation of PBMCs with extracts of SF produced different changes in the levels of IL 
la, IL IB, IL 2, and IL 4. Although these cytokines were present in low concentrations in 
supernatants of treated cells, the changes between the treated samples and the different 
controls were significant (Figure 8.4). IL la levels decreased significantly in CPT treated 
supernatants (p< 0.001) and were unchanged in PHA treated samples (p> 0.05). IL la 
levels were unchanged in SFE extract dilutions treated samples while it was significantly 
increased in the 1/50 SFW extract dilution (p< 0.001) as compared to the untreated control. 
The SFW extract dilutions generally increased IL la levels relative to the SFE extract 
dilutions which either decreased or maintained levels to that of the untreated control. A 
similar trend to that of IL la was seen with IL ip concentrations but this cytokine was 
found in higher concentrations relative to the others in this group (Figure 8.4). 
The IL 1 family of cytokines represents four peptides and IL la and 1(3 have similar 
biological activities and interact with similar affinities to the two IL 1 receptors. IL 1 is 
primarily produced by cells of the mononuclear phagocytic lineage but is also produced by 
oestoblasts, neutrophils, glial cells, and numerous other cells. One of the most important 
biological activities of IL 1 is its ability to activate T lymphocytes by enhancing the 
production of IL 2 and expression of IL 2 receptors. IL 1 augments B cell proliferation and 
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increases immunoglobulin synthesis (Borish and Steinke, 2003). Therefore higher 
concentrations of SF extracts, which tend to reduce expression of IL 1 cytokines, can 
suppress the immune response. This is in contrast to lower SF concentrations which 
enhanced the IL 1 cytokine levels and therefore can stimulate the immune response. 
Concentrations of IL 2 in all control samples and SF extract treated samples did not show 
any significant changes (p> 0.05) (Figure 8.4). IL 2, which is produced mainly by T helper 
cells, is a central regulator of T cell function. IL 2 induces proliferation and activation of 
both CD4+ and CD8+ T cell, potentiates the cytotoxicity of CD8+ T lymphocytes and NK 
cells and stimulates B cell function (Alfano and Poli, 2005). As stated above, increased 
production of pro-inflammatory IL 2 is dependent on the actions of another pro-
inflammatory cytokine, IL 1. Sutherlandia frutescens extract dilutions increased IL 1 levels 
while maintaining IL 2 to those of normal untreated cells. This might be a means to limit 
the pro-inflammatory actions of both cytokines. 
Interleukin 4 concentrations were unchanged in SF extract treated samples when compared 
with the untreated control samples. The SFE extracts decrease IL 4 levels while this 
cytokine was either maintained (1/200) or increased (1/50) in the SFW extracts but all 
these changes were not statistically significant (p> 0.05). Phytohaemaglutin significantly 
increased (p< 0.001) IL 4 levels compared to all the various samples and controls (Figure 
8.4). Interleukin 4 is an anti-inflammatory cytokine that down-regulates both the innate and 
the adaptive immune responses. It is mainly produced by T cells, NK cells and mast cells 
and targets other T cells, eosinophils and endothelial cells for its regulatory actions (Alfano 
and Poli, 2005). 
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The effects of the SF extracts on this group of cytokines (IL la, IL ip, IL 2, and IL 4) can 
be useful in predicting the effects of this medicinal plant in diseases such as cancer and 
HIV/AIDS. The increased production of pro-inflammatory IL 1 can be useful in 
stimulating the immune response against cancer cells while the up-regulatory effect of this 
cytokine on IL 2 can be useful in HIV infection. Interleukin 2 production has been shown 
to be deficient in HIV infected individuals as well as after in vitro infection of PBMCs. 
Due to the short half-life IL 2, changes in the levels of this cytokine are not easy to assay 
directly (Alfano and Poli, 2005). 
The reduction or maintenance to normal levels of IL 1P by the SFE extract dilutions and 
increased secretion caused by SFW extract dilutions contradict the results obtained by Tai 
et al., (2004). They found that there was no significant change or inhibition of IL ip 
mRNA expression in RAW 264.7 macrophage cells treated with dilutions of an ethanol 
extract of SF. This pro-inflammatory cytokine, along with TNF-a, has been implicated in 
the cachexia seen in patients with HIV/AIDS. Agents that can reduce their production are 
thought be clinically useful. This study has also demonstrated that high concentrations of 
SF extracted by 70% ethanol can reduce the levels of IL 1P and therefore can alleviate the 
wasting diseases seen in cancer and HIV/AIDS patients. Lower concentrations may need to 
be taken chronically to have a similar effect. 
Maintenance of IL 4 levels at those of normal untreated cells allows the process of immune 
stimulation to remain unimpeded. By not decreasing an anti-inflammatory cytokines like 
IL 4, our data supports the traditional use and scientific data showing that SF is a useful 
anti-inflammatory herbal plant (Fernandes et al., 2004 and Kundu et al., 2005). 
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Figure 8.4: Graphical illustration of changes in concentrations of IL 1A, IL IB, IL 2 
and IL 4 in controls and Sutheriandia frutescens extract dilutions treated samples. 
8.4.2 Interleukins 6,8,10, and 12 
The presence of IL -6 and -8 was relatively high in all the analysed supematants when 
compared to the other cytokines. Interleukin 6 concentrations in supematants of SF extract 
treated PBMCs were significantly decreased when compared to the untreated cells, with 
the SFE extract dilutions being more effective (p< 0.001) than SFW extract dilutions (p< 
0.01) (Figure 8.5). Interleukin 6 expression was virtually eliminated in CPT treated 
supematants (p< 0.001) while this cytokine was maintained at similar levels in PHA 
treated supematants to that of the untreated control (p> 0.05). Interleukin 8 concentrations 
were significantly increased in SF extract dilutions treated samples (p< 0.001) when 
compared to the control samples. Phytohaemaglutin maintained IL 8 levels to that of the 
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untreated control while this cytokine was significantly decreased (p< 0.001) in CPT treated 
supernatants (Figure 8.5). 
The ability of SF extracts to significantly decrease the levels of IL 6 is very important in 
the use of this herbal medicine in the treatment of various forms of cancer. Interleukin 6 is 
a key growth-promoting and anti-apoptotic inflammatory cytokine and is one of the 
effector signals of activated NF-KJB in the promotion of neoplasia (Germano et al., 2008). 
Depending on the type of cancer model, IL 6 activates different major pathways of cell 
proliferation, inducing tumour growth, metastasis, and resistance to chemotherapy 
(Salazar-Onfray et al., 2007). Decreased levels of IL 6 might also be useful in HIV 
infections as this would reduce the ability of infected T lymphocytes to resist induction of 
apoptosis. 
Interleukin 8 (CXCL8) is the most important chemo-attractant of polymorph nuclear cells 
and is derived mostly from mononuclear phagocytes, endothelial, and epithelial cell but 
also from T cells, eosinophils, neutrophils, and fibroblasts. Interleukin 8 is one of the most 
important chemo-attractants of neutrophils and its synthesis is enhanced by IL 1 (Borish 
and Steinke, 2003). The ability of SF to up-regulate both IL 1 and IL 8 while the pro-
inflammatory IL 2 is left stable may be important in maintaining a balance between 
immune stimulation and resisting excessive inflammation which might damage normal 
tissues. 
Sutherlandia frutescens ethanol extract dilutions significantly reduced (p< 0.001) and SFW 
extracts slightly (p< 0.01) decreased IL 10 concentrations when compared to the untreated 
control. PHA significantly increased (p< 0.001) while CPT significantly decreased (p< 
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0.001) the levels of IL 10. Concentrations of IL 12 did not change in either control samples 
or SF extract dilutions treated samples (p> 0.05) (Figure 8.5). 
Interleukin 10 is a cytokine mostly secreted by dendritic cells (DC), Th2 cells, B cells, 
monocytes, and macrophages. This cytokine inhibits the production of all pro-
inflammatory cytokines and chemokines and the expression of DC-co-stimulatory 
molecules, therefore shutting-off T-cell activation. Interleukin 10 levels have been found 
elevated in lymph nodes of HIV-infected individuals (Alfano and Poli, 2005). Therefore 
the ability of SF extracts to suppress the secretion of this cytokine, as shown in the results 
obtained in this study, might be useful in allowing activation of T-cells and reduction of 
HIV replication. Interleukin 10 has also been shown to down-regulate VEGF synthesis and 
inhibit angiogenic cytokine production (Minozzo et ai, 2007). Such effects can be useful 
in the treatment of cancer and inhibition of the production of IL 10 by SF extracts might 
limit the anticancer abilities of this herbal plant. 
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Tumour necrosis factor-a is produced by neutrophils, activated lymphocytes, monocytes, 
macrophages, NK, DC, and mast cells. Tumour necrosis factor-a interacts with endothelial 
cells to induce adhesion molecules known as intracellular adhesion molecule (ICAM)-l, 
vascular adhesion molecule (VCAM)-l, and E-selectin, thus permitting accumulation of 
granulocytes into inflammatory sites. Its pro-inflammatory actions allow for tumour 
regression by host immune reaction and inhibition of tumour angiogenesis (Minuzzo et al., 
2007). These important actions are tempered by severe side effects of this cytokine. 
Tumour necrosis factor is responsible for the severe cachexia (more so than IL 1P) seen in 
chronic infections such as cancer and HIV/AIDS. Other side effects include induction of 
vascular leakage, negative inotropic effects, and it is the primary endogenous mediator of 
toxic shock and sepsis (Borish and Steinke, 2003). 
Tai et al., (2004) demonstrated that SF did not significantly inhibit the expression of 
liposaccharide (LPS) induced TNF-a mRNA expression in RAW 264.7 cells. Our results 
are in contrast to Tai et al., (2004), as we have demonstrated that higher concentrations of 
both SFE and SFW extracts significantly reduced the levels of TNF-a in SF treated 
PBMCs. Even the lower concentrations reduced this cytokine but this was not statistically 
significant. These preliminary results provide evidence for the anti-wasting abilities of SF 
as noted by traditional healers and community workers. D-pinitol, one of active ingredients 
found in SF, has been suggested as a contributor of the positive effects against wasting. 
Levels of IL 17A did not show any significant change in either the controls or SF treated 
samples. The levels of IFN-y in SF and CPT treated samples were also unchanged while 
PHA induced a significant increase (p< 0.001) in the concentration of this cytokine (Figure 
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8.6). The lower dilutions of the SF extracts reduced GM-CSF levels, but not significantly 
ip> 0.05) while the higher dilutions increased this cytokine (not significant p> 0.05). 






























LM uit 0.2 0 
-0.2 J 0 control 20 uM 10ug/ml 1/50 1/200 1/50 1/200 
CPT PHA SFE SFE SFW SFW 
Sutherlandia frutescens dilutions 
Figure 8.6: Graphical illustration of changes in the concentrations of IL 17A, IFN-y, 
TNF-o, and GM-CSF in controls and Sutherlandia frutescens extract dilutions treated 
samples. 
8.4.4 Contribution of changes in cell viability in the production of the cytokines 
analysed 
As mentioned in the paragraph 8.3.2.1 above, before the supernatants of treated PBMCs 
were analysed for cytokines analyses, an ATP assay was performed to determine the 
cytotoxicity of SF extracts on these treated cells. Peripheral blood mononuclear cells 
treated with the negative control (20 uM CPT) had significantly reduced ATP levels (51%) 
when compared to the untreated control cells (p< 0.001). PHA (10 ug/ml) significantly 
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increased ATP levels (161%) over the 24 hours incubation period (p< 0.001). The 70% 
ethanol control was not included in the cytokines analyses setup because it was shown to 
have not changed ATP levels (97%) when compared to the untreated PBMCs (p> 0.05) 
(Figure 8.7). 70% ethanol was also shown to have not played a statistically significant role 
in the effects of SFE extracts on ATP levels in treated PBMCs (appendix 5). 
The lower dilutions of SF extracts (1/50 SFE and 1/50 SFW) significantly (p< 0.001) 
reduced ATP levels (25% and 60%, respectively) when compared to the untreated control. 
The 1/50 SFE extract dilution was more potent in reducing ATP levels than CPT (p< 
0.001). The dilutions (1/200 SFE and 1/200 SFW) did not change ATP levels to a 
significant when compared to the untreated control (Figure 8.7). These results further 
confirmed the cytotoxicity of higher concentrations of SF on cultured normal white blood 
cells in vitro (appendix 5). 
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Figure 8.7: Graphical Olustration of changes in PBMCs ATP concentrations after 
treatment with various dilutions of Sutherlandia frutescens extract dilutions over 24 
hours incubation period. 
The changes in ATP levels in the treated and control samples related to the effects of SF 
extract dilutions in cytokine concentrations in different ways. In the negative (CPT) and 
positive (PHA) controls, the changes in the cytokines were directly related to the number 
of viable cells (equivalent to % ATP levels) in each sample. In the CPT-treated PBMCs, all 
the cytokines decreased significantly as the viability of the cells decreased. PHA 
stimulated the immune cells to proliferate and this was reflected by the concomitant 
increase in most of the cytokines when compared to the untreated control cells. 
The level of cytokines in supernatants of SF extracts-treated PBMCs related differently to 
cell viability as represented by ATP concentrations. Some of the cytokines were up-
regulated (increased production) above or maintained to the levels of the untreated controls 
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while ATP levels were shown to be depleted by dilutions of the SF extracts (Figure 8.7). 
These observations give an impression that the cytotoxicity (changes in ATP 
concentrations) of the SF extracts was not related to the amount of cytokines secreted by 
the treated PBMCs. A possible exception to this would be the cells treated with the 1/50 
SFE extract dilution, which produced the levels of cytokines generally consistent viable 
cell. 
8.5 Conclusion 
Peripheral blood mononuclear cells were shown to secrete high concentrations of pro-
inflammatory cytokines than their anti-anti-inflammatory counterparts. It was the effect of 
SF extracts on these pro-inflammatory cytokines, as shown in the preliminary screening, 
which therefore can determine the outcome in disease conditions. The ELISA method used 
in this study has shown that high concentrations of SF extract dilutions can reduce the 
production of IL 1 p and TNF-a and this effect is regarded as being helpful in fighting 
muscle wasting in cancer and HIV/AIDS patients. The changes cytokine levels which 
occurred as a result of SF extracts-treatment were largely not related to changes in ATP 
content (and therefore cell viability) but the cytokines themselves might be one of the 
effectors of these changes in viability. Changes in the other cytokines, as effected by SF 




The past decade has seen a renewed interest in traditional medicine by scientists in search 
of new pharmaceuticals. This has resulted in a tremendous increase in publications 
concerning traditional medicinal plants and in particular ethnopharmacology (Editorial 
(Journal of Ethnopharmacology), 2008). Sutherlandia frutescens has a long history of 
medicinal use in southern Africa. It has been used for a wide variety of ailments including 
diabetes, stress, fever, internal cancer and more recently, HIV/AIDS (van Wyk and 
Albrecht, 2008; van Wyk, 2008; Ojewole, 2008). The aims of this research thesis were to 
investigate the anticancer abilities of SF using a T lymphocytes cell line, H9, and to 
ascertain whether this traditional medicinal plant can stimulate normal human T cells to 
proliferate. 
Using the MTT and ATP cytotoxicity assays, the effects of SFE and SFW extract dilutions 
in H9 and normal T lymphocytes were studied over 24 and 48 hours incubation. The SFE 
extracts were shown to be more potent in inducing cytotoxicity in H9 T cells with a 
calculated IC50 of 1/40 after 24 hours. Similar dilutions of the SFW extracts did not 
inducing significant cytotoxicity over 24 hours but were more effective after 48 hours 
incubation. Using the more sensitive ATP assay on treated H9 T cells, it showed similar 
trends to that of the MTT assay but with varying cytotoxicity levels. In the treated isolated 
normal T cells after 24 hours, the SFE extract dilutions induced an ethanol dependent cell 
proliferation while SFW extract did not significantly change cell viability. After 48 hours, 
SFE extracts-induced proliferation was reversed while the SFW extracts a very significant 
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increase in cell viability over the similar period. Reversal of proliferation by SFE extract 
dilutions was indicative of a possible cytotoxicity of high concentrations of the SF plant on 
normal cells in vitro. 
The mode of cell death induced by SF extract dilutions in treated cell lines was assessed 
using a luminometer based caspase-3/-7 activity assay. Dilutions of both SFE and SFW 
extracts were shown to inhibit caspase-3/-7 activity in both H9 and normal T cells in a 
concentration and time-dependent manner, with higher concentrations more effective in 
this action. Lower concentrations of the extracts increased activity of caspases-3/-7 activity 
above the levels of untreated cells, raising the possibility of induction of apoptosis by these 
concentrations. Inhibition of caspase-3/-7 activity by higher concentrations of SF extracts 
did not impact on induction of cytotoxicity as shown by the MTT and ATP assays. 
Therefore it is possible to conclude that higher concentrations of SF extracts induce more 
necrosis than apoptosis. 
The ability of SF extract dilutions to scavenge for lipid peroxides in supematants of treated 
cell lines was also investigated. Both SFE and SFW extract dilutions were shown to 
significantly reduce lipid peroxides in the extracellular environment of treated cells when 
compared to all the controls used. This was regardless of the concentration of SF extracts 
used to treat the cells or the type of cell line (normal T cells or H9 T cells). With regards to 
the effects of SF extracts on the intracellular GSH content, SF extracts decreased GSH 
levels in H9 cancerous cells while increasing the GSH levels in normal T cells depending 
on the type and concentration of the extracts. High concentrations of the SFE extracts 
negatively affected the GSH content in normal T cells independent of ethanol and this 
again showed that high concentrations of SF can seriously suppress T cell proliferation. 
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Lower concentrations of the SFW extracts significantly increased GSH levels in normal T 
cells over 48 hrs. 
Treatment of cancerous H9 T cells with SFE and SFW extract dilutions over 48 hours 
induced chromatin condensation and fragmentation of the nuclei. Normal T cells treated in 
a similar approach were seen to have normal nuclei while some cells had condensed 
chromatin but there was no fragmentation or blebbing of the nuclei. These results show 
that SF can induce apoptosis in malignant cell lines and also have similar effects on normal 
cells. The condensed chromatins of normal T cells may be another indication that higher 
concentrations of SF can be harmful to normal tissues. 
In the cytokines analyses of supernatants from treated PBMCs, high concentrations of SF 
extracts were shown to reduce the production of IL IB and TNF-a, and that this effect can 
be helpful in fighting wasting in cancer and HIV/AIDS patients. The cytokine changes 
which occurred as a result of SF extracts-treatment were largely not related to changes in 
cell viability but the cytokines themselves might be one of the effectors of these changes in 
viability. Changes in the other cytokines as affected by these extracts can also be helpful 
fighting many other diseases. 
This study has therefore shown for the first time that while high concentrations of SF 
extracts were more effective in inducing cytotoxicity to cancerous H9 T cells, they can be 
harmful to in vitro normal T cells by reducing cell viability, GSH levels and inducing 
chromatin condensation. Similar harmful effects on cell viability were also shown in 
treated PBMCs. Lower concentrations of the SF extracts were shown to increase cell 
viability, GSH content and being effective scavenging for lipid peroxides in normal T 
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cells. These results suggest that SF may be useful in cancer patients if taken in low doses. 
Induction of cytotoxicity in cancer cells and immune stimulation and tolerance by these 
doses can improve the diseases outcome. Further studies should be undertaken on the 
immune stimulating abilities of this medicinal plant both in vitro and in vivo. 
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APPENDICES 
Appendix 1: Reagents for cell culture 
1.1 Preparation of complete culture media (CCM) 
RPMI-1640 was supplemented with heat inactivated 10% foetal calf serum (FCS), 1% L-
glutamine and 1% Pen-Strep-Fungizone (PSF). 
1.2 Preparation of cry ©preservation media 
H9 and normal T lymphocytes were cryopreserved in 80% RPMI-1640 supplemented with 
10% FCS and 10% DMSO. 
1.3 Preparation of 0.4% trypan blue stain 
Trypan blue stain was prepared by dissolving 0.4g of trypan blue dye in 0.85% sodium 
chloride (NAC1) and this solution was stored at room temperature. 
1.4 Preparation of buffer for labeling and enrichment of T lymphocytes (BD IMag™ 
Buffer) 
Phosphate buffered saline (PBS) was supplemented with 0.5% BSA, 2 mM EDTA, and 
O.P/o sodium azide. 
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Appendix 2: Preparation of Sutherlandia frutescens extracts dilutions 
SF 70% ethanol and deionised water extracts were diluted into working concentrations in 

















Appendix 3: Reagents for TBARS assay 
3.1 20 mM butylatedhydroxytoluene (BHT) in ethanol 
0.1102g of BHT was dissolved in 25 ml ethanol and stored at room temperature. 
3.2 50 mM sodium hydroxide (NaOH) 
50mg of NaOH was dissolved in 2 ml deionised water and stored at room temperature. 
3.3 TBA/BHT solution 
125jttl of 20 mM BHT was added in 25 ml deionised water. 0.25 g of TBA was then 
dissolved in 25 ml of deionised water. To make the TBA/BHT solution, 0.5g of TBA and 
125/xl of 20mM BHT were added into 25 ml of the 50mM NaOH and stored at room 
temperature. 
3.4 3 mM HC1 in H20 
An initial concentration of 32 % HC1 stock was diluted to a 1M solution using molarity. 
The 1 M HC1 was then diluted to a 3 mM working solution and stored at room temperature. 
3.5 0.1%H3PO4 
85%o H3PO4 stock was diluted to 0.1% working solution in deionised water and stored at 
room temperature. 
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3.6 2% H3P04 
85%> H3PO4 stock was diluted to the 2% working solution in deionised water and stored at 
room temperature. 
3.7 7% H3PO4 
85% H3PO4 stock was again diluted to the 7% working solution in deionised water and 
stored at room temperature. 
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Appendix 4: Reagents for Hoechst 33342 staining 
4.1 Hoechst 33342 
Hoechst stain stock solution was prepared by dissolving 4 mg of bisbenzimide in 2 ml of 
DMSO. A working solution was then prepared by adding 1.4 ml of the stock solution into 
l m l of PBS. 
4.2 Paraformaldehyde (10%) 
1 gram of paraformaldehyde was dissolved in PBS (10 ml) and heated for 30-40 minutes in 
60 °C water bath. The pH was then adjusted to 7.2 with 1 M HC1. 
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Appendix 5: Raw data from plots used in the main script 
















































































































































































































































































5.2 Luminometer readings-ATP assay on normal T cells 
ATP levels in normal 




















































ATP levels in normal 









































































































































































































































































































































































































































































































































































































































































































































































































































































































% ATP change vs. 
control 
100 
97.26396 
50.61957 
161.0597 
25.26778 
90.4401 
59.71551 
99.13699 
STD 
DEV 
395.2727 
2108.592 
1985.556 
2040.003 
371.9382 
70.71068 
599.6266 
331.6331 
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